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INTRODUCTION
Human monitoring as a supplement to or replacement for environ-
mental (ambient) monitoring of toxic substances in the workplace has
recently become a major issue and has led to increased activity and
discussion among those concerned with occupational health and safety.
Congressional hearings' and an Office of Technology Assessment (OTA)
study2 have addressed problems associated with the genetic screening
of workers. The Occupational Safety and Health Administration's
(OSHA's) recently promulgated standard for occupational exposure to
lead focuses on the biological monitoring of workers for lead uptake.3 A
conference in which the United States, the European Community and
other countries participated addressed the problems arising from a variety
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i. See generally Hearings on Genetic Screening of Workers Before the Subcomm.
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Cong., Ist & 2d Sess. (1981-82).
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of methods of monitoring and screening workers.4 The American Con-
ference of Governmental Industrial Hygienists (ACGIH) sponsored a
symposium in 1981 on the protection of sensitive workers.5 Finally, hu-
man monitoring was a topic of major concern at the last two annual
meetings of the American Industrial Hygiene Association, 6 and at a two-
day conference sponsored by the American Society of Law and Medicine
in Washington. 7
These discussions have revealed that the purposes of human moni-
toring are diverse and sometimes conflicting. One purpose is to reduce
occupational disease or injury to the working population as a whole by
providing indicators of average harm or risk of harm from exposure to
toxic substances. The monitoring need not involve all workers, only a
statistically informative sample, in order to ensure an adequate average
level of toxic material control. Another purpose is to protect especially
sensitive workers, s workers exposed to a toxic material by means other
than inhalation, and workers for whom non-occupational sources may
add to occupational exposure. An employer may institute human moni-
toring to remove workers from potentially harmful exposures, avoiding
liability for increased worker compensation premiums and tort or prod-
ucts liability suits. Employers may also use human monitoring results to
avoid increased worker demands for preventive technology or other
health and safety measures.
This article fills an important gap in the literature on human moni-
toring. Previous writers have focused their attention on the problems of
screening workers generally, rather than on the important distinctions
among the several kinds of monitoring. 9 This article discusses additional
scientific distinctions and their legal implications, for example, the dif-
ferences between monitoring hypersensitive workers and monitoring
4. Berlin, Yodaiken & Logan, International Seminar on the Assessment of Toxic
Agents at the Workplace: Roles of Ambient and Biological Monitoring, 50 INT'L ARCHIVES
OCCUPATIONAL & ENVTL. HEALTH 197 (1982) [hereinafter cited as Luxembourg Report].
5. ACGIH Symposium on Protection of the Sensitive Individual (Nov. 9-11, 1981)
(Tucson, Ariz.).
6. The American Industrial Hygiene Association conducted its 1982 annual meeting
in Cincinnati, Ohio, on June 6-11, 1982. The annual 1983 meeting was held in Philadelphia,
Pennsylvania, on May 22-27, 1983.
7. The American Society of Law and Medicine and the Boston University Schools
of Law, Medicine, and Public Health sponsored a conference in Washington, D.C., on
Biological Monitoring and Genetic Screening in the Industrial Workplace on May 12-13,
1983.
8. The Occupational Safety and Health Act (OSHAct) authorizes the Secretary of
Health and Human Services to require employers to address the problems of susceptible
employees, 29 U.S.C. § 669(a)(5) (1982), and aging adults, 29 U.S.C. § 669(a)(7) (1982).
For a description of sensitive populations in general under various environmental legisla-
tion, see R. FRIEDMAN, SENSITIVE POPULATIONS AND ENVIRONMENTAL STANDARDS
(1981).
9. Rothstein, Employee Selection Based on Susceptibility to Occupational Illness, 81
MICH. L. REV. 1379 (1983); McGarity & Schroeder, Risk-Oriented Employment Screening,
59 TEX. L. REV. 999 (1981).
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workers at high risk.'° It places a broad proscriptive emphasis on pro-
tecting workers by integrating the employee's self-initiated right to refuse
hazardous work with remedies available under the Occupational Safety
and Health Act (OSHAct), the Toxic Substances Control Act (TSCA),
and the National Labor Relations Act (NLRA) for the employer's misuse
of monitoring results.
This article discusses:
(1) the scientific basis, appropriateness, and usefulness of various
human monitoring activities;"
(2) the legal basis for OSHA monitoring requirements and for access
to monitoring records provided under the OSHAct, TSCA, and
NLRA;12
(3) the legal and ethical problems of conducting monitoring tests on
workers and possible misuse of the results;'3 and,
(4) policy recommendations for the proper use of human monitoring
in reducing occupational disease and injury.
I. DEFINITIONS
At the outset, some important concepts that will appear throughout
this discussion must be clarified. The general concept of monitoring
encompasses five practices: medical surveillance, genetic monitoring,
genetic screening, biological monitoring and environmental monitoring.
The scientific and legal literature commonly uses "medical surveillance"
and "biological monitoring" interchangeably, but the terms are not the
same. This article employs the following definitions of these five con-
cepts, consistent with regulations recently promulgated by OSHA.'4
A. Medical Surveillance
The first practice, medical surveillance," is designed in an occupa-
tional setting to detect adverse health effects (or health status) resulting
from hazardous exposures in the workplace. Medical surveillance testing
serves to obtain certain types of information, such as the identification
of workers who are suffering from an occupational injury or illness,
epidemiological data on occupational disease, and general or specific data
on categories or types of workers. These data are intended to aid in
screening workers by monitoring specific organ systems that may be
10. See infra notes 258-263 and accompanying text.
II. See infra text accompanying notes 78-257.
12. See infra text accompanying notes 38-75, 369-475.
13. See infra text accompanying notes 319-368, 476-550.
14. See, e.g., 29 C.F.R. § 1910.20(c) (1983).
15. The Luxembourg Report defines health surveillance as "the periodic medico-
physiological examinations of exposed workers with the objective of protecting health and
preventing occupationally related disease." Luxembourg Report, supra note 4, at 199. The
authors prefer to use the term "medical" rather than "health" surveillance because the
former more accurately describes the nature of the tests performed.
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affected by exposure to workplace hazards. An employer may institute
testing on its own initiative, in response to OSHA requirements, or at
the request of employees or their unions.
Medical surveillance tests are generally diagnostic tools used in rou-
tine medical practice. They include chest x-rays, pulmonary function
tests, routine blood analyses, serum liver function tests, serum kidney
function tests and routine urinalyses.
The Luxembourg Report states that in some circumstances medical
surveillance can prevent occupationally related disease.' 6 Especially if a
disease is reversible or arrestable, medical surveillance may be preven-
tive insofar as it serves as a warning signal prompting timely action to
avoid future exposures and continuing or progressive adverse health
effects.
Pursuant to statute, OSHA can require employee medical surveil-
lance. '7 The required medical surveillance provisions vary for the twenty-
three OSHA health standards promulgated since 1972 (see Table 1), but
generally they are routine diagnostic tests used in medical practice. 8 In
January 1981, OSHA and the National Institute for Occupational Safety
and Health (NIOSH) published the Occupational Health Guidelines for
Chemical Hazards.'9 This volume includes a variety of information on
approximately 450 substances for which OSHA adopted consensus stan-
dards under section 6(a) of the OSHAct.2 0 The information for each
substance usually includes chemical, toxicological and health hazard
data, as well as recommendations for industrial hygiene and medical
surveillance practices. 2 '
Medical surveillance is most useful in three situations: (1) if compli-
ance with the permissible exposure limits established by OSHA will not
adequately ensure worker health; (2) if air measurement cannot suffi-
ciently monitor worker exposure (e.g., if a significant route of entry is
not inhalation); and (3) if high risk groups are exposed.2 2 Medical removal
may also be appropriate in these three situations.23
16. Luxembourg Report, supra note 4, at 198.
17. See infra note 53 and accompanying text.
18. Although all OSHA health standards contain required medical surveillance pro-
visions, the recently proposed ethylene oxide standard includes no such requirements.
Rather, the agency has departed from giving specific medical guidance and opened up the
possibility of unchecked discretion in testing by stating that "[t]he examining physician is
free to prescribe the specific tests to be included in the medical surveillance program." 48
Fed. Reg. 17,315 (1983).
19. NAT'L INST. FOR OCCUPATIONAL SAFETY AND HEALTH, U.S. DEP'T OF HEALTH
AND HUMAN SERVICES, PUB. No. 81-123, NIOSH/OSHA OCCUPATIONAL HEALTH GUIDE-
LINES FOR CHEMICAL HAZARDS (1981) (F. Mackison, R. Stricoff & L. Partridge eds.)
[hereinafter cited as NIOSH/OSHA OCCUPATIONAL HEALTH GUIDELINES].
20. Occupational Safety and Health Act of 1970, 29 U.S.C. § 655(a) (1982).
21. See infra text accompanying notes 45-46.
22. D. Hattis, E. Rothenberg & N. Ashford, Some Considerations for the Design of
OSHA Policy on Medical Surveillance and Removal Provisions in Occupational Health
Standards 2 (Nov. 1979) (CPAIWP-79-9) (submitted to the U.S. Dep't of Labor by the
Center for Policy Alternatives at the Massachusetts Institute of Technology) [hereinafter
cited as CPA Medical Surveillance Report].
23. See infra note 64.
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Table 1: Chemical Substances for which OSHA Has Promulgated
Health Standards 1972-1980*
2-Acetylaminofluorene 3, 3'-Dichlorobenzidine (and its salts)
Acrylonitrile 4-Dimethylaminoazobenzene
4-Aminodiphenyl Etyleneimine
Arsenic (inorganic) Lead (inorganic)
Asbestos Methyl chloromethyl ether
Benzenea 4, 4'-Methylene bis (2-chloroaniline)b
Benzidine alpha-Naphthylamine
bis-Chloromethyl ether beta-Naphthylamine
Coke oven emissions 4-Nitrobiphenyl
Cotton dust N-Nitrosodimethylamine
Cotton dust (in cotton gins) beta-Propiolactone
Dibromochloropropane Vinyl chloride
a. Remanded to OSHA by the U.S. Supreme Court on July 2, 1980 for reconsideration
of the permissible exposure level.
b. Deleted by the Third Circuit Court of Appeals on procedural grounds on August 20,
1976.
One particular type of medical surveillance that has received much
attention is genetic monitoring. This type of monitoring includes the
periodic testing of employees working with or possibly exposed to certain
substances (such as known or suspected carcinogens) suspected to cause
changes in chromosomes. Blood or other body fluid samples are collected
for this monitoring. Generally, such monitoring is conducted in an attempt
to determine if environmental exposures of a specific population (e.g.,
workers in the same job category) to particular substances causes changes
in genetic material in statistically significant numbers above background
levels.2 4
B. Other Human Monitoring Practices
A third kind of human monitoring, genetic screening, is practiced on
an employee only once, usually as part of a pre-employment or pre-
placement exam.25 This screening determines whether an individual pos-
sesses certain inherited genetic traits that may predispose him or her to
an increased risk of disease if exposed to particular substances. Labo-
ratory tests on body fluids, commonly blood, usually identify these traits.
*Adapted from NIOSH/OSHA OCCUPATIONAL HEALTH GUIDELINES, supra note 19,
at 31.
24. Proponents of genetic monitoring believe that the number of environmentally
induced alterations in chromosomes (above background incidence) may cause a worker to
be predisposed to certain occupational illnesses, particularly cancer. See Holden, Looking
at Genes in the Workplace, 217 SCIENCE 336, 337 (1982); see also M. Legator, Genetic
Toxicology: Relevant Studies with Animals and Humans 23-25 (June 24, 1983) (advance
copy of paper delivered to the Royal Society of Medicine at the Anglo-American Conference
on Pregnant Women at Work, London).
25. See infra text accompanying notes 237 & 240.
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The fourth practice, biological monitoring, should be distinguished
from medical surveillance. The former is a collection of activities de-
signed to determine both whether a person has been exposed to and
whether his or her body fluids or organs contain a particular substance
or its metabolites.26 The latter, in contrast, is used to determine the effects
of exposure. 27 The Luxembourg Report defines biological monitoring as
"the measurement and assessment of workplace agents or their metabo-
lites either in tissues, secreta, excreta, expired air or any combination of
these to evaluate exposure and health risk compared to an appropriate
reference." 28 The analysis most commonly uses urine, breath and blood
specimens, but sometimes hair, nails, tears, breast milk or perspiration,
as well.
Some observers believe that the information obtained from biological
monitoring can be used in conjunction with environmental monitoring
results to determine whether ambient data predicts the true exposure of
workers and thereby evaluate environmental control methods.29 Others,
however, believe that ambient environmental measurements cannot ac-
curately be correlated with biological measurements because of individual
pharmacokinetic and metabolic variability. One researcher states that
"biological measurements reflect uptake and not exposure . . . there are
numerous instances in which significant uptake of toxic materials have
[sic] occurred in spite of low air-levels of the contaminant in question."0
26. Ideally, the best indicator of risk would be a direct measure of the chemical or
its metabolite at the target site, not the broad concept of "uptake." According to Professor
Lauwerys,
[a] direct measure [at the site of action] is not usually feasible because the sites of action are
frequently located in tissues not accessible for sampling (e.g., brain acetylcholinesterase activity).
The concentration of the pollutant or its metabolites in another body compartment (blood, urine)
or the amount bound to another molecule may be used for this purpose if one has demonstrated
that the latter parameter is in equilibrium with the amount at the site of action.
R. LAUWERYS, INDUSTRIAL CHEMICAL EXPOSURE: GUIDELINES FOR BIOLOGICAL MONI-
TORING 5 (1983).
27. For example, medical surveillance (e.g., chest x-ray) would be an appropriate
part of a pulmonary evaluation for a worker exposed to silica dust, as the x-ray would
most likely show any effects due to such exposure. An x-ray, however, would not yield
useful biological monitoring information in this situation, as it is impossible to assess the
worker's level of uptake of silica dust. This observation is based on the professional
experience of author Christine J. Spadafor as a registered nurse.
28. Luxembourg Report, supra note 4, at 199 (emphasis added).
29. H.J. Dunster, Monitoring as Part of Occupational Hygiene: The Regulatory Ap-
proach 4 (paper presented at the International Seminar on the Assessment of Toxic Agents
at the Workplace: Roles of Ambient and Biological Monitoring, Luxembourg (Dec. 8-12,
1980) hereinafter cited as Luxembourg Seminar]); Monroe, The Role of Biological Moni-
toring in Medical and Environmental Surveillance, in CHEMICAL HAZARDS IN THE WORK-
PLACE: MEASUREMENT AND CONTROL 5 (G. Choudhary ed. 1981) (American Chemical
Society Symposium Series No. 149).
30. Gompertz, Solvents--The Relationship Between Biological Monitoring Strategies
and Metabolic Handling: A Review, 23 ANNALS OCCUPATIONAL HYGIENE 405, 410 (1980)
(emphasis added) [hereinafter cited as Solvents].
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Biological monitoring should not generally substitute for environ-
mental monitoring. Rather, "environmental and biological monitoring are
ways of investigating different problems and should be seen as comple-
mentary and not mutually exclusive procedures."' The substitution of
biological monitoring in favor of environmental monitoring in order to
determine compliance and control consistent with the OSHA standards
is not appropriate for the following reasons:
First, it is not clear whether OSHA has the authority to require
workers to submit to biological monitoring procedures for deter-
mining compliance. Second, a biological standard may provide an
incentive for employers to intervene in altering specific parameters
in their workers.3 2 Third, biological standards may reinforce a
"blame the worker" attitude among employers with regard to spe-
cific employees, rather than focusing attention on the workplace.
In addition, in some cases, biological standards may involve
greater risk of health damage due to possible delays between dan-
gerous air exposure and the monitored biological response.3 3
One cannot, however, always define certain biochemical tests as
either medical surveillance or biological monitoring. Certain tests are not
only indicators of metabolic effects (medical surveillance), but also can
be quantitatively linked to exposure (i.e., if a biological marker, though
technically an effect, indicates exposure).3 4
The fifth practice, environmental monitoring, measures the concen-
tration of harmful agents in the workplace, while the other types of
monitoring involve tests performed on the workers. Environmental mon-
itoring includes both ambient monitoring and personal monitoring.3 5 The
Luxembourg Report defines "ambient monitoring" as "the measurement
and assessment of agents at the workplace and . . . [the evaluation of]
ambient exposure and health risk compared to an appropriate refer-
ence."36 Ambient (work area) monitoring is useful if the hazard is a
31. See Gompertz, Assessment of Risk by Biological Monitoring, 38 BRITISH J.
INDUS. MED. 198, 201 (1981) [hereinafter cited as Assessment of Risk].
32. An example is chelation therapy used in industrial settings to decrease worker
blood lead levels.
33. See CPA Medical Surveillance Report, supra note 22, at 9.
34. Examples of these tests, cited in the Luxembourg Report, include zinc protopor-
phyrin (ZPP) and delta aminolaevulinic acid dehydrase (ALA-D). Luxembourg Report,
supra note 4, at 199. Both are quantitatively related to lead exposure.
35. "Personal monitoring" is "a term designating the determination of the inhaled
dose of an airborne toxic material or of an air-mediated hazardous physical force by the
continuous collection of samples in the breathing or auditory zone, or other appropriate
exposed body area, over a finite period of exposure time." I A.L. LINCH, EVALUATION
OF AMBIENT AIR QUALITY BY PERSONNEL MONITORING at preface (2d ed. 1981). Personal
monitors placed in the breathing zone (e.g., on shirt collars) are considered to provide a
representative dose of inhaled air that transports any airborne hazardous agents. Id. The
participants at the Luxembourg Seminar agreed that personal breathing zone sampling
provides a better measure of an employee's daily exposure than area ambient sampling.
Luxembourg Report, supra note 4, at 199.
36. Id. at 199.
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specific one for which a permissible exposure limit is known (e.g., a
consensus guideline or legal standard). An advantage is that it does not
use the worker as a sampling device. This article does not treat environ-
mental monitoring in any detail, but mentions it only in reference to the
other four practices.
II. LEGAL AUTHORITY FOR HUMAN MONITORING
A. Agency Authority
The OSHAct grants both OSHA and NIOSH the authority to pro-
mulgate regulations that require employers to conduct human monitoring,
although it is not clear whether it authorizes either agency to force
employees to submit to such monitoring. The authority granted to NIOSH
is broader in scope than that vested in OSHA, but financial limitations
on NIOSH in exercising that authority3 7 give OSHA the greater practical
grant of authority.
1. OSHA
OSHA may order biological monitoring under each of three sections
of the OSHAct. Section 8(c)(1) provides general authority:
Each employer shall make, keep and preserve ... such records regarding
his activities relating to this Act as the Secretary, in cooperation with the
Secretary of Health, Education, and Welfare, may prescribe by regulation
as necessary or appropriate . . . for developing information regarding the
causes and prevention of occupational accidents and illnesses. In order to
carry out the provisions of this paragraph such regulations may include
provisions requiring employers to conduct periodic inspections.38
Section 8(c)(3) contains a more specific mandate. It provides that OSHA
"shall issue regulations requiring employers to maintain accurate records
of employee exposures .. which are required to be monitored or mea-
sured under Section 6."39
This section also requires employers to "promptly notify" employees
if they have been exposed to any hazard in violation of "an applic-
able occupational safety and health standard promulgated under sec-
tion 6." 4 ° The Senate deliberated over this provision while considering
the OSHAct. Senator Peter H. Dominick (R-Colo.), who led an unsuc-
cessful effort to pass a substitute Nixon Administration bill,4 ' proposed
37. See infra text accompanying note 75.
38. 29 U.S.C. § 657(c)(1) (1982) (emphasis added).
39. Id. § 657(c)(3) (emphasis added).
40. Id.
41. S. 4404, 91st Cong., 2d Sess. (1970).
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an amendment that would have eliminated the provision.4 2 In objecting
to the language of section 8(c)(3), Sen. Dominick noted that it "indirectly
requires excessive employer monitoring of his entire operation," and thus
requires the employer "to be his own policeman, judge and jury."4 3 The
language of this section is broad as enacted. The fact that Congress chose
to include it in the Act, rather than accepting the substitute bill deleting
this language,4 4 supports the proposition that the OSHAct requires em-
ployers to conduct biological or environmental monitoring or both for
any exposure regulated under section 6.
Section 6 itself, however, casts some doubt on this interpretation.
On the one hand, section 6(a) makes no mention of human monitoring,
but merely requires OSHA to adopt previously existing health standards.
Section 6(b), on the other hand, specifically discusses both biological
monitoring and medical surveillance. Section 6(b)(7) mandates that,
where "appropriate," a section 6(b) standard "shall provide for monitor-
ing or measuring employee exposure . . . in such manner as may be
necessary for the protection of employees." 4 5
This provision raises an interesting issue. Unquestionably, section
8(c)(3) applies both to section 6(a) standards and section 6(b) standards,
as both are occupational safety and health standards that require "em-
ployee exposures to be measured" within the meaning of section 8(c)(3).
If section 8(c) grants broad power to order biological monitoring, then
why does section 6(b) also grant such power? The solution may lie in
the "accuracy" limitation of section 8(c).
Section 8(c)(3) requires only that employers maintain "accurate"
records of employee exposures. For many exposures, accurate measure-
ments may be possible without biological monitoring, i.e., by using en-
vironmental monitoring. Arguably, section 8 would not require biological
monitoring in those situations. Under section 6(b), however, OSHA could
still order biological monitoring if it were "necessary for the protection
of the employees." This interpretation finds an implicit congressional
attempt to balance the need for reliable information against the cost and
inconvenience of a physically invasive monitoring procedure. Accord-
ingly, potentially invasive monitoring would be subject to the specificity
and increased scrutiny of the section 6(b) standard-setting procedure.
Biological monitoring results are included in an employee's exposure
record.4 6 The final OSHA rule states that this record must contain any
42. S. 2193, 91st Cong., 2d Sess. (1970), reprinted in SUBCOMM. ON LABOR OF THE
SENATE COMM. ON LABOR AND PUBLIC WELFARE, LEGISLATIVE HISTORY OF THE OCCU-
PATIONAL SAFETY AND HEALTH ACT OF 1970, 92d Cong., Ist Sess. 368-69 (1971) [herein-
after cited as LEGISLATIVE HISTORY].
43. Id.
44. For a comparison of the Administration's substitute bill on this point with the
Senate bill, and additional remarks by Senator Dominick, compare id. at 436-41 with 29
U.S.C. § 655(b)(7) (1982).
45. 29 U.S.C. § 655(b)(7) (emphasis added).
46. 45 Fed. Reg. 35,278 (1980).
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information concerning "biological monitoring results which directly as-
sess the absorption of a substance or agent by body systems (e.g., the
level of a chemical in the blood, urine, breath, hair, fingernails, etc.) but
not including results which assess the biological effects of a substance
or agent."47 Biological monitoring results are also considered part of an
employee's medical record under the same final rule. This OSHA defi-
nition of biological monitoring clearly distinguishes the results of these
tests from the results of medical surveillance tests and is consistent with
the definition in the Luxembourg Report.4 8
Currently, only the OSHA lead standard requires biological moni-
toring.49 Some consensus health standards adopted under section 6(a) of
the Act recommend biological monitoring for certain substances such as
carbon monoxide, fluoride (inorganic) and pesticides, including endrin
and parathion.5 0
Under the NIOSHIOSHA Occupational Health Guidelines men-
tioned earlier,5 ' OSHA has issued biological monitoring guidelines for
some consensus health standards adopted under section 6(a). These
guidelines "provide a basis for promulgation of new occupational health
regulations."52 As these guidelines are not regulations, they probably will
not be subject to judicial review.
Section 6(b)(7) specifies that, where appropriate, section 6(b) stan-
dards "shall prescribe the type and frequency of medical examinations
or other tests which shall be made available, by the employer or at his
cost, to employees exposed to [the regulated hazard] to most effectively
determine whether the health of such employees is adversely affected by
such exposure."5 3 Further, if such examinations are "in the nature of
research," NIOSH may provide the funding.54 These provisions give clear
authorization for OSHA to require medical surveillance to determine the
health effects of hazards regulated under section 6(b), even if such sur-
veillance is considered "research."
Results from medical surveillance tests become part of an employ-
ee's medical record.55 According to OSHA's most recent ruling, an em-
ployee medical record must contain any information concerning the
health status of the employee including "the results of medical exami-
nations (pre-employment, pre-assignment, periodic, or episodic) and lab-
oratory tests (including x-ray examinations ... ).56
47. Id.
48. Luxembourg Report, supra note 4, at 199.
49. 29 C.F.R. § 1910.1025 (1983).
50. 29 U.S.C. § 655(a). See NIOSH/OSHA OCCUPATIONAL HEALTH GUIDELINES,
supra note 19; see also text accompanying notes 167 & 192.
51. See supra note 19 and accompanying text.
52. NIOSH/OSHA OCCUPATIONAL HEALTH GUIDELINES, supra note 19, at I (em-
phasis added).
53. 29 U.S.C. § 655(b)(7) (emphasis added).
54. Id.
55. 45 Fed. Reg. at 35,278.
56. Id. See also infra text and figure accompanying note 235.
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Section 6(a) does not mention human monitoring. The NIOSHI
OSHA Occupational Health Guidelines, however, contains extensive
medical surveillance guidelines for approximately 450 substances.5 7 Be-
cause the guidelines provide a basis for new regulations and do not
constitute required practices, no one has yet decided the legality of adding
medical surveillance requirements to existing section 6(a) standards.
A special kind of medical surveillance involving genetic testing of
workers has caused some concern.58 Standards that OSHA promulgated
under section 6(b) and the proposed Cancer Policy for thirteen carcino-
gens require medical examinations to include a personal history of the
employee, his family or both, including "genetic and environmental fac-
tors."' 59 OSHA later issued a clarification, emphatically denying that the
standards require genetic testing 6o of any employee.6 '
57. It is important to note that these substances are accompanied by medical sur-
veillance guidelines and not regulations. Therefore, industry has no legal responsibility for
instituting the medical surveillance provisions suggested in the document, but may imple-
ment such medical guidelines voluntarily.
58. Severo, 59 Top U.S. Companies Plan Genetic Screening, N.Y. Times, June 23,
1982, at A12, col. 4 (morn. ed.).
59. See paragraph (g)(l)(i) of each section in 29 C.F.R. §§ 1910.1003-.1016 (1983).
See also infra note 61.
60. Genetic testing includes both genetic monitoring (cytogenetic and noncytogenetic,
see infra note 94) and genetic screening.
61. Office of Information, U.S. Dep't of Labor, News 80-107 (Feb. 20, 1980). In
February 1980, Dr. Eula Bingham, then the Assistant Secretary of Labor for OSHA, issued
a news release responding to an article in the New York Times reporting that there was "a
Government regulation mandating genetic screening in industry." Severo, Federal Mandate
for Gene Tests Disturbs U.S. Job Safety Official, N.Y. Times, Feb. 6, 1980, at Al, col. I
(last of a four article series entitled The Genetic Barrier: Job Benefit or Job Bias?). Dr.
Bingham corrected this statement, which implied that genetic testing was a mandatory
component of OSHA medical surveillance provisions, and commented that "there is ab-
solutely no OSHA standard that requires genetic testing of any employee." U.S. Dep't of
Labor, Office of Information, News 80-107 (Feb. 20, 1980). The OSHA Office of Compliance
Programming followed this announcement by issuing an interpretive directive to the OSHA
enforcement staff in August 1980. The interpretation applied to all OSHA standards that
required a medical exam (including a personal history of the employee or his family or
both, and occupational background, including genetic and environmental factors) as part
of the medical surveillance provisions. OSHA Office of Compliance Programming, U.S.
Dep't of Labor, OSHA Medical Surveillance Regulations - Genetic Testing (Aug. 22, 1980)
(OSHA Instruction STD 1-23.4) [hereinafter cited as OSHA Medical Surveillance Regula-
tions]. The standards affected by this interpretation included 29 C.F.R. § 1910.1003-.1016
(the 13 carcinogen standards), specifically paragraph (g)(1)(i) in each, and 29 C.F.R.
§ 1990.151 (the OSHA Cancer Policy - "model standard"). According to Dr. Bingham,
such a personal history is "a routine part of standard medical practice. To read into [this]
a 'mandate for genetic screening' is a gross distortion." N.Y. Times, Mar. 22, 1980, at 20,
col. 3 (letter to the editor submitted by Dr. Bingham, then Assistant Secretary for Occu-
pational Safety and Health). The directive specifically states that "these provisions do not
require genetic testing of any employee." OSHA Medical Surveillance Regulations, supra.
Consistent with the agency's policy on genetic monitoring, OSHA has not authorized
the use of genetic screening as part of any OSHA standard to date. There are hints,
however, that OSHA currently is reconsidering its position on genetic testing. On April 21,
1983, the agency published in the Federal Register a proposed rule for ethylene oxide.
"Screening for chromosome damage" is suggested in the proposal, but is not required. This
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The OSHAct contains several sections authorizing environmental
monitoring. Section 6(b)(7) states that "[a]ny standard promulgated under
this subsection . . . shall provide for monitoring or measuring employee
exposure at such locations and intervals, and in such manner as may be
necessary for the protection of employees." 62 Section 6(a), addressing
consensus standards, does not specifically require monitoring under sec-
tion 6(a) as well as under section 6(b). Rather, section 8(c)(3) requires
"employers to maintain accurate records of employee exposures to po-
tentially toxic materials or harmful physical agents which are required to
be monitored or measured under section [6]."63
The OSHAct of 1970 does not contain specific language that ex-
pressly authorizes medical removal protection (MRP) 64 in occupational
health standards. Various sections of the Act, however, indicate congres-
sional intent to include MRP as part of the agency's rulemaking author-
ity.6 5 The mechanism of MRP is consistent with section 2(b) of the Act,
requiring that "so far as possible every working man and woman in the
nation [has] safe and healthful working conditions .... "s66 Section 2(b)(4)
suggestion may be interpreted as recommending the practice of not only genetic screening
but also genetic monitoring (periodic testing at the physician's discretion rather than one-
time testing), for the proposal states "the employer is required to make any prescribed tests
available more often than specified if recommended by the examining physician." 48 Fed.
Reg. 17,315 (1983) (emphasis added).
62. 29 U.S.C. § 655(b)(7) (1982).
63. Id. § 657(c)(3).
64. As with the definitions of medical surveillance and biological monitoring, the
terms medical removal and medical removal protection (MRP) are used inconsistently.
Because of the apparent state of confusion of these and the related term rate retention, the
authors offer the following definitions, which again are consistent with OSHA standards.
According to OSHA,
MRP is a protective, preventive health mechanism integrated with the medical surveillance
provisions [which include biological monitoring] of the final [lead] standard. [ItJ provides tem-
porary medical removals for workers discovered through medical surveillance to be at risk of
sustaining material impairment to health from continued exposure .... [It] also provides tem-
porary economic protection for those removed.
43 Fed. Reg. 52,972 (1978) (emphasis added). Medical removal benefits include the main-
tenance of "the earnings, seniority and other employment rights and benefits of a worker
as though the worker had not been removed or otherwise limited." Id. at 52,976. Under
MRP, earnings include base wage, overtime, shift differentials, incentives and other com-
pensation regularly earned while working. 29 C.F.R. § 1910.1025, app. B, ¶ (K) (1982).
This maintenance of economic benefits is sometimes also referred to as rate retention. The
authors view MRP as an entire package that includes temporary removal with accompanying
continuation of economic and employment benefits. Rate retention, therefore, is a standard
condition in MRP. This definition is consistent with the OSHA lead standard.
Medical removal, to be distinguished from MRP, involves removing the worker from
exposure without regard for earnings, seniority and other employment benefits.
65. The agency considers MRP to be a protective, preventive health mechanism for
the purposes of: (I) maximizing meaningful participation in a medical surveillance program
under the standard; (2) facilitating the use of temporary medical removals; and
(3) appropriately allocating the costs of temporary medical removals. See 43 Fed. Reg.
52,972-73 (1978).
66. 29 U.S.C. § 651(b) (1982).
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asks that employers protect worker health "by building upon advances
already made through employer and employee initiative for providing
safe and healthful working conditions,"67 and section 2(b)(5) that em-
ployers provide healthful working conditions "by developing innovative
methods, techniques, and approaches for dealing with occupational safety
and health problems. "6 8
Sections 3(8) and 6(b)(5) grant the statutory authority for including
MRP in occupational health standards. Section 3(8) states that a standard
can require "the adoption or use of one or more practices, means, meth-
ods, operations or processes, reasonably necessary or appropriate to
provide safe or healthful employment and places of employment."69 MRP
meets the definitional criteria of section 3(8). Section 6(b)(5) requires
OSHA to base occupational health standards on "experience gained un-
der this and other health and safety laws." 70 Section 6(b)(7) specifies that
an OSHA standard shall prescribe such control procedures "as may be
necessary for the protection of employees." 7' The general rulemaking
authority of section 8(g)(2) provides additional authority for the agency
to include MRP in a health standard. It states that "[t]he Secretary ...
shall . . . prescribe such rules and regulations as he may deem necessary
to carry out [his] responsibilities under this chapter .... 72
After promulgating the final lead standard in 1976, OSHA considered
the merits of developing a generic standard for medical removal protec-
tion.73 To date the agency has not taken any further action on issuing a
generic MRP rule.
67. Id. As stated in the preamble of the final lead standard, "OSHA's adoption of
MRP is a direct result of the proven value of this protective mechanism, and by adopting
MRP, OSHA is following the Congressional mandate in section (b)(4) .... " 43 Fed. Reg.
52,977 (1978).
68. 29 U.S.C. § 651(b)(5).
69. Id. § 652(8).
70. Id. § 655(b)(5). Medical removal provisions and economic provisions are provided
in the Black Lung Medical Surveillance and Transfer Program, part of the Federal Coal
Mine Health and Safety Act of 1969. Although the Supreme Court has not yet spoken
directly on the issue, OSHA's authority to include a mandatory MRP provision in a section
6(b) standard has been upheld by the Court of Appeals for the District of Columbia Circuit.
The court upheld OSHA's general authority to require MRP programs in appropriate
circumstances, and specifically approved the MRP provision in the lead standard. United
Steelworkers of Am. v. Marshall, 647 F.2d 1189, 1230 (D.C. Cir.), cert. denied, 453 U.S.
913 (1980). Pending the denial of certiorari, the Supreme Court stayed all portions of the
lead standard except the MRP provision. In American Textile Mfrs. Inst. v. Donovan, 452
U.S. 490 (1981), the Supreme Court invalidated an MRP provision for cotton dust, noting
that OSHA had failed to make a record for the connection between such a provision and
a "safe and healthful working environment." Id. at 520. Nonetheless, the Court noted that
justification for an MRP program "very well may" exist. Id. at 539. In dicta, the Court
noted that one such justification may be the usefulness of an MRP provision as an induce-
ment to employees to cooperate with human monitoring programs. Id. The D.C. Circuit
also cited this rationale in upholding the MRP provisions in the lead standard. United
Steelworkers of Am. v. Marshall, 647 F.2d at 1228.
71. 29 U.S.C. § 655(b)(7).
72. Id. § 657(g)(2).
73. See generally CPA Medical Surveillance Report, supra note 22 (discussion of the
usefulness of a generic MRP standard).
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2. NIOSH
In its capacity as a research agency, NIOSH has broad power to
order human monitoring. Inherent authority to do so is granted in sections
20(a)(1), 20(a)(4) and 20(a)(7) of the OSHAct, all of which include man-
dates to NIOSH to conduct various studies pertaining to occupational
health. Section 20(a)(5) gives specific authority to order both biological
monitoring and medical surveillance. It states that NIOSH may
prescribe regulations requiring employers to measure, record, and make
reports on the exposure of employees to substances or physical agents
which [NIOSHI reasonably believes may endanger the health or safety of
employees ... [and] establish such programs of medical examinations and
tests as may be necessary for determining the incidence of occupational
illnesses and the susceptibility of employees to such illnesses.74
This section envisions collecting information for extensive epidemi-
ological studies. It is not limited to hazards already regulated under
section 6. Therefore, its potential scope is much broader than that per-
taining to OSHA. Section 20(a)(5), however, also directs NIOSH to
"furnish full financial or other assistance" to "any employer who is re-
quired to measure and record exposure of employees . . . under this
subsection," to defray "any additional expense" the employer incurs in
fulfilling those requirements.75 Budgetary limitations thus place a decided
constraint on NIOSH's ability to impose biological monitoring require-
ments. The reimbursement provision does not appear to apply to medical
surveillance.
B. Employer Authority Absent Agency Directive
In general, employers have the authority at common law to gather
information regarding the health, fitness, and physical and mental capa-
bilities of their employees. This authority grows out of the employer's
right to set reasonable conditions of employment that will protect his or
her interest in having work performed in an efficient and socially ac-
ceptable fashion. A recent decision of the Kansas Court of Appeals stated
the rationale for this right:
As a matter of public policy, employers must have the right to establish
reasonable standards of physical fitness for their employees to insure in-
sofar as possible that work is performed by employees who will not en-
danger themselves, their fellow employees, or the public at large.76
74. 29 U.S.C. § 669(a)(5) (emphasis added).
75. Id.
76. Cussimanio v. Kansas City S. Ry., 5 Kan. App. 2d 379, 383-84, 617 P.2d 107,
112 (1980).
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As human monitoring is one method by which an employer can obtain
the information necessary to determine whether an employee meets "rea-
sonable standards of physical fitness," employers have the general au-
thority to implement human monitoring programs even without state or
federal regulation directing them to do so.
III. SCIENTIFIC AND TECHNICAL CONCERNS IN HUMAN MONITORING
A. Testing Principles and the Adequacy of the Tests
Conducting any or all of the four types of human monitoring tests is
certain to be a complex activity. Before deciding how to interpret the
results of the tests and what possible action to take, one must assess the
goodness of the tests. To determine whether a test reliably detects a
certain disease or abnormality, one must consider the test's sensitivity,
specificity and predictive value, the frequency of the condition within a
population, and the reproducibility of the results.7
The sensitivity of a test is a measure of how accurately the test
identifies those people with the disease or abnormality, who will correctly
test positive. Specificity is a measure of how accurately the test identifies
people without the disease or abnormality, who will correctly test nega-
tive. A test's predictive value is the accuracy of the test in eliminating
people with false results. For example, among all people who test positive
for having the disease or abnormality, the "predictive value positive" is
the proportion of those who truly have the condition. Merely because
someone tests positive does not necessarily mean that he or she actually
has the condition for which he or she has been screened.
The frequency of the disease or abnormality within the test popula-
tion is an important but commonly overlooked factor that can dramati-
cally influence the test's predictive value.78 Unless one knows the fre-
quency of the condition in the population to be screened, one cannot
77. See Table 2 for a mathematical definition of sensitivity, specificity and predictive
value.
78. Vecchio, Predictive Value of a Single Diagnostic Test in Unselected Populations,
274 NEW ENG. J. MED. 1171, 1173 (1966). When applying diagnostic test results to unse-
lected populations, false-positive errors may be magnified due to the relatively low preva-
lences of disease in the general population. The terms "prevalence" and "incidence" are
epidemiologic terms related to the frequency of disease in a population. Point prevalence
is the frequency of the disease at a designated time. The incidence of a disease is the
number of cases of the disease that come into being during a specified period of time. See
B. MACMAHON & T. PUGH, EPIDEMIOLOGY: PRINCIPLES AND METHODS 60-61 (1970).
An example from Dr. Paul Rockey of the U.S. Public Health Service can be used to
illustrate the importance of this factor:
An electrocardiogram (EKG) taken during exercise ... is about 95% sensitive and 95% specific
for coronary artery disease. If this test is given to 1000 patients with angina pectoris (chest
pain). ... and the frequency of coronary artery disease (in the group) is 80%e, of the 800 persons
with disease. 95% or 760 persons will have positive exercise tests. Of the 200 persons without
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estimate the test's predictive value. Few frequencies are in fact known
for conditions related to work environments.
Reproducibility of results is also an important component in any
testing program. One or more laboratories should repeat a test often
enough to ensure the reliability of the results. Comparability of test
results also depends on the standardization of techniques and methods.
Currently, however, little data exists to compare the testing methods
used in various occupational health studies.9 Along with the standard-
ization of techniques, laboratory quality assurance and control are
essential. s
B. Limitations of the Tests Used in Human Monitoring
This section addresses the specific types of tests used to conduct
medical surveillance, genetic monitoring, genetic screening and biological
the disease, 95% or 190 persons will have negative exercise tests, but 10 will have positive tests.
Therefore, . the positive predictive value of the test is
760
= 98.7%(760 + 10)
Hearings Before the Subcomm. on Investigations and Oversight of the House Comm. on
Science and Technology, 97th Cong., Ist Sess. 126-28 (1981) (Statement of Dr. Paul Rockey,
U.S. Public Health Service, Transcript No. 53).
This percentage indicates that of all those who tested positive for coronary artery
disease (total of 770), 98.7% or 760 persons actually have the disease. Conversely, if the
same EKG test were given to healthy job applicants (e.g., 18 to 30 years old), a group in
which the frequency of coronary artery disease is 2%, one would see very different results
in the predictive value. If 1000 applicants were tested, then of the 20 persons with the
disease, (20 x .95) or 19 persons would have positive tests and one would have a false
negative test. Of the 980 applicants without the disease, (980 x .95) or 931 persons would
have negative tests, but 49 would have false positive results. Therefore, the predictive
value positive of the test is
19 28%(19 + 49)
The predictive value positive of 28% means that of those who tested positive (total
of 68). only 28% or 19 persons actually have coronary artery disease. The other 72% or 49
persons in fact have no coronary disease.
This example demonstrates a major problem with the use of certain diagnostic tests,
particularly in an occupational setting for pre-employment exams. Individuals free of dis-
ease falsely tested positive, and if such a test were to be conducted on a similar population
as a condition of employment, 72% might wrongly be denied work based on the misclassified
test results. Not only may false positive results cause denial of employment, but they may
cause persons without the disease to undergo further testing. This second level of testing
may subject the person to more risky diagnostic procedures and cause unnecessary social
costs associated with testing people who are in fact free of disease.
79. P. Hughes, Biological Monitoring 9 (paper presented at the Luxembourg Seminar,
supra note 29).
80. S. Crisp & H. Egan, Standardisation, Good Laboratory Practice and Quality
Control: Exchange of Information and International Co-operation 7 (paper presented at the
Luxembourg Seminar, supra note 29).
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Table 2: Sensitivity, Specificity, and Predictive Value of a Test*
Disease
Test Outcome
Present Absent Total
Positive a b (a + b)
(true positives) (false positives)
Negative c d (c + d)
(false negatives) (true negatives)
TOTAL (a + C) (b + d)
Sensitivity a true positivesSensitivity = (a + c) true positives + false negatives
d true negativesSpecificity =(b + d) false positives + true negatives
Predicted Value a true positives
Positive (a + b) true positives + false positives
Predicted Value _ d true negatives
Negative (c + d) false negatives + true negatives
monitoring,8 ' discussing certain limitations severely affecting test inter-
pretation and use of the results.
i. Medical Surveillance
The limitations of medical surveillance tests in an occupational set-
ting include nonspecificity, nonselectivity, and the fact that they may
detect a disease or abnormality after possibly serious and irreversible
adverse health effects have occurred. The frequency of false positive and
false negative results in routine tests depends on where the "normal"
limits of the test are set.2 (Limits are related also to determining the
frequency of the occurrence of the condition in the population under
scrutiny.) For continuous variables, such as serum measurements, it is
difficult to define the "normal" range because of individual variability. In
fact, what may be "normal" for one person may be a disease state for
another. (See the shaded area in Figure 1.)8 -3
*Adapted from Thorner & Remein, Principles and Procedures in the Evolution of
Screening for Disease, 67 PUB. HEALTH MONOGRAPH 1-24 (1967); Vecchio, Predictive
Value of a Single Diagnostic Test in Unselected Populations, 274 NEW ENG. J. MED. I 171
(1966); Cole & Morrison, Basic Issues in Population Screening for Cancer, 64 J. NAT'L
CANCER INST. 1263 (1980).
81. For the background and uses of these types of monitoring, see supra text accom-
panying notes 15-34.
82. A. HARVEY, J. BORDLEY & J. BARONDESS, DIFFERENTIAL DIAGNOSIS: THE
INTERPRETATION OF CLINICAL EVIDENCE II (3d ed. 1979).
83. For example, the accepted range of blood urea nitrogen (BUN) is considered to
be 10-20 milligrams per 100 milliliters of whole blood (mg/100 ml). HARRISON'S PRINCIPLES
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Figure 1: False Positives and False Negatives
Relative to "Normal" Limits*
% of Population
0 5 10 15 20
Serum Variable
Reprinted with permission from: Cutler, P.: Problem Solhing in Clinical Medicine. From
Data to Diagnosis. (1979), the Williams & Wilkins Co., Baltimore.
Exposure to noise and resulting hearing loss is an example of a
different difficulty in determining "normal" levels. Figure 2 serves as an
illustration.
Figure 2 demonstrates how the definition of "normal" can obscure
the full impact of exposure to an occupational hazard. Curve I represents
the hearing loss in a population that has not been exposed to noise. Curve
II represents the hearing loss in an exposed population. The vertical line,
called a "fence," separates the population with "normal" hearing acuity
from the population with impaired hearing. The "fence" is placed some-
what arbitrarily. Persons with impaired hearing lie to the right of the
fence on both curves. When the entire population is exposed to noise,
the population's hearing shifts. The handicaps of those with impaired
hearing before noise exposure increase after the population shift. They
are not counted, however, as an increase in the number of impaired
persons because they were impaired from the start. Other persons who
had no hearing impairment initially crossed the fence after exposure to
noise. They are considered newly impaired. Finally, a sizable number of
OF INTERNAL MEDICINE A-4 (R. Petersdorf, R. Adams, E. Braunwald, K. Isslebacher, J.
Martin & J. Wilson 10th ed. 1983). A person who is initially monitored as having a BUN
of 10 mg/100 ml and then increases to 19 mg/100 ml still falls within accepted limits, even
though that individual's kidney function may have been impaired. In this situation, the
diseased individual has a serum level that may also be exhibited by non-diseased individuals.
Therefore, the false negative result occurs because the serum measurement is not a perfect
predictor of disease.
*Adapted from P. CUTLER, PROBLEM SOLVING IN CLINICAL MEDICINE: FROM DATA
TO DIAGNOSIS 16 (1979).
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Figure 2: Shifts in Hearing Acuity with the Addition of Noise*
% of
Population
Hearing Loss
persons who do not cross the fence, and who therefore are not considered
impaired, nonetheless suffer a significant loss in hearing acuity.
Another problem with the results of routine medical surveillance
tests is that they may be nonselective in that they do not identify a
particular pollutant (or agent) as the cause for disease. The health effects
observed may be due to any one of several factors (both occupational
and non-occupational) other than the one for which the worker is being
considered for treatment or removal. Cutler points out that
... when new tests are first discovered many are thought to be specific
for certain diseases .... Subsequent studies showed these tests [e.g.,
rheumatoid factor for rheumatoid arthritis, SGOT-SGPT for acute myocar-
dial infarction or liver cell necrosis] to be nonspecific and positive in other
diseases which were either closely related or not related at all.4
Cutler cites pulmonary function tests, which medical surveillance
programs frequently use, as an example. He observes that "[p]ulmonary
function tests tell only the physiologic derangement, not the cause of
disease. "85
*Adapted from N. ASHFORD, D. HATTIs, E. ZOLT, J. KATZ & G. HEATON, ECONOMIC
AND SOCIAL IMPACTS OF OCCUPATIONAL NOISE EXPOSURE REGULATIONS 5-2 (1976) (Office
of Noise Abatement and Control, U.S. Envtl. Protection Agency, EPA Pub. No. EPA550/
9-77-352).
84. P. CUTLER, PROBLEM SOLVING IN CLINICAL MEDICINE: FROM DATA TO DIAG-
NOSIS 16 (1979).
85. Id. at 164. Another illustration of the inability of a routine medical surveillance
test to identify the cause of a disease can be made by again using BUN as an example.
The OSHA lead standard requires that BUN analysis be conducted on all employees who
are or may be exposed to lead concentrations above 30 micrograms per cubic meter of air,
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The interpretation of medical surveillance results also provides an
opportunity for abuse. Employers may attribute elevated blood urea
nitrogen (BUN) levels, detected in workers exposed to lead, to other
causes such as physical stress and water depletion. Thinking that those
two factors rather than lead exposure are the cause for elevated BUN
levels, an employer may incorrectly believe that he need not impose
further controls on lead in the workplace.
Another limitation on many routine medical surveillance tests is that
they may detect a disease or abnormality only after adverse health ef-
fects, sometimes serious and irreversible, have occurred. For example,
tests will detect an elevated BUN level in workers who have nephrotox-
icity because of lead exposure only after 66% of kidney function is lost
or when symptoms of renal failure are present.86
2. Genetic Monitoring
One controversial type of medical surveillance is genetic monitoring:
the periodic testing of blood and body fluids of employees working with
or possibly exposed to substances that may cause alterations in chro-
mosomes. As pointed out earlier, such monitoring attempts to determine
whether environmental exposures to particular substances cause statis-
tically significant changes in genetic material.87 Genetic monitoring is
usually used to determine the mutagenicity (ability to cause a permanent
change in the genetic make-up, other than one brought about by new
associations of genes from different parents)88 or clastogenicity (ability
to act as a chromosome-damaging agent)89 of a chemical or ionizing
radiation. It is also used to identify or monitor exposure to substances
suspected of causing chromosomal changes.90
It has been proposed that such monitoring techniques might also
identify those individuals susceptible to certain agents and serve as an
"early warning system" to identify those at risk before clinical signs
averaged over an eight hour period for more than 30 days per year. 43 Fed. Reg. 53,010
(1978). This measurement is required because BUN levels serve as an indicator of renal
function, and exposure to lead causes known adverse effects to the renal system. Although
exposure to lead may cause an increase in the BUN measurement, an increase in BUN
levels may also be seen from other causes, such as impaired kidney function, stress and
any other cause of decreased renal blood flow like salt and water depletion or decreased
fluid intake. J. WALLACH, INTERPRETATION OF DIAGNOSTIC TESTS: A HANDBOOK SYNOPSIS
OF LABORATORY MEDICINE 40 (3d ed. 1978). Therefore, if testing for elevated BUN levels
were conducted in a foundry where there was some exposure to lead, a number of workers
might test positive for BUN elevation, not necessarily because of exposure to lead that
affected the kidneys, but because of physical stress and sweating (causing salt and water
depletion).
86. See 43 Fed. Reg. 52,965 (1978).
87. See supra note 24 and accompanying text.
88. THE COMM. ON CHEMICAL ENVTL. MUTAGENS OF THE NAT'L RESEARCH COUN-
CIL BD. ON TOXICOLOGY AND ENVTL. HEALTH HAZARDS, IDENTIFYING AND ESTIMATING
THE GENETIC IMPACTS OF CHEMICAL MUTAGENS 245 (1983).
89. OTA REPORT, supra note 2, at ix.
90. Id. at 67.
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become apparent.9 ' One researcher maintains that these tests may serve
as "advanced warning procedures" for populations, but cautions that
interpretation of test results on an individual basis is unjustifiable because
environmental factors and inter-individual and temporal variation may
confound the results.92 The same researcher suggests testing populations
with a statistically appropriate number of subjects to compensate for
expected individual variability.93
There are two types of genetic monitoring - cytogenetic and non-
cytogenetic. The cytogenetic technique, which is considered the more
reliable method, detects major changes in the gross structure of chro-
mosomes. Noncytogenetic techniques detect actual damage to deoxyri-
bonucleic acid (DNA). 94 Chromosomal aberrations and sister chromatid
exchanges (SCE) 95 are commonly the markers or endpoints in quantifying
abnormalities in cytogenetic monitoring. Both types of cytogenetic mon-
itoring commonly use peripheral blood lymphocytes and sometimes bone
marrow. The endpoints for noncytogenetic monitoring techniques include
the detection of mutagens in body fluids (urine, blood, feces), germ cell
damage (sperm), and somatic cell damage.9
a. Cytogenetic Monitoring
Four common problems arise in using cytogenetic techniques for
monitoring purposes. First, the population's background frequency of
both chromosomal aberrations and SCEs fluctuates greatly, giving highly
variable baseline data.97 The occurrence of SCEs presumably involves
91. See generally Dabney, The Role of Human Genetic Monitoring in the Workplace,
23 J. OCCUPATIONAL MED. 626 (1981) (discussion of this proposal).
92. M. Legator, supra note 24, at 24.
93. Id. at 25.
94. See OTA REPORT, supra note 2, at 10.
95. A chromosomal aberration is an "abnormal chromosomal complement resulting
from the loss, duplication, or rearrangement of genetic material." R. KING, A DICTIONARY
OF GENETICS 51 (2d ed. 1974). A sister chromatid exchange (SCE) is an exchange at one
locus between sister chromatids of a chromosome, not resulting in an alteration of overall
chromosomal structure. See CASARETr AND DOULL'S TOXICOLOGY: THE BASIC SCIENCE
OF POISONS 126 (J. Doull, C. Klaassen & M. Amdur eds. 2d ed. 1980) [hereinafter cited
as CASARETr AND DOULL'S TOXICOLOGY]. These two changes are commonly quantified in
the attempt to determine a "safe" exposure level to a certain substance in the practice of
genetic monitoring.
96. Some believe that chromosomal aberrations may be early signals of adverse health
effects, see Holden, supra note 24, at 337, and may mean that exposure to a hazardous
substance is too high. Conversely, others believe that one cannot distinguish between the
background number of chromosomal aberrations and the aberrations caused by chemicals.
See the discussion in West, Genetic Testing on the Job, SCIENCE 82, Sept. 1982, at 16.
This view also holds that there is not a definite link between chromosome breakage and
cancer, see also infra note 100; Holden, supra note 24, at 337 ("not a shred of evidence
that directly links chromosome damage to any disease").
97. Carrano, Minkler, Stetka & Moore, Variation in the Baseline Sister Chromatid
Exchange Frequency in Human Lymphocytes, 2 ENVTL. MUTAGENESIS 325 (1980) [herein-
after cited as Carranol; GUIDELINES FOR STUDIES OF HUMAN POPULATIONS EXPOSED TO
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the breakage and reunion of DNA, although the exact mechanism for
SCE formation remains unknown.98 Cell-to-cell differences in the mean
SCE frequency of single individuals are probably the primary source of
highly varying background SCE frequencies. 99
Next, the state-of-the-art of such testing is not developed to the
point that scientists know the meaning of "positive" findings (a statisti-
cally significant increase in the number of abnormal chromosomes rela-
tive to an appropriate control group). Although such findings are not
widely accepted as an indicator of an increased risk of cancer,'°° some
researchers believe that chromosomal aberrations are related to the oc-
currence of cancer.'0 '
SCE frequency is easier and quicker to detect under laboratory
conditions than are chromosomal aberrations,102 and the practice is
widely advocated as an indicator of potential genetic or carcinogenic
hazard. 03 Some researchers believe that SCE techniques may be valuable
in identifying exposures to genotoxins and recommend their use, espe-
cially if available experimental data indicate the SCE-inducing capacity
of the agent in question. '04 The relation of the presence of SCEs to disease
MUTAGENIC AND REPRODUCTIVE HAZARDS 4 (A. Bloom ed. 1981) [hereinafter cited as
Bloom]; OTA REPORT, supra note 2, at 70. Fluctuations due to intra-individual and inter-
individual variations make cytogenetic monitoring results very difficult to interpret, give
them limited utility, and make it particularly difficult to define either a "normal" or "bio-
logically significant" range for testing results.
98. Latt, Schreck, Loveday, Dougherty & Shuler, Sister Chromatid Exchanges, 10
ADVANCES HUMAN GENETICS 283 (1980) [hereinafter cited as Chromatid Exchanges];
Carrano, supra note 97, at 326.
99. Carrano, supra note 97, at 325. The results are necessarily limited by the number
of individuals examined (eight) but the variation would not be much different even with a
larger population.
100. Bloom states that
in human populations, no associations have been definitely drawn between those individuals
with induced breakage and subsequent development of cancer ... although the presence of the
chromosomal breakage in the lymphocytes of mutagen-exposed persons is at times a marker of
exposure, it is not by definition a harbinger of cancer for the carrier individual.
Bloom, supra note 97, at 31.
101. For example, Legator believes that there is in fact a link between chromosomal
abnormalities and cancer. He states that "[a]ll carcinogens that have been thoroughly tested
have been found to induce some kind of chromosomal rearrangement . ..." The detection
of chromosome abnormalities indicates that the chemical is in all likelihood a human
carcinogen-mutagen. M. Legator, supra note 24, at 24.
102. Wolff, Cytogenetic Analyses at Chemical Disposal Sites: Problems and Pros-
pects, in ASSESSMENT OF HEALTH EFFECTS AT CHEMICAL DISPOSAL SITES 70 (W. Lowr-
ance ed. 1981) (proceedings of a symposium held June 1-2 at the Rockefeller University in
New York City).
103. Bloom, supra note 97, at 5.
104. Vainio, Sorsa & Hemminki, Biological Monitoring in Surveillance of Exposure
to Genotoxicants, 4 AM. J. INDUS. MED. 87-103 (1983) [hereinafter cited as Vainio]. These
authors believe that many agents in the environment are not known to be genotoxic.
Therefore. monitoring for genotoxic effects, such as SCEs, may be useful in determining
a hazard potential. as genotoxic manifestations are usually delayed a number of years after
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or illness, however, is more uncertain even than that of chromosomal
aberrations. 105
A third problem is that external variables other than the suspected
agent may affect the outcome of the results. For instance, chromosomal
aberrations may not necessarily result from exposure to the substance in
question, but also from a viral infection, exposure to ionizing radiation,
or previous or simultaneous exposure to another chemical.'" Substances
other than the one suspected in monitoring may similarly induce SCEs.
For example, agents that strongly tend to cause SCEs include viral
infections, saccharin, x-rays, and chlorambucil (a chemotherapeutic
agent). 107
Finally, flaws in study design and interpretation of results, lack of
proper validation, and lack of standardization of methods and statistical
analysis have frequently clouded the results of cytogenetic monitoring
studies in well-defined industrial settings.'08 The timing of genetic moni-
toring may be crucial.
Differences in longevity of aberrations found in lymph cells'09 have
important implications for when a worker is monitored. For instance,
workers with intermittent vinyl chloride exposure would need to be tested
more frequently than benzene workers because the chromosomal marker
disappears more rapidly for vinyl chloride." ° Without more frequent
testing, the chromosomal aberrations from vinyl chloride exposure would
not be detected.
In addition, according to the OTA, studies do not show whether
monitoring will detect endpoints at chronic, low-levels of exposure."'
These uncertainties led OTA to conclude that "the appropriateness of
chromosomal endpoints for occupational monitoring needs to be deter-
mined on a case-by-case basis for each chemical."" 2
exposure. Because conducting epidemiological studies can take a long time, they believe
it is necessary to identify genotoxic exposure as early as possible and thereby probably
prevent some of the long-term health hazards.
105. Wolff, supra note 102, at 71; Chromatid Exchanges, supra note 98, at 267. A
complete, detailed discussion of SCEs is provided in the Gene-Tox Program Report of the
Environmental Protection Agency.
106. CASARETT AND DOULL'S TOXICOLOGY, supra note 95, at 166.
107. Chromatid Exchanges, supra note 98, at 282-83.
108. Dabney, supra note 91, at 626-31.
109. See infra note 115.
110. OTA REPORT, supra note 2, at 74.
Ill. Id.
112. Id. In occupational settings, an increase in SCEs has been detected only for
effective alkylating agents, such as ethylene oxide. See Vainio, supra note 104, at 92.
Recently the Committee on Science, Engineering and Public Policy (a joint committee of
the National Academy of Sciences, the National Academy of Engineering, and the Institute
of Medicine) identified the need for developing "[alnalyses of chromosomal alterations to
detect genetic damage in peripheral blood cells (lymphocytes) of large exposed populations"
because of the "little information available to measure or verify actual human exposure"
to chemicals. See Comm. on Sci., Engineering and Public Policy, Report of the Research
Briefing Panel on Human Health Effects of Hazardous Chemical Exposures 106-07 (1983).
This research recommendation is contained in one of the seven research briefings prepared
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Analysis of the four problems that SCEs have in common with
chromosomal aberrations leads to the conclusion that occupational mon-
itoring for SCEs is highly experimental" 3 at this time. Without quanti-
tative data directly linking SCE occurrence to the onset of disease,
scientific commentaries on the application of this test as a worker sur-
veillance tool have suggested SCE studies are still in their formative
stages. Accordingly, test results must be interpreted with caution when
making assessments of the risk to workers from exposure to occupational
hazards. 14
Occupational studies investigating the occurrence of chromosomal
aberrations and exposure to certain chemicals have been conducted."5
An increase in chromosomal aberrations associated with exposure to
ionizing radiation is a finding that is widely accepted." 6 There is no
similar wide acceptance, however, of such an association of chromosomal
aberrations and exposure to workplace carcinogens and mutagens.
The literature that discusses cytogenetic monitoring as a method of
determining the adverse health effects of occupational hazards suggests
much uncertainty in performing such an activity routinely on a worker
population." 7 The large variability of baseline levels, the unknown clin-
ical relevance of "positive" findings, other variables influencing the test-
ing results, and the lack of standardization of methods and analysis
indicate that these tests currently are not practical for general use. The
scientific recommendation that these tests not be used in routine medical
by the committee in response to a request from the White House to "identify those research
areas . .. likely to return the highest scientific dividends as a result of incremental federal
investments .... Id. at v.
113. Dabney, supra note 91, at 627.
114. Bloom, supra note 97, at 33.
115. For example, related occupational studies have been conducted for benzene,
Forni, Cappellini, Pacifido & Vigliani, Chromosome Changes and Their Evolution in Sub-
jects with Past Exposure to Benzene, 23 ARCHIVES ENVTL. HEALTH 385-91 (1971); Picci-
ano, Cytogenetic Study of Workers Exposed to Benzene, 19 ENVTL. RESEARCH 33-38 (1979),
and vinyl chloride, Kucerova, Polivkova & Batora, Comparative Evaluation of the Fre-
quency of Chromosomal Aberrations and the Sister Chromatid Exchange Numbers in
Peripheral Lymphocytes of Workers Occupationally Exposed to Vinyl Chloride Monomer,
67 MUTATION RESEARCH 97-100 (1979); Anderson, Richardson, Weight, Purchase &
Adams, Chromosomal Analysis in Vinyl Chloride Exposed Workers, Results from Analysis
18 and 42 Months After an Initial Sampling, 79 MUTATION RESEARCH 151-62 (1980).
Dabney has critically reviewed three of the four studies (Forni, Picciano, Kucerova).
Dabney, supra note 91, at 626-31. The aberrations detected in the benzene studies remained
in peripheral lymphocytes for longer periods than the aberrations detected in workers
exposed to vinyl chloride. The aberrations among those with vinyl chloride exposure
disappeared quickly after exposure was reduced. These results indicate that perhaps chro-
mosomal aberrations from vinyl chloride exposure could be used to document recent
exposure and those from benzene exposure could be used to document cumulative expo-
sure. OTA REPORT, supra note 2, at 74.
116. Bloom, supra note 97, at 4-5; Wolff, supra note 102, at 75-76.
117. For a discussion of the latest research in the field of cytogenetic monitoring, see
Donahue, Essigmann & Wogan, Aflatoxin-DNA Adduct Detection in Urine as a Dosimeter
of Exposure, in INDICATORS OF GENOTOXIC EXPOSURE, BANBURY REPORT 13, at 221-230
(B. Bridges, B. Butterworth & I. Weinstein eds. 1982).
286 [Vol. 8:263
Human Monitoring
surveillance programs"' is consistent with OSHA policy to date that
medical surveillance "provisions do not require genetic testing of any
employee." 19
The OTA recently completed an assessment of the role of genetic
testing. Regarding cytogenetic monitoring, the OTA report stated that a
review of epidemiologic studies discussing the cytogenetic technique did
not establish a dose-response relationship between worker exposure and
the chromosomal aberrations. The OTA found that the studies generally
did not account for other possible causes of chromosomal aberrations,
such as age, nutritional status, and the presence of disease. '20 The report
also found that: "[n]o occupational studies relate positive findings for any
chromosomal endpoint with increased risk for any disease. Therefore,
the clinical significance of a positive occupational cytogenetic study is
unknown; nor is it known whether cytogenetic monitoring can be used
to determine 'safe' levels of exposure."' 2 '
b. Noncytogenetic Monitoring
Noncytogenetic monitoring techniques detect directly or indirectly
the presence of mutagens or DNA damage resulting from the presence
of mutagens. 22 The tests commonly identify: (1) mutagens in body fluids,
(2) somatic cell damage, and (3) germ cell (sperm) damage. The possible
methods for evaluating populations exposed to mutagenic hazards for
each of these three testing schemes lies beyond the scope of this article. ' 3
This type of testing uses urine, feces, and blood as test materials in
bacterial or in vitro cell culture mutagenicity assays. Primarily urine is
analyzed for the presence of mutagens and therefore it will receive more
discussion in this section than the other two body fluids.
118. Dabney, supra note 91, at 626. It is interesting to note that in the same issue of
the Journal of Occupational Medicine another article reached opposite conclusions, see
Fabricant & Legator, Etiology, Role and Detection of Chromosomal Aberrations in Man,
23 J. OCCUPATIONAL MED. 617, 624 (1981). The Dabney article states that the genetic
monitoring tests are still research tools not to be used for routine medical surveillance and
that the predictive value of these short-term genetic tests has not been established. In
contrast, the Fabricant and Legator article states that "[i]ndustrial cytogenetic monitoring,
as a form of preventive medicine, is now possible .... Chromosomal studies are now
considered to be the best method for examining genetic damage in routine industrial medical
surveillance." Fabricant & Legtor, supra, at 624. The authors of this second article also
conclude that genetic monitoring provides a reliable and objective method for evaluating
genetic change in the worker population.
119. See supra note 61 and accompanying text.
120. OTA REPORT, supra note 2.
121. Id. at 74.
122. Id. at 75.
123. Details and reviews of these numerous methods are available elsewhere in the
literature. See, e.g., Green & Auletta, Editorial Introduction to the Reports of "The Gene-
Tox Program," 76 MUTATION RESEARCH 165-68 (1980); Waters & Auletta, The GENE-TOX
Program: Genetic Activity Evaluation, 21 J. CHEMICAL INFORMATION & COMPUTER SC.
35 (1981); Bloom, supra note 97, at 123-25.
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The urine analysis method is now believed to be readily applicable
to human monitoring situations. 124 There are limitations, however, to the
use of urine analysis in detecting the presence of mutagens. For example,
"only recent exposures can be measured" and "the presence of mutagens
in urine has not been translated into a known risk to the individual."'2
One must know the metabolic fate of the mutagen in order to know when
to test and how to interpret the results properly.' 26 In general, the body
fluid analysis tests are limited in that they do not measure cumulative
exposure nor do they translate the results into quantitative risks for either
individuals or populations.' 27
Somatic cell damage usually involves the analysis of hemoglobin,
lymphocytes, or chemically damaged DNA. While these tests may show
promise in reliably identifying mutations, there are presently technical
and theoretical (e.g., variables that may affect the results) limitations
that must be resolved before such testing can be considered useful in an
occupational setting.' 28
Germ cell tests use sperm for mutation analysis. As with somatic
cell testing, studies using germ cell analysis show promise. Germ cell
tests, however, need further development. The endpoints of the sperm
test have not been shown to be associated with heritable disease states
and, until fully validated, the tests should be regarded as experimental.' 29
Noncytogenetic techniques are considered to be in a developmental
phase. In sum, to date these tests have not
124. Analytical methods for urine are readily applicable to human monitoring in the
workplace because:
I) Preliminary studies in humans have demonstrated that mutagens can be detected in the urine
of humans exposed to various therapeutic drugs [citations omitted]. Because results were ob-
tained from only a single patient, conclusions may not be appropriate for general application.
Mutagens can also be detected in the urine of humans exposed to industrial chemicals and
cigarette smoke [citations omitted];
2) the collection of urine samples is noninvasive and easy to obtain from males and females on
a regular schedule;
3) multiple analyses can be performed simultaneously from a single urine sample; and
4) costs and performance time associated with this approach are amenable to large-scale sam-
pling studies.
Bloom, supra note 97, at 127.
125. OTA REPORT, supra note 2, at 76.
126. For example, the presence of mutagens in the urine may indicate exposure to a
mutagenic agent or an agent that forms a mutagenic metabolite. Excretion of the mutagen
may work as a protective process. Conversely, the absence of mutagens in the urine of
those exposed may give a false sense of security. In fact, the mutagen may not be excreted
because it is bound to cellular molecules, possibly posing a hazard. Bloom, supra note 97,
at 127.
127. Id. at 128. According to Dabney, "[flurther research and comparison with other
tests need to be completed before any judgment can be made on the general utility of body
fluid analysis." Dabney, supra note 91, at 627.
128. OTA REPORT, supra note 2, at 77-80.
129. Dabney. supra note 91, at 627.

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been established as a reliable technique for monitoring human populations
.... At present, there is not enough research experience using humans
for most noncytogenetic techniques to determine accurately their useful-
ness in workplace monitoring situations .... The most obvious deficiency
in these tests is the lack of the availability of the normal baseline
response.130
Although many of these tests hold promise in the identification of
mutations, "extrapolations of these test results to human health is difficult
.... Given our limited understanding of, and experience with, direct
laboratory tests for mutations in man, current use of these tests should
be limited largely to studies aimed at evaluating the tests rather than
evaluating exposed human populations."' 3'
3. Genetic Screening
An employee undergoes genetic screening only once, usually as part
of a pre-employment or pre-placement exam, to determine individual risk
from exposure to a certain workplace substance or substances because
of an inherited genetic defect. This practice should not be confused with
genetic monitoring described above, which is conducted periodically to
determine risk to a group of employees who may exhibit chromosomal
changes that are not inherited but due possibly to exposure to certain
substances in the workplace.
There are numerous human traits for which screening can determine
genetic predisposition to occupational disease. OTA reviewed only a
small percentage of the traits,' 32 and this article does not discuss them in
detail. The general findings of OTA regarding these screening techniques
are that "while the biological foundations of the concept of genetic screen-
ing to identify predisposition to occupational disease are sound,"' more
epidemiologic investigation is needed. OTA also concluded that factors
other than genetic status may cause the response, and the
identification of genetic factors that may contribute to the occurrence of
job-related disease is a science truly in its infancy .... [G]enetic differ-
ences may in part explain the variability of responses to chemicals in the
workplace. What percentage of the total variability may be explained by
genetic factors is uncertain.' 4
Geoffrey M. Karny of OTA testified before a congressional subcom-
mittee that "few data" presently "support the correlation between any of
these traits and an increased risk for disease from occupational exposure,
130. Id. at 75.
131. Bloom, supra note 97, at 118 (emphasis added).
132. OTA REPORT, supra note 2, at 89-105.
133. Id. at 99.
134. Id. at 98-99.
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mainly because of serious flaws in study design."'3 5 As with genetic
monitoring, genetic screening methods are neither adequately specific
nor sufficiently developed for current use in monitoring incidences of
occupational disease.'3 6
Much controversy surrounds the practice of genetic screening, par-
ticularly because fifty-nine corporations informed OTA that they plan to
begin genetic screening programs of their workers in the next five
years,'3 7 even though the usefulness of such tests has not been con-
firmed.'3 8 Genetic factors do not exist in isolation. Nutritional status,
age, pre-existing disease and the interactions of various medications may
affect an individual's susceptibility to toxic substances.'3 9 The overall
state-of-the-art for genetic screening has not been developed broadly
enough to distinguish genetic factors from these other variables that may
135. Genetic Screening in the Workplace: Hearing Before the Subcomm. on Inves-
tigations and Oversight of the House Comm. on Science and Technology, 97th Cong., 2d
Sess. 21 (1982) (statement of Geoffrey M. Karney, Project Director, Biological Applications
Program, OTA) (discussing traits for glucose-6-phosphate dehydrogenase (G-6-PD) defi-
ciency, sickle cell, and alpha and beta thalassemias).
136. This statement is supported by the fact that the DuPont Corporation, which had
conducted G-6-PD testing at its Deepwater, New Jersey, plant until mid-1980, discontinued
giving the tests to both blacks and white workers of Mediterranean ancestry. The company
determined that the test did not have good predictive capability and was not helpful "in
[its] attempt to place people in jobs where there would be no unusual health risk." Hess,
Is Genetic Screening a Chemical Industry Ploy?, CHEMICAL BUS., CHEMICAL MARKETING
REP., Dec. 14, 1981, at 42; see also infra note 245.
137. Severo, supra note 58, at A12, col. 4; OTA REPORT, supra note 2, at 9. Propo-
nents of genetic screening believe that employees with particular genetic traits may be
more "susceptible" to certain illnesses than employees without the trait when both groups
are exposed to the same substance. For example, a deficiency of G-6-PD, a component of
red blood cells, is believed by some to cause affected individuals to become anemic when
exposed to certain substances, such as oxidizing agents. See infra note 267. By preventing
workers with certain genetic traits from performing jobs where exposure to particular
substances may occur, advocates believe that such screening serves a function in reducing
the incidence of occupational disease and acts as a means of protecting employees, partic-
ularly the "hypersusceptibles," from workplace hazards, as it is not economically feasible
to provide an environment that is risk-free for all workers.
The critics' arguments against the use of genetic screening include scientific uncer-
tainty, its use as a tool for discriminatory practices, and its use as an alternative to cleaning
up the workplace. As far as the scientific community is concerned, "there appears to be
very little support at present for biochemical genetic screening .... The tests are regarded
as arbitrary and, although valid, not very predictive." Holden, supra note 24, at 336. See
supra note 136 and accompanying text.
138. The information supplied to OTA was disclosed at a hearing before Congress on
June 22, 1982. Genetic Screening of Workers: Hearings Before the Subcomm. on Investi-
gations and Oversight of the House Comm. on Science and Technology, 97th Cong., 2d
Sess. 7-38 (1982). On October 14 and 15, 1981, this same subcommittee had conducted
hearings on screening research into human variation and the application of that research
to occupational settings. Genetic Screening and the Handling of High-Risk Groups in the
Workplace: Hearings Before the Subcomm. on Investigations and Oversight of the House
Comm. on Science and Technology, 97th Cong., Ist Sess. (1981).
139. E. Calabrese, Predicting Susceptibility to Occupational Diseases via Genetic
Markers 2 (March 1982) (report submitted to the Office of Technology Assessment).
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cause a response to a toxic substance. For example, during World War
I, it was speculated that TNT-induced adverse effects were intensified
by inadequate diets.'40
A substantial amount of evidence exists to support the proposition
that some individuals have a genetic predisposition to industrially related
disease (e.g., G-6-PD deficiency related to an increased risk of hemolytic
anemia' 4 '). The principal problem, however, is that the levels of exposure
required to cause the response are not usually documented. Therefore,
it is difficult to estimate risk or to determine the adequacy of established
workplace exposure standards in protecting worker health.
Because of this obvious gap in the scientific data and the inability to
distinguish genetic factors from other variables, screening for the pur-
poses of pre-employment testing, pre-placement testing, job denial or job
transfer seems misguided and unjustified at this time.' 42 Speculation on
its use as an accurate and reliable tool in the future is difficult, as workers
are exposed to thousands of chemicals in industry. One would need to
test each of those chemicals for adverse effects in those with heritable
traits, take into consideration other variables, and perform statistical
analyses on the data before one could ascertain the goodness of the tests.
Those who favor the practice of genetic screening believe that it
serves to reduce occupational disease by protecting the employees, par-
ticularly the "hypersusceptibles," from workplace hazards.'43 It may be
difficult, however, to determine which workers are actually "hypersus-
ceptible" as a result of genetic predisposition. This difficulty is reflected
by the fact that of the ninety-two human disorders for which a genetically
determined specific enzyme deficiency has been identified, only five meet
the prerequisite for a different job assignment.'44
The U.S. National Cancer Institute recently awarded a Canadian
scientist a contract to "perfect a simple test for identifying cancer-prone
individuals."'45 Such a test has serious potential for misuse. From a
140. 1 E. CALABRESE, NUTRITION AND ENVIRONMENTAL HEALTH 379 (1980).
141. E. Calabrese, supra note 139, at 79.
142. Regarding the general application of genetic screening, OTA concluded that the
"biological foundations of the concept of genetic screening to identify predispositions to
occupational diseases are sound." OTA REPORT, supra note 2, at 99. OTA also stated,
however, that the predictive value of the test is low in the general population so epidemi-
ologic studies using genetic screening tests could be "seriously flawed." Id. at I 1. Based
on these facts, OTA indicated that more research on tests identifying traits in the general
population and epidemiologic studies need to be conducted. This recommendation is con-
sistent with OTA's conclusion on the overall state-of-the-art, that presently "[n]one of the
current genetic tests evaluated by OTA meets established scientific criteria for routine use
in an occupational setting." Id. at 9.
143. N. ASHFORD, CRISIS IN THE WORKPLACE: OCCUPATIONAL DISEASE AND INJURY
118 (1976). See also Stokinger & Scheel, Hypersusceptibility and Genetic Problems in
Occupational Medicine - A Consensus Report, 15 J. OCCUPATIONAL MED. 564, 572-73
(1973).
144. N. ASHFORD, supra note 143, at 118.
145. A Test for Cancer-Prone People, CHEMICAL WEEK, Aug. 18, 1982, at 23. The
recipient of the contract stated that the test could be used in industries where "workers
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scientific point of view, the test would have to demonstrate acceptable
sensitivity, specificity, predictive value, and reliability. Individual biolog-
ical variation must be factored in along with variables like age, nutritional
status and pre-existing disease. The test must also include appropriate
markers that identify disease with certainty and be subject to verification
by appropriate statistical analysis and epidemiologic evidence. To date,
the state-of-the-art for genetic screening has not achieved this.'4 6
Some critics contend that genetic screening may lead to discrimi-
natory employment practices 4 7 against certain ethnic and racial groups
by industry. 48 Opponents of genetic screening also contend that such
screening practices shift the focus from cleaning up the workplace so
that all workers are protected as much as possible from harmful expo-
sures to a "blame the worker" attitude resulting in the removal of work-
ers. This removal may create a false sense of security that all of those
who will develop cancer have been identified and removed, as well as
encourage the employer to divert attention from the detection and re-
moval of chemical and physical workplace hazards that pose a continuing
threat to those workers who remain.
Results from genetic screening tests may be interpreted wrongly to
mean that some workers will experience responses from exposures to
certain chemicals. Such workers, who exhibit what is in fact normal
variation, are inappropriately categorized as "hypersusceptible."' 4 9
4. Biological Monitoring
Biological monitoring determines both the occurrence of exposure
and the uptake (or presence) of a particular substance or its metabolites
in body fluids or organs. It may complement medical surveillance and
environmental monitoring.
Biological monitoring may be an important tool when inhalation is
not the only significant route of exposure. It detects total uptake from
all routes (inhalation, ingestion, skin absorption) and estimates individual
health risk as well by measuring or approximating internal exposure. It
can take account of the individual differences in uptake, metabolism, and
response, and thereby reflect the risk for an individual worker.'5 0
are exposed to radiation or carcinogenic chemicals, allowing employers to screen out
workers with a high susceptibility to cancer - perhaps 2-3% of the population." Id.
(emphasis added). The test could be as "simple as 'detecting VD"' and would be marketed
as a "simple kit." Id. It is likely that industries that use carcinogens in the workplace would
use the screening technique.
146. OTA REPORT, supra note 2, at 9, 89, 100.
147. See infra text accompanying notes 489-549.
148. Regarding screening as a general practice for sickle cell trait, a genetic charac-
teristic particular mostly to blacks, Marc Rothstein, professor of law at West Virginia
University, stated that "[b]ecause certain biochemical genetic tests have a marked impact
along racial lines, any differentiation based on such a test would establish a prima facie
case of discrimination." Severo, supra note 58. See also Rothstein, supra note 9, at 1389-
91.
149. See infra note 260 and accompanying text.
150. Assessment of Risk, supra note 31, at 201.
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Results from biological monitoring procedures may in some instances
provide indications of a medical disorder much earlier than those of
medical surveillance. Biological monitoring serves as an indicator that
exposure and uptake have occurred, although harm may not yet have.' 5'
Medical surveillance results, by contrast, show possible adverse effects
from such exposure, indicating that harm, sometimes irreversible, has
already occurred.
In conducting biological monitoring tests, one must assess the ap-
propriateness of the biological parameter under consideration and the
goodness of the test being used. Stated another way, one must question
whether a change in the parameter being observed (e.g., a metabolite of
the exposure substance) is an indicator of the actual or potential health
damage that is the endpoint. If, in fact, the observed change does indicate
an actual or potential adverse health effect, one must then determine
how well the test monitors that change. In selecting a biological test, one
must consider the predictive value, specificity, sensitivity, and occur-
rence of false positives and false negatives'5 2 as well as other factors.'5 3
The frequency with which biological monitoring should be conducted
"does not follow any general rule, [but] depends on the variability and
the intensity of exposure, the toxicity of the agent, and the pharmacok-
inetic properties [such as] short versus long biological half-time[s]" of
residence in the body.'5 4 In general, monitoring should take place more
frequently if the substance is suspected of producing irreversible changes
in the body, if it is highly volatile, if the level of exposure is high, and at
each change in production technology.'55
The first limitation of biological monitoring is that few reliable tests
are available. 56 In addition, some of the tests available (e.g., for blood
151. R. LAUWERYS, supra note 26, at 1.
152. See supra Table 2 and accompanying text.
153. Factors to take into account in the choice of biological tests include: (1) the test
should measure or evaluate absorption of an agent in a reproducible manner; (2) the
analytical error and biological variability should be small; (3) the test should be quantita-
tively reliable for the relevant range of occupational exposure; (4) convenience and risk
factors (associated with obtaining a specimen) should be considered; (5) the concentrations
of the agent measured in the body media should be quantitatively relatable to a health
effect; and (6) the test should provide useful information over and above that obtained by
ambient monitoring. See Luxembourg Report, supra note 4, at 206.
154. Zielhuis, Biological Monitoring, 4 SCANDINAVIAN J. WORK, ENV'T & HEALTH
1, 13 (1978) (guest lecture delivered at the 26th Nordic Symposium on Industrial Hygiene
in Helsinki, Finland, October 1977).
155. Bardodej, Biological Monitoring of Exposure to Chemical Pollutants; Exposure
Tests, Biological Limits and Methods of Analysis: A Review, 8 DEVELOPMENTS IN ToxI-
COLOGY & ENVTL. SCI. 335, 338 (1980).
156. Of those available, "[o]nly a few have well-established predictive validity .... "
P. Hughes, supra note 29, at 7.
Considering biologic tests in general, many score high in sensitivity, but unfortunately, rather
low in specificity. The results are then difficult to interpret .... So while the search goes on
for chemical tests relatively simple to perform, yet of a high degree of specificity, the results of
which may be interpreted with reasonable confidence, there are not very many such tests at
hand today.
Id. at 11-12.
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analyses) are invasive, 5 7 and an invasive technique may deter workers
from participating in monitoring activities.
A second limitation is that it is difficult to establish whether the
exposure substance in question causes any observed changes in the
biological parameter. This limitation makes it difficult to pinpoint a cause-
effect relationship. Cells and tissues generally respond in a limited num-
ber of ways to a wide variety of stresses, and the changes observed are
often not specific. Frequently, workers are exposed simultaneously to
multiple substances, so one must also consider whether a different sub-
stance or a combination of substances caused the observed changes in
the parameter of interest. Another complicating factor in ferreting out a
cause-effect relationship is non-occupational exposures that may cause
the observed effects.
A third limitation involves variability of response. Multiple factors
can cause biological variations in response among workers exposed to
the same substance. Numerous factors must be considered in developing,
applying and interpreting biological analyses.'5 8 Realizing that multiple
factors can cause such variability in response, it is difficult to determine
the "normal" response for an individual. This makes the interpretation
of results difficult, even when they are accurate. Apparently healthy
individuals with the same biological monitoring results may differ greatly
in sensitivity.
A fourth limitation is that the parameter of interest for biological
monitoring can be altered artificially (e.g., by prophylactic chelation),' 59
157. See infra text accompanying notes 189-90.
158. General factors to consider include:
(I) rate of metabolism, see infra note 264a:
(a) individual variations in enzyme complement,
(b) diet,
(c) stimulation or inhibition of enzymes in the metabolic sequences,
(d) dose of the exposure chemical, and
(e) competition for the necessary enzyme;
(2) the ratio of bound to free chemical in the blood;
(3) special situations in which excreted levels of the index chemical do not
indicate current exposure levels;
(4) concentration changes due to volume changes in the bioassay material;
(5) non-workplace occurrence of the index chemical in the body and the resulting
natural variations in concentration;
(6) age of the worker;
(7) disease;
(8) sex of the worker;
(9) normal range of the index chemical to be expected in the bioassay material;
(10) time required for the index chemical to appear in the bioassay material;
(I 1) analytical methodology, see supra notes 79 & 80; and
(12) route of exposure.
See Waritz, Biological Indicators of Chemical Dosage and Burden, in 3 PATTY'S INDUS-
TRIAL HYGIENE AND TOXICOLOGY 257, 263, 265 (L.J. Cralley & L.V. Cralley 3d ed. 1978);
see also infra text accompanying notes 258-318.
159. Blood lead levels are commonly used to assess lead body burden. These levels
can be artificially decreased by a chelating agent, which is a substance that chemically
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and this limitation may carry with it associated health risks. The practice
of prophylactic chelation has the potential for serious misuse. Chelating
the workers would keep their blood lead levels below the removal trigger
level,'60 so employers might also realize an economic advantage in not
having to remove workers. For employers who expose employees to lead
levels above the permissible OSHA standard, such a practice would be
more cost-effective than installing expensive engineering controls to bring
ambient lead levels within the regulated level. The installation of engi-
neering controls may not then seem necessary because of the "accept-
able" blood lead levels of the employees. This response is inconsistent
with the OSHA policy that requires altering the workplace via engineering
controls rather than altering the worker to control lead exposure in the
workplace.
Changes in a biochemical parameter of interest for an individual
worker may be nonspecific and variable. A trend for a cause-effect re-
lationship is possible, however, if results of a working population (with
baseline parameter determinations) are properly analyzed along with a
comparable control population.
Understanding the rate of metabolism relative to the type of speci-
men is particularly important in timing biological monitoring. For ex-
ample, some substances are excreted in the urine very rapidly after
exposure (e.g., the metabolite trichloroethanol from trichloroethylene
exposure), while others have a longer retention time once exposure has
been discontinued (e.g., lead). To best determine the occurrence of ex-
posure or uptake for trichloroethylene, the workers should be monitored
one to three hours after exposure. 6 Conversely, lead is excreted so
slowly via the kidneys that the level of lead found in the urine is not
informative as to uptake at any particular time.
The most reliable way to quantify the presence of a substance or its
metabolite in the body would be to measure the concentration in the
binds lead and makes the lead biochemically and toxicologically inactive or unavailable.
43 Fed. Reg. 53,001 (1978). Workers engaging in prophylactic chelation therapy would,
therefore, have lower blood lead levels than they would otherwise. The workers then might
not need to be removed from the workplace because their blood lead levels would be within
the limits required by OSHA. See infra text accompanying note 321. The potential risks of
this practice differ according to the different chelating agents but generally include ner-
vousness, feelings of pressure in the chest, transient rise in blood pressure, kidney prob-
lems, aplastic anemia and possible increases in the absorption of lead from the gastroin-
testinal tract if lead exposure continues. 43 Fed. Reg. 53,001-02 (1978).
The OSHA lead standard does not authorize the use of prophylactic chelation as an
alternative to controlling employee exposure. However, diagnostic or therapeutic chelation
in situations of acute overexposure to lead is approved so long as the employer assures
"that it be done under the supervision of a licensed physician in a clinical setting with
thorough and appropriate medical monitoring and that the employee is notified in writing
prior to its occurrence." Id. at 53,011.
160. See infra text accompanying note 321.
161. Ogata, Takatsuka & Tomokuni, Excretion of Organic Chlorine Compounds in
the Urine of Persons Exposed to Vapours of Trichoroethylene and Tetrachloroethylene,
28 BRITISH J. INDUS. MED. 390 (1971) [hereinafter cited as Ogata].
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adversely affected organ (e.g., biopsy). This certainly is not a practical
large-scale testing scheme for a working population. As a surrogate,
biological monitoring usually involves the collection and analysis of urine,
blood, and expired air. Other specimens less commonly used are biopsied
fat, saliva, breast milk, hair, nails, and feces.' 16 2 Although these specimens
may be useful for certain analyses, they produce associated problems of
collection, storage, and analysis. 63 A discussion of the three more com-
monly used specimens follows.
Urine is one of the most frequently used biological monitoring spec-
imens. Samples are easy to collect and collection is noninvasive. Analysis
usually involves measuring a metabolite of the substance of concern (e.g.,
measurement of urinary phenol resulting from benzene exposure). Cri-
teria have been established for the reliability of urine analysis for a
particular organic index chemical.'64
OSHA has promulgated no standards to date that require urinary
biological monitoring. The OSHA benzene standard, however, which was
remanded to the agency by the Supreme Court,' 65 did contain a provision
162. R. BASELT, BIOLOGICAL MONITORING METHODS FOR INDUSTRIAL CHEMICALS
3 (1980).
163. Id.
164. Studies indicate that urine analysis for a particular organic index chemical will
be most reliable if:
(1) the index chemical has no non-workplace progenitors;
(2) the slope of the dose-response curve is fairly steep;
(3) the time needed to eliminate half of the substance from the body (half-life) is no
longer than eight hours and preferably no greater than four hours;
(4) the method of analysis is specific for the exposure substance;
(5) the method of analysis is validated in humans at the highest exposure level of interest
(dose-response curves should not be extrapolated beyond the highest experimental level);
(6) urine collection times are consistent and appropriate for the excretion half-life time;
(7) urine samples are analyzed shortly after collection;
(8) the method and determination of the concentration of the index chemical are first
validated for the group of workers of interest before routine application;
(9) the worker is not on a diet, has no pre-existing disease, and is not taking any medicine
that could interfere with the kinetics of the reaction of interest or any procedures;
(10) the worker is not being exposed off-the-job to the index chemical or another pro-
genitor of the index chemical;
(11) the urinary level of the index chemical is relatable to the amount of exposure
chemical absorbed by all routes;
(12) the dose-response equations are shown to apply to both men and women, or separate
ones are developed and applied to each sex; and
(13) the workdays of the group of interest and the group used to derive the concentration
of the index chemical in the urine are the same, if the half-life of elimination is much
greater than eight hours.
Waritz, supra note 158, at 294-95.
It is also customary laboratory practice in the United States to correct urine samples
to a specific gravity ("the measured mass of a substance compared with that of an equal
volume of another taken as a standard," BLAKISTON'S GOULD MEDICAL DICTIONARY 1271
(4th ed. 1979)) of 1.024 for comparability, Elkins, Pagnotto & Smith, Concentration Ad-
justments in Urinalysis, 35 AM. INDUS. HYGIENE ASS'N J. 559, 565 (1974), although some
investigators have used values of 1.016 and 1.018. R. BASELT, supra note 162, at 2.
165. Industrial Union Dep't v. American Petroleum Inst., 448 U.S. 607 (1980).
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in the medical surveillance section for urinary phenol levels. Phenol is
one of the principle urinary benzene metabolites. The urinary phenol
levels were to be monitored only in emergency situations, not on a routine
basis. 66
NIOSH recommended in 1975 that urinary fluoride analyses be con-
ducted at least every three months among a select group of workers,
using post-shift urine samples. 167 A pre-shift urinary fluoride sample
would serve as a baseline reference. 168 NIOSH's analysis suggested diet
as part of the evaluation. 69
The NIOSHIOSHA Occupational Health Guidelines also makes rec-
ommendations for urinary biological monitoring for some substances,
although it does not provide trigger levels and guidance on steps to take
if the substance (or metabolite) is found. For example, the medical guide-
lines for inorganic mercury, tellurium and manganese state that urinary
determinations of the substances "may be helpful" in assessing absorption
or exposure.'70
In view of the previously mentioned factors that must be taken into
account in interpreting urinary biological monitoring results, published
scientific reports on occupational biological applications give widely vary-
ing conclusions. For example, some researchers believe that the mea-
surement of urinary phenol is unreliable as an indicator of benzene ex-
posure,'7 ' while others believe it to be a good index of workplace
166. That part of the remanded standard states that "[i]f the employee is exposed to
benzene in an emergency situation, the employer shall provide the employee with a urinary
phenol test at the end of the employee's shift." Industrial Union Dep't v. American
Petroleum Inst., 448 U.S. 607 (1980). The biological trigger level was 75 milligrams of
phenol per liter of urine (mg. phenoUL). If the urine level was lower than 75 mg. phenol/
L, no further testing would be required. If higher, then the employer was to provide
additional hematology tests as soon as practicable, to be repeated in one month.
167. NAT'L INST. FOR OCCUPATIONAL SAFETY & HEALTH, U.S. DEP'T OF HEALTH,
EDUCATION, & WELFARE, PUB. NO. 76-103, CRITERIA FOR A RECOMMENDED STANDARD
... OCCUPATIONAL EXPOSURE TO INORGANIC FLUORIDES 3 (1975) [hereinafter cited as
FLUORIDE CRITERIA DOCUMENT].
168. If the preshift sample has a fluoride level of 4.0 mg./L. or the postshift sample
has a level of 7.0 mg./L., "steps shall be taken to evaluate dietary sources, personal hygiene,
basic work practices, and environmental controls." Id. (emphasis added).
169. Note that diet is a variable to be considered in evaluating the results of biological
monitoring tests. See supra notes 158 & 168.
170. NIOSH/OSHA OCCUPATIONAL HEALTH GUIDELINES, supra note 19.
171. Even though the OSHA benzene standard provided for urinary phenol deter-
minations, researchers have reported that individual determinations may be unreliable
because of inter-individual variability in metabolism of benzene and differences in nutri-
tional status. Docter & Zielhuis, Phenol as a Measure of Benzene Exposure, 10 ANNALS
OCCUPATIONAL HYGIENE 318, 323 (1967). Others conclude that urinary phenol levels do
not serve as reliable indicators of benzene exposure if such exposure is less than eight
hours at five parts of benzene per million parts of air (ppm). Roush & Ott, A Study of
Benzene Exposure Versus Urinary Phenol Levels, 38 AM. INDUS. HYGIENE ASS'N J. 67,
74 (1977). The current average eight hour permissible exposure level for benzene is ten
ppm. AM. CONFERENCE OF GOVTL. INDUS. HYGIENISTS, TLVsR: THRESHOLD LIMIT VAL-
UES FOR CHEMICAL SUBSTANCES AND PHYSICAL AGENTS IN THE WORK ENVIRONMENT
WITH INTENDED CHANGES FOR 1983-1984 11 (1983) [hereinafter cited as THRESHOLD LIMIT
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exposure.7'2 Urinary biological monitoring is also used to discover any
uptake of organics like toluene and styrene, as well as metals like lead
and cadmium.' 73
Analyzing contaminants in expired air is a biological monitoring
technique that is increasing in application.'74 Generally, this type of anal-
ysis has been limited to chlorinated hydrocarbon solvents like methylene
chloride, carbon tetrachloride and trichloroethylene.'75 The chemicals
enter the body via the lungs (although some may be absorbed through
the skin), then enter the vascular system, equilibrate with the body, and
are later excreted in exhaled air. Equilibrium of the contaminants between
the body and respired air can be used as "an indication of the concentra-
VALUES]. So in workplaces where benzene exposure is less than five ppm averaged over
eight hours, some may consider urinary phenol measurements inappropriate or useless. In
addition, ingestion of the recommended dosages of over-the-counter medicinals such as
Pepto-BismolR and ChlorasepticR has been reported to cause urinary phenol levels in excess
of 75 mg. phenoUL/ without exposure to benzene. Fishbeck, Langner & Kociba, Elevated
Urinary Phenol Levels Not Related to Benzene Exposure, 36 AM. INDUS. HYGIENE ASS'N
J. 820, 824 (1975). The results of the Fishbeck study must be interpreted and generalized
with caution, as only one worker who used over-the-counter medicinals was sampled. Also
note that this study disapproves of the practice of adjusting urine specific gravity to 1.024,
as the authors believe that it does not accurately reflect the average specific gravity for
urine. See supra note 164.
172. Except in those cases in which medicines cause elevated urinary phenol levels,
other researchers believe that urinary phenol is probably a good index of workplace
exposure to phenol or benzene. Waritz, supra note 158, at 286-87; Ohtsuji & Ikeda,
Quantitative Relationship Between Atmospheric Phenol Vapour and Phenol in the Urine
of Workers in Bakelite Factories, 29 BRITISH J. INDUS. MED. 70 (1972). Results of the
Ohtsuji study are necessarily limited by its small sample size (seven). Although the mea-
surement of urinary phenol may be nonspecific and insensitive for individual assessments
of exposure to low levels of benzene in the air, Luxembourg Report, supra note 4, at 201,
such monitoring conducted among a statistically significant sample of workers may indicate
the potential risk for the exposed working population as a whole.
173. "Excessive exposure to cadmium is most likely to occur in the workplace." H.
Perry & E. Perry, Evaluation of Cadmium as a Biological Hazard I (paper presented at
the Luxembourg Seminar, supra note 29). Concern about worker exposure to cadmium
and its known toxic effects on the kidney has prompted the practice of urinary cadmium
monitoring. See NAT'L INST. OF OCCUPATIONAL SAFETY & HEALTH, U.S. DEP'T OF
HEALTH, EDUCATION, & WELFARE, PUB. No. 77-181, OCCUPATIONAL DISEASES: A GUIDE
TO THEIR RECOGNITION 347 (M. Key, A. Henschel, J. Butler, R. Ligo, I. Tabershaw & L.
Ede eds. 1977) [hereinafter cited as OCCUPATIONAL DISEASES].
As with benzene, the goodness of this testing to determine the body burden of
cadmium has been disputed. Some researchers believe that "cadmium ... in urine ...
may be used for estimating the internal dosage of cadmium and hence the risk of health
impairment." R. Lauwerys, Cadmium 11 (paper presented at the Luxembourg Seminar,
supra note 29). The Luxembourg Report concurs. Luxembourg Report, supra note 4, at
201. Still, others believe that the "body burden of cadmium can be estimated with certainty
only by measuring the renal and/or hepatic cadmium concentrations with biopsy or at
autopsy .... Urinary cadmium concentration may provide some measure of cadmium
exposure; however at present, the evidence is only indirect .... " H. Perry & E. Perry,
supra, at 11-12.
174. Soule, Industrial Hygiene and Sampling Analysis, in I PATTY'S INDUSTRIAL
HYGIENE AND TOXICOLOGY 762, 765 (G. Clayton & F. Clayton 3d ed. 1978).
175. Id. at 765-67.
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tion of the contaminant in the workroom air to which the individual has
been exposed."' 6 Experimental inhalation studies also have shown "a
good correlation between concentration decrease of the index chemical
in post-exposure exhaled air and prior exposure."' 7 The concentration
of chemicals in the exhaled air decreases exponentially with time, not
only when the chemical is inhaled, but also when it is absorbed via the
skin and ultimately exhaled unchanged.' 78
In addition, the expired air samples are easily obtained through a
comfortable procedure. As a result, worker acceptance for this type of
monitoring may be greater than for urine or blood sampling, for all the
employee need do is take several deep breaths and force expired air
through a tube into a container.
According to one researcher, "[i]f the concentration of the exposure
chemical in exhaled air varies in some regular fashion with body burden,
regardless of route of absorption, this would provide a very desirable
method for measuring industrial exposure."' m9 This type of monitoring
would have further advantages over other methods of monitoring, in
addition to the already mentioned positive aspects,' 0 but also some
limitations.
The first limitation of expired air analysis is that its use is limited to
those substances that are sufficiently volatile to be exhaled in measurable
amounts.' 8 ' This limitation is crucial to the issue of the timing of the
test.'82 A second limitation is that although exhaled air is ideally repre-
176. Id. at 765.
177. Waritz, supra note 158, at 299.
178. Id. at 295.
179. Id.
180. Advantages of expired air analyses over other monitoring methods include the
following factors:
(1) Metabolism usually would not be involved, so all metabolic factors that can affect
the rate of appearance of the index chemical would not affect the analysis.
(2) The index chemical appears rapidly in exhaled air. Therefore, it is not necessary to
wait hours or weeks for the index chemical to appear in the bioassay material.
(3) The analysis would be amenable to gas-chromatographic techniques, which can be
made quite specific, thereby eliminating interference from non-index chemicals. This
technique also makes it possible to analyze several chemicals at the same time.
(4) Several samples can be taken in rapid succession.
(5) Usually the subject can be observed while providing the sample, to assure he or she
follows instructions.
(6) Very few non-workplace progenitors exist for the index chemical. Therefore, the
excreted material is more likely to represent workplace exposure than in the analyses of
other biological materials (e.g., urine).
(7) The technique is noninvasive.
(8) The technique measures individual exposure without the bother of a personal moni-
toring device.
Id. at 295-96.
181. R. BASELT, supra note 162, at 2.
182. For example, if a substance is highly volatile, the exposed worker needs to be
tested shortly after exposure. This limitation may impose inconvenient testing times, de-
pending on the time of the worker's last exposure relative to when the employee is, for
example, to go to lunch or to go home.
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sentative of the average exposure, some data suggest that samples taken
shortly after exposure represent the latest exposure level and not an
average.' 3 Also, because chemicals are excreted at different rates, decay
curves need to be developed for all chemicals for which exhaled air
analysis will be conducted. There is a related need to gather accurate
data on exposure time, as that measurement is necessary to calculate
exposure from the developed decay curves.'" Finally, problems remain
in determining the appropriate time to sample as well as in developing
satisfactory sampling and analytical methods.'85
Physiological factors like blood concentration and solubility of the
index chemical in tissues and fat may affect exhaled air levels of the
exposure chemical. This article does not discuss the fundamental physi-
ological concepts related to post-exposure air concentrations.'" There
are also non-physiological factors that can affect the index chemical
concentration in exhaled air, causing variability in results.'87
To date, OSHA has promulgated no standards requiring expired air
analysis as part of a biological monitoring scheme. Even though the
analysis has been used as a biological monitor for benzene,'" the re-
manded OSHA benzene standard did not provide for it.
Collecting blood samples is another biological monitoring practice
conducted to determine toxic chemical exposure to a particular sub-
stance. Most commonly, this analysis has been employed to measure
carbon monoxide exposure, using carboxyhemoglobin levels as an index,
or pesticide exposure, using cholinesterase levels as an index, and to test
directly for metals such as lead and cadmium.
The principal limitation on this type of biological monitoring is that
the procedure for obtaining a specimen is an invasive one.'8 9 This can
make it difficult to obtain full worker participation and to acquire speci-
183. Stewart, Hake & Peterson, Use of Breath Analysis to Monitor Trichloroethylene
Exposures, 29 ARCHIVES ENVTL. HEALTH 6, 6 (1974).
184. Waritz, supra note 158, at 302.
185. Solvents, supra note 30, at 408.
186. For a discussion of these concepts, see Waritz, supra note 158, at 296.
187. Non-physiological factors that can cause variability in the concentration of index
chemicals in expired air include:
(I) non-workplace progenitors of the index chemical (e.g., perhaps the chemical entered
the bloodstream prior to workplace inhalation; also, it is not possible to detect if the
breath sample of the chemical came from the bloodstream or the mouth);
(2) respiratory rate - until the chemical is in equilibrium in the body, respiratory rate
can affect the rate of uptake (e.g., increased uptake with increased respiration when
body compartments are not saturated);
(3) sex - males and females are reported to have different absorption coefficients; and
(4) skin absorption of the exposure chemical - kinetics in the lung for some solvents
may differ between skin absorption exposure and exposure via inhalation.
See id. at 297.
188. L. Lave & E. Callison, An Economic View of Biological Monitoring in the
Workplace Il (paper presented at the Luxembourg Seminar, supra note 29).
189. See supra text accompanying note 157.
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mens frequently. In addition, blood containers and collection devices
must usually be selected for a specific application.'90
The OSHA lead standard is the only health standard that requires
blood analysis as a biological monitoring tool. A blood lead level deter-
mination for workers who are or may be exposed to more than thirty
micrograms of lead per cubic foot of air, averaged over eight hours, is a
component of the medical surveillance provisions.' 9 ' The NIOSHIOSHA
Occupational Health Guidelines recommends biological monitoring blood
analysis for substances like carbon monoxide and pesticides like endrin
and parathion.' 92 Blood analysis as a biological monitoring technique for
cadmium also has been studied, but there is no consensus about the
goodness of the test. 193
In addition to the need to develop analyses for chromosomal alter-
ations,' 94 the Committee on Science, Engineering and Public Policy, a
joint committee if the National Academy of Sciences, the National Acad-
emy of Engineering, and the Institute of Medicine, has identified a further
need to develop analyses of expired air, blood, and urine as a means for
evaluating exposure. 195 Potential applications for these indicators include
use to increase the power of epidemiologic studies'96 and use as a tool
to assess the consequences of human exposure in industrial settings. 197
The terms "biologic threshold limit values"'9 8 and "biological per-
missible limits" (BLVs)' 99 refer to the concept of measuring levels of the
190. R. BASELT, supra note 162, at 2. For example, some anticoagulants present in
collection tubes interfere with the determination of the substance to be measured (e.g.,
fluoride is a good anticoagulant but it has been observed to inhibit enzymes such as
cholinesterase).
191. 43 Fed. Reg. 53,010 (1978); 29 C.F.R. § 1910.1025(j)(l)(i) (1983).
192. NIOSH/OSHA OCCUPATIONAL HEALTH GUIDELINES, supra note 19.
193. Some observers believe that "in occupationally exposed persons, cadmium levels
in blood is [sic] a good indicator of the average intake during recent months but not of
body burden nor of the most recent exposure." R. Lauwerys, supra note 173, at 11-12.
Others agree that cadmium in the blood is a poor index of body burden but hold that blood
concentrations reflect recent exposure. H. Perry & E. Perry, supra note 173, at 11. The
Luxembourg Report concludes that cadmium in the blood is a good biological indicator for
estimating both the body burden of cadmium and the risk of health impairment. Luxembourg
Report, supra note 4, at 201.
194. See supra note 112.
195. COMM. ON SCI., ENGINEERING AND PUBLIC POLICY, supra note 112, at 7. The
Committee believes that the "development and validation of techniques of high sensitivity
and specificity ... [see supra text accompanying note 78] would be powerful tools for
direct evaluation of human exposure to environmental chemicals and its impact on human
health." The Committee cited the lack of available information to measure or verify actual
human exposure as one rationale for the recommended research. According to the Com-
mittee, "[s]pecific biologic markers of human exposure (as an adjunct to environmental
monitoring) [see supra text accompanying note 31] ... offer a great opportunity to improve
the ability to assess the effects of chemicals .... " Id. (emphasis added).
196. See infra text accompanying notes 226-227.
197. COMM. ON SCI., ENGINEERING AND PUBLIC POLICY, supra note 112, at 7.
198. Elkins, Excretory and Biologic Threshold Limits, 28 AM. INDUS. HYGIENE ASS'N
J. 305, 307 (1967).
199. Zielhuis, supra note 154, at 13.
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exposure chemical or its metabolites or both in biological specimens that
correspond to the permissible air limits of exposure. The American Con-
ference of Governmental Industrial Hygienists (ACGIH) defines BLVs
as values representing "limiting amounts of substances (or their effects)
to which the worker may be exposed without hazard to health or well-
being as determined in his tissues and fluids or in his exhaled breath."2 0
According to the ACGIH, the BLVs and their associated compliance
procedures "should thus be regarded as an effective means of providing
health surveillance of the worker." 20'
The ambient analogue of BLVs is the familiar threshold limit values
(TLVs), which are "the time-weighted average concentration for a normal
8-hour workday and a 40-hour workweek, to which nearly all workers
may be repeatedly exposed, day after day, without adverse effect." 20 2
The ACGIH states that BLVs may be used as an adjunct to or in place
of TLVs.2 0 3 The rationale for the adoption of BLVs is that
there are situations where air analyses, in combination with the atmospheric
TLV, are not adequate to evaluate precisely the peril of the hazard, since
the amount absorbed cannot be predicted from the data obtained by such
determinations. In such situations, it is highly desirable to have other means
of estimating exposure. With many substances this can be done by analyz-
ing suitable biologic specimens or excretion products for the toxic agent or
a metabolite derived therefrom.204
Scientists are in widespread agreement as to the need to develop
biologically permissible levels for toxic substances. 20 5 As a result, some
are undertaking efforts to develop such levels. For example, participants
at the Luxembourg Seminar identified the need for consistent interna-
tional biological indicator levels.2 6 In a survey of nine European coun-
tries, conducted in 1980, the seven governments that responded answered
200. THRESHOLD LIMIT VALUES, supra note 171, at 8.
201. According to the ACGIH, biologic measurements on which the BLVs are based
can furnish two kinds of information useful in the control of worker exposure:
(I) Measuring the individual worker's overall exposure. This measurement can be ob-
tained by: (a) determining in blood, urine, hair, nails, body tissues and fluids, the amount
of the substance to which the worker was exposed; (b) determining the amount of the
metabolite(s) of the substance in tissues and fluids; and (c) determining the amount of
the substance in the exhaled air.
(2) Measuring the worker's individual and characteristic response. These measurements
provide a good assessment of the physiologic status of the worker and include:
(a) changes in the amount of some critical biochemical constituent; (b) changes in activity
of a critical enzyme; and (c) changes in some physiologic function.
See id. at 8-9.
202. Id. at 3.
203. Id. at 9.
204. Elkins, supra note 198, at 306-07.
205. Zielhuis, supra note 154, at 13.
206. Otherwise, they reported, "it would be highly detrimental to workers' faith in
occupational health and safety programs designed to protect worker health, if [they] varied
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affirmatively the question: "Does your department consider to introduce
[sic] in the future biological 'standards' for some agents, which will have
in your country about the same significance as standards for concentra-
tion in air (e.g., mean air concentration, TLV)?" 207 Biological threshold
limit values have been established for nineteen cyanogenic chemicals0 8
and suggested for three pesticide absorption and response levels.209
Although enthusiasm for developing BLVs is growing, some serious
issues regarding the development and use of BLVs must be addressed.
First, what is a "normal" limit?210 "Normal" may be considered to be a
"statistical expression [of a distribution] of a large number of individual
responses." 21 Comparing an individual value to general norms, however,
may result in false negative results.2 2 Alternatively, a BLV could be set
high enough to eliminate all "normal" values, but then some overexposed
workers might never reach it.2I3 The limit could also be set at a level that
included many people who had not been overexposed to the workplace
chemical, but this option would require later confirmation that elevated
levels were in fact due to workplace exposure. 4
The problem lies in trying to devise a single value (or fence) as the
dividing line between normal and abnormal test results. Attempts to do
so are usually flawed methodologically. In addition, one researcher has
found that clinical studies on the relationship between uptake and quan-
titative changes in the proposed biological parameter are still insufficient,
making definition of meaningful BLVs not yet possible.2 5
Two other important considerations involve the goodness of the tests
and individual variability. Before any BLVs are determined, the ability
of the test to provide accurate, reproducible results with adequate sen-
sitivity, specificity and predictive value must be demonstrated.26 Many
factors may cause variability of response to a given substance including
with place of employment or when crossing national boundaries." Luxembourg Report,
supra note 4, at 202. "Where the threshold limit values in air are well documented and the
absorption balance, biotransformation pathways and elimination kinetics of [the] pollutant
and its metabolic products are known, then the biological limit can be derived from the
experimentally established relationship between pollutant concentrations in air and in bi-
ological material." Bardodej, supra note 155, at 338.
207. Zielhuis, supra note 154, at 5-6. The seven European governments that provided
positive responses were Denmark, France, the Federal Republic of Germany, Great Britain,
Ireland, Italy and the Netherlands.
208. Linch, Biological Monitoring for Industrial Exposure to Cyanogenic Aromatic
Nitro and Amino Compounds, 35 AM. INDUS. HYGIENE ASS'N J. 426, 430 (1974).
209. Zielhuis, supra note 154, at 15.
210. See supra note 82 and accompanying text.
211. E. CALABRESE, METHODOLOGICAL APPROACHES TO DERIVING ENVIRONMENTAL
AND OCCUPATIONAL HEALTH STANDARDS 243 (1978).
212. Id.
213. Waritz, supra note 158, at 287.
214. Id.
215. R. LAUWERYS, supra note 26, at 4.
216. See supra Table 2 and accompanying text.
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pre-existing disease, nutritional status and prior exposures. 2 ' Further-
more, many workplace substances are not suitable for biological thresh-
old limit determinations. 218
To date, OSHA's lead standard is the only standard that requires
adherence to a biological threshold limit value. 219 The biologically per-
missible limit for lead in the blood is fifty micrograms of lead per 100
grams of blood. The remanded OSHA benzene standard provided for a
urinary BLV of seventy-five milligrams of phenol per liter of urine.220 In
addition, NIOSH has recommended a urinary BLV for fluoride.2 2 '
Although the idea of establishing BLVs is attractive, the seriousness
of the limitations of the concept cannot be ignored. If BLVs are even-
tually established, based on reliable and accurate tests, then they should
be used as an adjunct to medical surveillance testing and environmental
monitoring, but certainly not in place of either one.
C. Frequency and Timing of Exams
The decision as to when to administer tests to workers in the em-
ployment cycle is usually determined by OSHA regulations, by manage-
ment alone, or as a result of an agreement between management and
labor. Tests most commonly conducted in the employment cycle include:
- pre-employment
- pre-placement
- periodic
- post-illness or injury
- episodic
- termination or retirement
The twenty-three OSHA health standards provide for testing on some of
these occasions, and the NIOSHIOSHA Occupational Health Guidelines
provides substance-by-substance recommendations on when to test.222
Table 3 provides categories for the general application of the tests relative
to the four types of human monitoring.
The decision as to when to conduct testing should be considered on
a substance-by-substance basis. The rate of metabolism of the
217. See infra text accompanying notes 258-318. Various environmental and biolog-
ical factors may modify the concentration of the chemical or its metabolite in biological
media. Accordingly, these factors must be considered when interpreting results. R. LAU-
WERYS, supra note 26, at 5.
218. Elkins, supra note 198, at 307-09.
219. 29 C.F.R. § 1910.1025(k)(1)(i)(D) (1983).
220. Industrial Union Dep't v. American Petroleum Inst., 448 U.S. 607 (1980).
221. FLUORIDE CRITERIA DOCUMENT, supra note 167, at 3.
222. NIOSH/OSHA OCCUPATIONAL HEALTH GUIDELINES, supra note 19.
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Table 3: Temporal Characteristics of Tests for the Four Types
of Human Monitoring
Medical Genetic Genetic Biological
Surveillance Monitoring Screening Monitoring
Pre-Employment X X X
Pre-Placement X X X X
Periodic X X X
Post-Illness or Injury X X
Episodic X X X
Termination/Retirement X
substance 2 3 and the natural history of the disease caused by exposure
to that substance 2 4 must be factored into the decision.
From 1972 to 1974, data were collected from 5000 U.S. workplaces
for the first NIOSH National Occupational Health Survey. The survey
included workplaces representing a range of plant sizes and industry
types. It provided information on the percentage of workers in the study
population receiving pre-employment, pre-placement, periodic, post-ill-
ness and termination exams. 2 What is done with the information gath-
ered during these procedures? So far, the data obtained from screening
workers has not been well coordinated or analyzed, either in isolation or
in conjunction with other worker information (e.g., exposure data).22 6
223. Metabolic rates for chemicals vary from individual to individual and from sub-
stance to substance. The time between exposure to a certain agent and the appearance of
the agent or its metabolite in the urine may vary from a few hours to days. For example,
not until 42 to 69 hours after exposure to trichloroethylene does the metabolite trichloro-
acetic acid peak in the urine. Ogata, supra note 161, at 390. In this case, urinary biological
monitoring would not be useful if conducted on those exposed workers at the end of a
shift.
224. Asbestos-related pulmonary diseases usually appear no sooner than 15 years
after first exposure. OCCUPATIONAL HEALTH: RECOGNIZING AND PREVENTING WORK-
RELATED DISEASE 164 (B. Levy & D. Wegman eds. 1983) [hereinafter cited as OCCUPA-
TIONAL HEALTH]. Therefore, screening for asbestos disease in the first year of exposure
would be highly unlikely to detect an asbestos-related pulmonary illness. Analyzing data
gathered from populations for which the latency period (time between exposure and the
development of disease) has not yet "ripened" may lead an observer to conclude, based
on analysis of the data, that no occupationally related disease exists among the workers.
This finding cannot be adopted with confidence, as the natural history of the disease relative
to the exposure substance has not been considered. The workers may in fact have a dormant
occupationally related disease that will be detected clinically or symptomatically after the
latency period is reached or exceeded.
225. J. Ratcliffe, The Usefulness of Medical Screening Examinations in the Preven-
tion of Occupational Diseases 2 (1982) (unpublished paper prepared for the National Insti-
tute for Occupational Safety and Health).
226. According to OSHA, "most companies have no mechanism (such as a unique
identifying number) to permit easy linkage of medical and work history records, job de-
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The data could be used for epidemiological (i.e., relating to morbidity,
mortality) and biostatistical analyses as well as integrated with industrial
hygiene data.=7
The OSHA standards provide little guidance on what to do if an
abnormal testing result is observed. Only the asbestos,2 ' vinyl chlo-
ride,'9 cotton dustu and lead2' standards mention any action to be
taken based on abnormal human monitoring results. The remanded ben-
zene standard provided guidance for further testing based on urinary
phenol trigger levels, u2 and the recently proposed ethylene oxide stan-
dard recognizes the possibility of medical removal of the worker at a
physician's discretion, as a means of placing "recommended limitations
on the employee's exposure."233 The asbestos, vinyl chloride, and cotton
dust standards contain provisions for medical removal, and the lead
standard contains provisions for medical removal protection. 3 4 The
OSHA Final Rule, "Access to Employee Exposure and Medical Rec-
ords," considers information gathered in the different testing schemes as
part of the employee's medical record.23 The components of the record
include data obtained from any and all of the testing schemes.6
scriptions, exposure data and medical test results." U.S. DEP'T OF LAOi, AN INTERIM
REPORT FOR CONGRESS ON OCCUPATIONAL DISEASES 120 (1980).
227. According to the Occupational Medical Practice Committee of the American
Occupational Medical Association,
(wlhen appropriate, these data should be used to conduct epidemiological studies to assess the
effects the workplace may have had or is having on the employees .... [(The occupational
health program must maintain occupational medical records on each employee, documenting the
reasons for and the results of all physical examinations .... These data must be maintained
confidentially .... [Plrocedures ... allowing access to those with a bona fide need to know,
must be developed.
Occupational Medical Practice Comm. of the Am. Occupational Medical Ass'n, Scope of
Occupational Health Programs and Occupational Medical Practice, Committee Report,
21 J. OCCUPATIONAL MED. 497, 498-99 (1979) [hereinafter cited as AOMA Comm. Report].
228. 29 C.F.R. § 1910.1001(d)2Xiv)(c) (1983).
229. Id. 1910.1017(kXS).
230. Id. § 1910.1043(fX2Xv).
231. Id. § 1910.1025(k).
232. See supra note 166 and accompanying text.
233. 48 Fed. Reg. 17,312 (1983).
234. The distinction between medical removal and medical removal protection is
important. See supra note 64.
235. 45 Fed. Reg. 35,278 (1980).
236. OSHA defines "employee medical record" as follows:
(6Xi) 'Employee medical record' means a record concerning the health status of an employee
which is made or maintained by a physician, nurse, or other health care personnel, or technician,
including:
(A) medical and employment questionnaires or histories (including job description and
occupational exposure),
(B) the results of medical examinations (pre-employment, pre-assignment, periodic, or
episodic) and laboratory tests (including X-ray examimntions and all biological monitoring),
(C) medical opinions, diagnoses, progess notes, and recommendations,
(D) descriptions of treatments and prescriptions, and
(E) employee medical complaints.
Id.
Human Monitoring
A pre-employment exam is generally a routine procedure (like the
familiar check-up exam given by a family doctor), frequently made a
condition of employment. The purposes of conducting a pre-employment
exam include: (1) to establish a baseline of medical testing results that
can be used for comparison against future results; (2) to determine if the
individual can physically perform the intended work; and (3) to determine
whether there is any health condition that might require special precau-
tionary care or job placement consideration. '37 A pre-employment exam
commonly includes a medical history (including any pre-existing disease),
selected medical information about the worker's parents, a smoking his-
tory, a physical exam, and routine medical surveillance tests like blood
analysis, urinalysis and chest x-ray. If appropriate, baseline biological
monitoring tests and pulmonary function tests may be conducted.
An occupational history is also a component of a thorough pre-
employment exam. The importance of a complete occupational history
cannot be stressed enough. Unfortunately, it often is overlooked, or the
history consists of only the title of the employee's last job. Such incom-
pleteness is not adequate to determine the work-relatedness of disease
for either epidemiologic or legal purposes. While routine medical sur-
veillance tests can raise suspicion or help confirm that a disease or injury
is work-related, "ultimately it is information obtained from an occupa-
tional history that determines the likelihood that a given medical problem
is work-related."'2X A complete occupational history should include: a
description of all jobs held; work exposures; the timing of symptoms;
the occurrence of symptoms or illness among other workers; and any
non-work exposures and other factors (e.g., alcohol, smoking, location
of residence). 39
A pre-placement exam is conducted when an already employed
worker is assigned to a particular job where certain exposures may be
new or different from those associated with a current job. In some
instances, a pre-placement exam can be the same as a pre-employment
exam, depending on job assignment.
A pre-placement exam has basically the same purposes as those
outlined above for a pre-employment exam. T0 According to the Occu-
pational Medical Practice Committee of the American Occupational Med-
ical Association, a pre-placement exam is considered to be an essential
part of an occupational health program. It should include an assessment
of health status and emotional status in order to ensure that the person
can perform a job safely and efficiently without endangering the person's
safety or health and that of others. 24" The recommendations made to
237. Genetic Screening and the Handling of High-Risk Groups in the Workplace.
1981: Hearings Be;re the Subcomm. on Investigation and Oversight of the House Comm.
on Sci. and Technolaoyv. 97th Cong.. Ist Sess. 12 (1981) (statement of Everett Dixon, M.D.)
[hereinafter cited as Genetic Screening Hearingsl.
238. OCCUPATIONAL HEALTH. supra note 224, at 29.
239. Id. at 30-34.
240. Genetic Screening Hearings, supra note 237, at 12.
241. AOMA Comm. Report, supra note 227, at 498.
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management by a physician before job placement should be based on:
(1) a medical history; (2) an occupational history (including a complete
account of past work performed); (3) an assessment of organ systems
likely to be affected by the assignment; and (4) an evaluation of the
description and demands of the job under consideration. 4 2
The components of a pre-placement exam must be valid and
reliable24 3 and any abnormal findings must have a relationship to an
adverse health effect. In some instances, these two criteria are not met,
and the tests are used improperly as a discriminatory tool. Discrimination
in this context can be on an individual2 " or group basis.24 5
Periodic examinations are conducted most commonly on an annual
or semi-annual basis for workers who are exposed to known health
hazards via skin absorption, inhalation or ingestion.2 46 These examina-
tions should give special attention to target organs or bodily organ sys-
242. Id.
243. See supra text accompanying note 78.
244. Low back pain is a common complaint among workers from many occupations,
but it is most commonly associated with lifting and materials handling. For workers applying
for physically demanding jobs, it has not been unusual for a low back x-ray to be included
as part of a pre-placement exam. It was believed that abnormalities detected on x-ray
served as predictors of future back injuries. The current opinion on this practice is that
defects discovered on x-ray "are not etiologically related to the soft-tissue injuries of the
back presented by workers." Felton, The Industrial Medical Department, in ENVIRON-
MENTAL AND OCCUPATIONAL MEDICINE 945 (W. Rom ed. 1983). Because developmental
defects have no demonstrated predictability for future back injuries, the procedure served
only to expose the job applicant to unnecessary doses of ionizing radiation. In addition, if
employers incorrectly believed that any abnormal findings were linked to future back
injuries, those workers having defects on their x-rays would probably not be hired for the
job. To state it another way, those workers would be discriminated against for hiring or
transfer purposes so as to protect the employer from liability in case of injury. This is
discrimination on an individual basis.
245. Genetic screening as part of a pre-placement exam serves as an illustration of
the possibility of discrimination on a group basis. For example, the DuPont Company, the
thirteenth largest employer in the United States, routinely screens blacks for sickle-cell
trait. Severo, Screening of Blacks by Dupont Sharpens Debate on Gene Tests, N.Y. Times,
Feb. 4, 1980, at 1, col. 5. The company believes that sickle cell trait in combination with
certain chemical exposures causes blood oxygen levels to decrease. At DuPont's largest
plant, in Deepwater, New Jersey, Italian workers comprise the largest single ethnic group
employed. Id. at 13, col. 1. Italians are a group ethnically linked to genetic traits for both
beta thalassemia and G-6-PD deficiencies, and these genetic traits are believed to surpass
the sickle-cell trait as health risks. In spite of this fact, the Mediterraneans received no
genetic testing. Even though only 0.2 of 1% of American blacks develop sickle cell anemia,
the blacks were the only ones tested for genetic traits. Id. at 13, col. 1. (Recall that OTA
has determined that the state-of-the-art for genetic screening is not developed enough at
this time to justify screening in the workplace.) In the future, however, the screening
methods may become more scientifically valid and reliable. Even if the technology for
genetic screening is improved to the point of workplace implementation, the very real and
disturbing possibility of more group discrimination seems likely. See generally infra text
accompanying notes 489-549.
246. The 23 OSHA standards all require periodic examinations, usually annually or
semi-annually. The NIOSHIOSHA Occupational Health Guidelines (see supra note 19)
recommends periodic testing, with the timing determined on a chemical-by-chemical basis.
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tems that are most likely to be affected. 247 The testing intervals should
be designated on a substance-by-substance basis so as to detect any
adverse health effects early enough to permit remedial action and pre-
clude lasting consequences.248 Understanding the natural history of an
occupationally related disease is of prime importance in determining the
appropriate tests and testing intervals for workers exposed to specific
substances. Both should be selected with reference to specific risks as-
sociated with certain exposures or occupations.249
The health status of a worker should be determined after an absence
from work because of injury250 or illness.'5 ' This determination will ensure
247. See AOMA Comm. Report, supra note 227, at 498.
248. Genetic Screening Hearings, supra note 237, at 12.
249. For example, consider a non-smoking worker who will be exposed to chronic
low levels of sulfur dioxide (SO2). Studies show that SO2 is very irritating to the mucous
membranes of the upper respiratory tract, where 90% of the SO2 is absorbed. OCCUPA-
TIONAL DISEASES, supra note 173, at 437. There is only slight SO2 penetration in the lower
respiratory tract (i.e., lungs). 40 Fed. Reg. 54,520-21 (1975). To date OSHA has not
promulgated a sulfur dioxide rule. Beliles, OSHA Occupational Health Standards and the
Sensitive Worker, 3 ANNALS AM. CONFERENCE GOVTL. INDUS. HYGIENISTS 71, 75 (1982).
Pulmonary response to low-level SO2 includes broncho-constriction accompanied by in-
creased pulmonary resistance. Therefore, workers exposed to low-level sulfur dioxide
should have a pre-employment/pre-placement chest x-ray and pulmonary function tests in
order to obtain baseline data measurements. Subsequent periodic exams should continue
to include pulmonary function tests, comparing those results to the baseline measurements.
Annual chest x-rays, however, for the purpose of detecting occupationally-related pulmo-
nary disease related to low-level SO2 exposure are not appropriate, as pulmonary function
tests better determine the pulmonary pathology induced from sulfur dioxide. 40 Fed. Reg.
54,530 (1975). Consideration should also be given to smoking habits and exposures to other
pulmonary irritants in both pre-placement and periodic exams. OCCUPATIONAL DISEASES,
supra note 173, at 437.
In 1979, the Canadian Task Force on the Periodic Health Examination conducted a
study on the usefulness of annual health examinations. Canadian Task Force on the Periodic
Health Examination, The Periodic Health Examination, 121 CANADIAN MED. ASS'N J.
1193 (1979). The Task Force found insufficient justification to continue conducting annual
exams and recommended that periodic exams be substituted in their place. Some of the
conditions for which there was sufficient scientific evidence to warrant periodic examination
include: (1) smoking - workers in asbestos, silica, uranium, coal and grain industries;(2) cancer of the bladder - smokers and workers exposed to bladder carcinogens;(3) cancer of the skin - outdoor workers and others in contact with polycyclic aromatic
hydrocarbons; and (4) tuberculosis - those exposed to the disease through work.
250. The logging industry provides an example of testing after injury. NIOSH rec-
ommends that those workers employed in logging (from felling to first haul), who are absent
for five or more days due to injury, receive a medical exam upon return in order to determine
fitness. BioTechnology, Inc., OSHA Medical Surveillance Requirements and NIOSH Rec-
ommendations for Employees Exposed to Toxic Substances and Other Work Hazards (1980)(report prepared for the NASA Occupational Health Office).
251. The OSHA lead standard contains provisions for blood lead level testing before
the return (to former job status) of workers who were removed because of high blood lead
levels or other medical determinations. 29 C.F.R. §§ 1910.1025(k)(l)(iii)(A)(l)-(3) (1983).
Depending on the blood lead level that caused the employee to be removed, the employee
can be returned to former job status after two consecutive blood samples indicate that the
employee's blood lead is at or below a specified level. An employee removed based on a
medical determination can also be returned when it is medically determined that "the
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that the worker has sufficiently recovered from the illness or injury to
perform the job without undue risk to the individual or others, and that
the worker is not taking any medication that increases the risk of illness
or injury in the workplace.2 5 2
For the purposes of this discussion, episodic exams are those appro-
priate human monitoring tests that are administered after an emergency
exposure, such as an accidental spill. Vinyl chloride25 3 and 1,2-Dibromo-
3-chloropropane (DBCP),25 4 two OSHA standards, serve as examples for
such testing following an emergency during employment.
An employee's health status should be evaluated upon termination
or retirement. The employee should be informed concerning his or her
health status and advised of any adverse health effects from his or her
job. 255 Termination exams, also referred to as exit examinations, are
required by several OSHA health standards.25 6 Some NIOSH Criteria
Documents provide recommendations, not requirements, for termination
or retirement exams.25 7
employee no longer has a detected medical condition which places the employee at in-
creased risk of material impairment to health from exposure to lead." Id.
§ 1910.1025(k)(l)(iii)(A)(4).
252. AOMA Comm. Report, supra note 227, at 498.
253. Subpart 3 of the medical surveillance provisions of the vinyl chloride standard
states that "each employee exposed to an emergency shall be afforded appropriate medical
surveillance." 29 C.F.R. § 1910.1017(k)(3) (1983). An "emergency" in the vinyl chloride
standard is defined as "any occurrence such as, but not limited to, equipment failure, or
operation of a relief device which is likely to, or does, result in massive release of vinyl
chloride." Id. § 191Q. 1017(a)(5).
254. Subpart 6 of the medical surveillance provisions of the DBCP standard states
that "[i]f the employee is exposed to DBCP in an emergency situation, the employer shall
provide the employee with a sperm test as soon as practicable .... The employer shall
provide these same tests three months later." Id. § 1910.1044(m)(6). The "emergency sit-
uation" provision also contains specific requirements for those workers who have had a
vasectomy or are unable to produce a sperm specimen. In this standard, an "emergency"
is defined as "any occurrence such as, but not limited to, equipment failure, rupture of
containers, or failure of control equipment which may, or does, result in an unexpected
release of DBCP." Id. § 1910.1044(b).
255. AOMA Comm. Report, supra note 227, at 498.
256. Workers who are covered by the arsenic, 29 C.F.R. § 1910.1018(n)(3)(iii) (1983),
coke oven, id. § 1910.10290)(3)(iv), or acrylonitrile, id. § 1910.1045(n)(3)(ii), standards and
have not received medical exams within six months of terminating employment must have
such examinations available to them before termination. Employees covered by the asbestos
standard are to have exit exams within 30 calendar days before or after terminating em-
ployment. Id. § 1910.1001)(4).
257. For example, NIOSH recommends that workers engaged in the manufacture
and formulation of pesticides have a comprehensive medical exam within one month after
the end of employment. NAT'L INST. OF OCCUPATIONAL SAFETY & HEALTH, U.S. DEP'T
OF HEALTH, EDUCATION, & WELFARE, PUB. No. 78-174, CRITERIA FOR A RECOMMENDED
STANDARD . . . OCCUPATIONAL EXPOSURE DURING THE MANUFACTURE AND FORMULA-
TION OF PESTICIDES 10 (1978). A termination exam is recommended for workers exposed
to toxicants in coal gasification plants if no comprehensive medical exam was conducted
within the preceding calendar year. NAT'L INST. OF OCCUPATIONAL SAFETY & HEALTH,
U.S. DEP'T OF HEALTH, EDUCATION, & WELFARE, PUB. NO. 78-191, CRITERIA FOR A
RECOMMENDED STANDARD ... OCCUPATIONAL EXPOSURES IN COAL GASIFICATION
PLANTS 8 (1978).
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The accuracy, reliability and predictive value of tests used in human
monitoring vary greatly and may be especially sensitive to the timing of
the exams. Because monitoring schedules must reflect both the need to
track a variety of exposures and consequences and a concern for business
or production constraints, a comprehensive industrial program for a
workplace with multiple hazards and complex exposure patterns may be
less-than-ideal on many counts.
IV. HUMAN VARIABILITY AND HIGH-RISK GROUPS
The rationale behind human monitoring is to identify those individ-
uals or working populations that exhibit the early signs of occupational
disease or the propensity to develop disease. 5 8 Individuals may differ in
their responses to an increasing dose of a toxic substance. These indi-
vidual responses contribute to a population dose-response curve, on
which the percentage of the population affected is plotted against dose.2 5 9
Those who react at low doses are the first to contribute to building up
the incidence in the population.
Employer actions to change the work environment, provide alter-
native employment or suggest medical treatment ideally follow from the
correct interpretation of monitoring results. The previous Part addressed
the adequacy of tests and their interpretation. This Part discusses the
application of monitoring results to the discovery of high-risk groups, 260
258. This monitoring can yield information important for standard setting to ensure
that the permissible exposure limit protects all workers, or it can be used to encourage the
removal of workers from a harmful environment. Section 20(a)(5) of the OSHAct authorizes
the Secretary of Health, Education, and Welfare to "establish . . . programs of medical
examinations and tests as may be necessary for determining the incidence of occupational
illnesses and the susceptibility of employees to such illnesses." 29 U.S.C. § 669(a)(5) (1982)
(emphasis added). See R. FRIEDMAN, supra note 8.
259. See infra note 339.
260. Calabrese defines high-risk groups as "those individuals who experience toxic
and/or carcinogenic effects significantly before the general population as a result of one or
more biologic factors, including developmental influences [e.g., pregnancy, aging], genetic
factors, nutritional inadequacies, disease conditions, and behavioral or life style character-
istics." E. CALABRESE, supra note 211, at 47. Levy and Wegman caution of the need to
distinguish between hypersusceptibility and hypersensitivity. According to them, the term
hypersusceptibility indicates
an unusually high response to some dose of a substance. This term requires careful interpretation,
however, because it is used in several different ways. It may refer to a genetic predisposition to
a toxic effect; it may indicate a statistically defined deviation from the mean (average]; it may
reflect an observer's subjective impression; or it may be used, incorrectly, as a synonym for
hypersensitivity [whichl is one form of hypersusceptibility, characterized by an acquired, im-
munologically mediated sensitization to a substance.
OCCUPATIONAL HEALTH, supra note 224, at 134-35. Using this definition, workers at high
risk may be considered to be hypersusceptible but not necessarily hypersensitive. To avoid
confusion, this article refrains from using the term "hypersusceptible" in favor of using the
term "high-risk."
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the methodological limitations of the discovery process and the under-
lying causes of human variability. A monitoring activity is only a single
snapshot that gives a measure of the specific chosen parameter at one
time. Unless a sufficient number of successive snapshots are taken,2 6' an
incorrect interpretation and inappropriate remedial action may result.
A. Distribution of Monitoring Results and the Distinction between
High-Risk and Hypersensitive Populations
Monitoring activities yield one of two kinds of experimental data: a
distribution of indicators of health status or a distribution of uptake
Figure 3: Distribution of Monitoring Results
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indicators. Medical surveillance generally provides the first type of data
and biological monitoring the second.2 62 In the graph of each distribution,
the vertical line represents a somewhat arbitrary fence separating the
"high-risk" individuals from the remaining "normal" population. Reme-
dial action concentrating on only the high-risk group is often misguided.
More informative are the changes observed over time on an individual
basis, because both "normal" and "high-risk" populations may shift over
time as a result of continuing exposure. (See Figure 4.)
Often, remedial action taken for individuals not yet in the high-risk
category may reverse or arrest a disease process that later may be difficult
to affect significantly, if at all. Therefore, action directed exclusively
toward the high-risk groups may result in the least effective preventive
strategies.
The reasons that distributions of health status or toxin uptake occur
lie in variations like current and past exposures, current health status,
261. This stipulation relates to the timing of tests. See supra text accompanying note
223.
262. Examples are lung function results and lead uptake as reflected by blood lead
levels, respectively.
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Figure 4: Population Shifts over Time as a Result of Exposure
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and "biological make-up." The distribution of "thresholds," the minimum
dose necessary to exceed "normal" health status or "acceptable" toxin
uptake, is shown in Figure 5. This graph represents the sensitivity
distribution.
Those individuals who cross the normal fence for a health status
indicator or toxin uptake indicator at low doses or exposure have been
called sensitive or "hypersensitive" 2 6 3 individuals. They may or may not
be in a high-risk group. The high-risk group may include those with
greater exposure, prior disease, or a variety of other characteristics, as
well as some who are hypersensitive.
The underlying causes of variability in sensitivity and variability of
high-risk status are complex. Both sensitivity and an individual's position
on a monitoring results distribution are dynamic. Hence, distributions
are dynamic. An individual can be in the sensitive area one month and
in the resilient area the next. Furthermore, sensitive populations may or
may not comprise a significant portion of the high-risk group. This out-
come is due in part to the fact that acute responses (revealed in moni-
toring results of health status or toxic uptake) may not be strongly cor-
related with human disease.
263. For a discussion of hypersensitivity, see OCCUPATIONAL HEALTH, supra note
224, at 134-35. See also supra note 260.
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Figure 5: Sensitivity Distribution
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B. Underlying Causes of Human Variability
Different workers exposed equally to the same substance may exhibit
differences in the results of both medical surveillance and biological
monitoring. There are a number of factors that cause a wide distribution
of testing results in a homogeneously exposed population, including fac-
tors that are determined by nature, factors somewhat in the control of
the employee, and factors in the control of the employer. The following
discussion of variability follows these three controlling factors and in-
cludes stochastic variability, genetic predisposition, age, sex, environ-
mental factors (including behavioral/life style components), and pre-ex-
isting disease.
1. Stochastic, Genetic, Age and Sex Variability
Stochastic variability, which relies on the premise that population
subjects are the same, includes differences in response or uptake occur-
ring "by chance." In the simplest sense, it addresses variability based on
biological differences. 264 Even though the amount, route, and duration of
Fraction of
Exposed
Population
First
Exceeding a
Harmful
Threshold
264. The authors acknowledge the term "ecogenetics," which refers to studies of
"genetically determined differences among individuals in their susceptibility to the action
of physical, chemical, and biologic agents in the environment. The underlying biochemical
mechanisms for such individuality may include differences in rates of metabolic activation
and inactivation and variation in susceptibility of tissue enzymes or receptors." Omenn &
314 [Vol. 8:263
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exposure can be controlled, "there is still likely to be a great deal of
variation in the response of individual members of a population to a
specific toxic agent. Some of this variation can be attributed to factors
that influence the absorption, distribution, metabolism or excretion of
the toxic agent . . 265
Motulsky, 'Eco-genetics': Genetic Variation in Susceptibility to Environmental Agents, in
GENETIC ISSUES IN PUBLIC HEALTH AND MEDICINE 83 (B. Cohen, A. Lilienfield & P.
Huang eds. 1978). Further,
the field of human ecogenetics deals with the question of why only a certain proportion of
exposed human beings will be injured by harmful environmental agents .... [Tlhe working
hypothesis of ecogenetics is the concept that an individual's internal make-up will often determine
the response to an environmental agent, particularly if not all human beings react equally to that
particular agent.
Motulsky, Ecogenetics: Genetic Variation in Susceptibility to Environmental Agents, in
HUMAN GENETICS, PROCEEDINGS OF THE FIFTH INTERNATIONAL CONGRESS OF HUMAN
GENETICS, MEXICO CITY, OCTOBER 10-15, 1976 376 (S. Armendares & R. Lisker eds.
1977). The term by definition encompasses the concept of stochastic variability, but for
purposes of this brief discussion, the authors have separated out the genetically determined
biochemical mechanisms that affect rates of metabolism and excretion from those genetic
traits that might be used for worker screening purposes (e.g., G-6-PD).
Recently, Hattis and Ballew have begun efforts to quantify observed stochastic var-
iability in physiological parameters that determine susceptibility to the action of ordinary
toxic agents. D. Hattis & M. Ballew, Human Variability in Susceptibility to Toxic Chemicals
- I. A Preliminary Analysis of Pharmacokinetic Data from Normal Volunteers (Dec. 15,
1983) (manuscript submitted to the U.S. Envtl. Protection Agency, Envtl. Criteria and
Assessment Office). They divide these physiological parameters into three broad groups:
(I) Exposure-determining parameters that alter the dose taken into the body for a given con-
centration of chemical present in air, water or food. These include, for example:
- Differences among people in breathing rates for a given amount of activity.
- Behavioral differences such as dietary habits (people who eat a great deal of swordfish will
tend to get a larger dose of swordfish mercury than people who do not).
(2) Pharmacokinetic parameters that determine the relationship between the external dose and
the concentration and length of time of the chemical in the blood or at its site of action in the
body. Such parameters include internal body half-lives of chemicals.
(3) Response parameters that determine differences in toxic responses, after controlling for
differences in the first two kinds of parameters, that is, controlling for differences in concentration
of chemicals in the blood for each unit of chemicals in the environment.
Hattis and Ballew reviewed data on the second group of parameters listed above for 32
chemicals from studies conducted in normal healthy adults, For the typical chemical, the
variability in this restricted set of parameters was such that the most sensitive two percent
of the normal healthy population would be expected to be about 1.8 times as sensitive as
the median normal healthy person. For the four chemicals with the greatest inter-individual
variation in the parameters studied, the most sensitive two percent of the normal healthy
population would be expected to be over three times as sensitive as the median normal
healthy person. It should be stressed that these data represent a minimal estimate of
stochastic inter-individual variability because they exclude variability that would be pro-
duced by "exposure" and "response" type parameters.
265. CASARETTr AND DOULL'S TOXICOLOGY, supra note 95, at 70. In the review of
studies related to solvent exposure, Gompertz accounts for variability in uptake by noting
that "[e]xperimental studies have shown that uptake of any solvent depends on pulmonary
ventilation . . . [the solvent's] solubility in blood and tissues and the relative size of adipose
tissue [deposits]." Solvents, supra note 30, at 407.
Harvard Environmental Law Review
The concept of biochemical individuality may also account for var-
iability in testing results. According to Calabrese, "[o]verwhelming bio-
chemical evidence has shown that each person has his/her own charac-
teristic metabolic pattern, identifiable and recognizable by the activities
of the enzymes involved . . . . Each . . . responds in an individualistic
fashion to various toxic agents."6
Certain easily recognized genetic traits may cause a variation in
response to toxic agents.2 6 ' Genetic factors may also play a role in
infectious resistance as well as adaptation to climate and high altitude in
certain populations. 268 The mechanism accounting for the biologic vari-
ation may be the inherited structure of protein receptors, which causes
abnormal reactivity to toxic agents or drugs. 26 9
It is often difficult to distinguish genetic from environmental contri-
butions to variability. According to one researcher, "a major problem in
man is that most populations are markedly heterogeneous with respect
both to environmental and genetic factors . .. " and "many environmental
factors that alter rates of drug disposition do so by affecting genetic
mechanisms .... 270 Pharmacokinetic factors that control the results of
clearance and metabolism of solvents are probably both genetically and
environmentally determined.2 '
Approximately 150 genetic diseases have been identified in humans,
and 26 of those were identified as having a "theoretical basis for causing
enhanced susceptibility to toxicants." 27 2 Stokinger reported that only five
genetically determined specific enzymes should be used to predict in-
creased susceptibility to toxicants in industrial settings.27 3 The OTA has
reviewed genetic traits for screening, 4 but the extent to which these
traits are responsible for occupational disease is unknown. It is believed,
266. E. CALABRESE, supra note 211, at 243.
267. See generally Omenn, Predictive Identification of Hypersusceptible Individuals,
24 J. OCCUPATIONAL MED. 369 (1982). For example, individuals with G-6-PD deficiency
are considered more susceptible (i.e., sensitive) to chemicals like aniline, methylene blue
and naphthalene and to certain drugs like aspirin. OCCUPATIONAL HEALTH, supra note
224, at 359. When exposed to these agents, their red blood cells have a decreased capacity
to carry oxygen. Also, serum alpha,-antitrypsin deficiency has been linked to emphysema.'
Omenn & Motulsky, supra note 264, at 89. See also E. CALABRESE, POLLUTANTS AND
HIGH RISK GROUPS: THE BIOLOGICAL BASIS OF INCREASED HUMAN SUSCEPTIBILITY TO
ENVIRONMENTAL AND OCCUPATIONAL POLLUTANTS 55 (1978).
268. Motulsky, supra note 264, at 383.
269. CASARETT AND DOULL'S TOXICOLOGY, supra note 95, at 76. One researcher
found that genetic factors are predominantly responsible for large inter-individual variations
in drug disposition in twin (fraternal and identical) studies. Vesell, Genetic and Environ-
mental Factors Affecting Drug Disposition in Man, 22 CLINICAL PHARMACOLOGY & THER-
APEUTICS 659, 659 (1977).
270. Vesell, supra note 269, at 659.
271. Solvents, supra note 30, at 409.
272. E. CALABRESE, supra note 211, at 54.
273. Stokinger & Scheel, supra note 143, at 572-73.
274. See supra note 132.
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however, that enhanced susceptibility to stressor agents due to genetic
deficiency usually affects only minor subsegments of the population.275
Persons are more susceptible to adverse effects from environmental
agents at certain ages.276 Studies using laboratory animals of different
ages have shown that "differences in the rate of drug metabolism have
been shown in senescent animals and thus metabolic and excretion pat-
terns may be contributing to toxicity variation at both extremes of the
life-span rather than simply in the newborn."2 77 Although at least one
researcher has found that "age plays a small role in controlling the rate
of elimination of certain drugs," 278 others believe that the blood level and
excretion following a given dose of a medicine changes with age. Because
the metabolism and excretion of industrial chemicals use the same en-
zymes and excretion mechanisms, similar changes could be expected for
industrial chemicals.27 9
Other changes occur with age. Blood pressure increases, 280 and in-
dividuals above the age of fifty may retain pollutants such as fluoride.2 '
After adolescence, the immune system progressively degenerates, pos-
sibly increasing sensitivity to carcinogens and respiratory irritants.282
In humans, sex is a factor that might affect chemical concentration
in expired air analysis. 283 Differences result from variations in total blood
volume and extra-cellular fluid, affecting the rate of saturation of the
chemical. 284 Another source of sex-related differences is that sex hor-
mones influence the enzymatic biotransformation of an agent.285
275. E. CALABRESE, supra note 211, at 54.
276. Section 20(a)(7) of the OSHAct directs the Secretary of Health and Human
Services to "conduct and publish industry-wide studies of the effect of chronic or low level
exposure to industrial materials, processes, and stresses on the potential for illness, disease,
or loss of functional capacity in aging adults." 29 U.S.C. § 669(a)(7) (1982). The very young
and the very old have enhanced susceptibility to respiratory infections. E. CALABRESE,
supra note 211, at 47. Infants and children show differential absorption of pollutants such
as barium, lead and radium as a function of age. E. CALABRESE, supra note 267, at 187;
see also Redolfi, Borgogelli & Lodola, Blood Level of Cimetidine in Relation to Age, 15
EUR. J. CLINICAL PHARMACOLOGY 257, 257-61 (1979).
277. CASARETT AND DOULL'S TOXICOLOGY, supra note 95, at 78.
278. Vesell, supra note 269, at 644.
279. Waritz, supra note 158, at 280, 282.
280. Tuthill & Calabrese, Age as a Function in the Development of Sodium-Related
Hypertension, 29 ENVTL. HEALTH PERSPECTIVES 35, 35 (1979).
281. E. CALABRESE, supra note 267, at 187.
282. Id.; Doll, An Epidemiological Perspective of the Biology of Cancer, 38 CANCER
RESEARCH 3573 (1978). To date, according to Bennett, "one can state that susceptibility to
chemical carcinogenesis is associated with relative dysfunctions of the immune system and
that age is important because it affects immune function." Bennett, Effect of Age on Immune
Function in Terms of Chemically Induced Cancers, 29 ENVTL. HEALTH PERSPECTIVES 17,
20 (1979).
283. See supra note 187.
284. Waritz, supra note 158, at 298.
285. CASARETT AND DOULL'S TOXICOLOGY, supra note 95, at 77. Animal studies
show differences in toxicity based on sex. For example, aspirin and nicotine have been
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2. Environmental Factors
This subsection treats behavioral and lifestyle factors as environ-
mental factors. This discussion moves out of the area in which variables
are controlled by "nature" and into an area in which the worker may be
able to exert more control over exposures. Exposures to environmental
factors are numerous and complex, making it "exceedingly difficult to
attribute quantitatively different portions of the total interindividual var-
iation to specific single environmental factors." 286 Environmental factors
can cause variability in biological response, toxin uptake, or both.
Nutritional deficiencies may exacerbate the toxic effects of certain
pollutants. 28 7 Dietary factors can influence toxicity by producing changes
in body composition, physiologic and biochemical functions, and nutri-
tional status.288 Diet, particularly an unbalanced one, could alter enzy-
matic activity, leading to changes both in metabolism and in excretion of
workplace chemicals.289 Diets low in vitamin E can enhance toxicity to
environmental agents, especially ozone, nitrous oxide,290 and lead.29' A
vitamin E deficiency coupled with a G-6-PD deficiency may markedly
enhance the toxicity of ozone to red blood cells.2 2 Vitamin C deficiencies
may enhance the toxicity of agents like carbon monoxide, arsenic, lead
and mercury.293 Persons deficient in riboflavin (30% of women and 10%
of men aged 30-60 ingest less than two thirds of the recommended daily
allowance) may exhibit enhanced toxicity to lead, ozone and hydrocarbon
carcinogens.294
Alcohol is the most widely used and abused liver-damaging agent in
the United States across all age ranges.295 Persons who ingest large
quantities of alcohol frequently have otherwise inadequate diets, partic-
ularly in B vitamins, which are necessary for normal liver maintenance. w
Alcohol intake may also affect the absorption, metabolism or excretion
of some nutrients. 297 Alcohol, metabolized in the liver, may damage that
organ and thereby reduce the ability of the liver to deactivate toxins. For
employees who drink alcohol and work with various chemicals like lead
found more toxic to female than male rats, and epinephrine and digoxin have been found
more toxic to male rats and dogs, respectively. There is also inconclusive evidence that
benzene is more toxic to women than to men. Goldstein, Benzene Haematotoxicity 2 (paper
presented at Luxembourg Seminar, supra note 29).
286. Vesell, supra note 269, at 659.
287. E. CALABRESE, supra note 211, at 55.
288. CASARET AND DOULL'S TOXICOLOGY, supra note 95, at 76.
289. Waritz, supra note 158, at 267.
290. Menzel, Nutritional Needs in Environmental Intoxication: Vitamin E and Air
Pollution, An Example, 29 ENVTL. HEALTH PERSPECTIVES 105, 111 (1979).
291. E. CALABRESE, supra note 140, at 575.
292. Id. at 574.
293. E. CALABRESE, supra note 211, at 51.
294. Id. at 52.
295. E. CALABRESE, supra note 140, at 221.
296. Id. at 215.
297. Id.
[Vol. 8:263318
Human Monitoring
or pesticides, toxicity may be enhanced.' 9 8 Thus, alcohol may not only
contribute to nutritional deficiencies, but also potentially cause damage
to the liver, decreasing the ability of the body to detoxify workplace
chemicals.
Adverse health conditions related to cigarette smoking, such as lung
cancer, cardiovascular disease, chronic bronchitis and emphysema are
well known. Cigarette smoking coupled with certain occupational expo-
sures places workers at an even greater risk of developing disease. For
example, significant exposure to cigarette smoke is associated with a risk
of death from lung cancer that is eleven times greater than that to the
general population.2 9 Smokers working in occupations with asbestos
exposures, however, have a risk fifty-five times as great.300
Workers may develop airway obstruction as a result of occupation
alone (e.g., coal miners, firefighters and cotton textile workers). Those
who smoke develop an even greater degree of airway obstruction than
nonsmokers.3 0' In addition, cigarettes may facilitate oral entry of some
substances, such as lead, simply by contamination. Some substances that
enter the body by cigarette contamination are chemically transformed by
the heat of the cigarette, and workers may become ill after inhaling the
combination of the transformed substance and cigarette smoke.30 2
A multitude of non-occupational agents may account for variability
in observed responses and testing results. Those more or less under the
direct control of the worker have already been mentioned. Environmental
chemicals may alter the receptor for the toxic agent in the biologic test
system or the absorption, distribution and excretion of the toxic agent.30 3
Some of these environmental factors include outdoor and indoor air
pollutants, drinking water contaminants and consumer products like
household cleaning agents3 4 and cosmetics. Exposures to these agents
may cause allergic sensitization,3 0 5 possibly resulting in exacerbated re-
sponses to workplace chemicals among some workers.306
Aside from causing allergic sensitization, environmental exposures
may also burden the body with the same substance that the worker is
being exposed to at work. For example, a particular blood lead level
298. E. CALABRESE, supra note 267, at 193.
299. OCCUPATIONAL HEALTH, supra note 224, at 157.
300. Id.
301. Holbrook, Cigarette Smoking, in ENVIRONMENTAL AND OCCUPATIONAL MED-
ICINE 793 (W. Rom ed. 1983). The cilia, which are instrumental in clearing the lungs, may
become paralyzed by cigarette smoke. Id. at 787-88.
302. Id. at 792-93.
303. CASARETr AND DOULL'S TOXICOLOGY, supra note 95, at 82.
304. Swartz, Litigating Household Caustics Injuries, 88 CASE & COMMENT 3 (1983).
305. Sensitization is an immunologically mediated response that requires prior ex-
posure or preconditioning. For example, the use of certain soaps or cosmetics may sensitize
an employee to workplace agents that contact the skin, causing or exascerbating a
dermatitis.
306. Steinberg, ACGIH TLV's and the Sensitive Worker, 3 ANNALS AM. CONFERENCE
GOVERNMENTAL INDUS. HYGIENE 77 (1982).
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measurement will generally reflect lead exposure from work, ambient air
exposure to lead in gasoline, and dietary lead exposure. The most recent
documented decrease in blood lead levels among workers in lead exposed
industries resulted as much from decreases in ambient air lead concen-
trations due to the lowered lead content of gasoline as from decreases in
occupational exposure.307
The influence of other less studied environmental factors on human
responses to toxins is beginning to receive more attention. For example,
emotional factors may "influence the susceptibility of man to toxic agents
in his environment . . . [and] epidemiologists increasingly include con-
sideration of such effects as urbanization, noise, adaptive response to
change, and other social and economic pressure in the etiology of disease
states associated with air and water pollution. " 0 Growing experimental
data indicate that environmental factors such as vibration, acceleration,
and magnetism may influence biologic responses both in experimental
animals and in man.3 9 Increasing exercise can cause a considerable
increase in solvent uptake simply by increasing the respiratory rate and
volume of contaminated air inhaled. 310
Some environmental exposures may lead not only to allergic sensi-
tization but also to increased risk of disease or exacerbation of existing
disease. For example, living near a hazardous waste site could increase
the risk of certain diseases for local residents.3 ' In atmospheres where
there is a significant concentration of cigarette smoke coupled with poor
ventilation, enough carbon monoxide may build up to exacerbate symp-
toms of angina pectoris (cardiac-related chest pain) and chronic obstruc-
tive pulmonary disease. 2 Peak levels of nitrous oxide have been ob-
served in homes using gas stoves for cooking purposes.3 '3 This exposure
could trigger an asthmatic attack in sensitive persons.'
3. Pre-Existing Disease
Pre-existing disease can result from non-occupational origins as well
as from past or current occupational exposures. Regardless of the origin,
poor health, varying degrees of organ pathology and various disease
conditions are likely to influence the toxic response in the exposed in-
307. R. Goble, D. Hattis, M. Ballew & D. Thurston, Implementation of the Occu-
pational Lead Exposure Standard (1983) (CPA-83-11) (Center for Policy Alternatives, Mas-
sachusetts Institute of Technology).
308. CASARETT AND DOULL'S TOXICOLOGY, supra note 95, at 78.
309. Id. at 79.
310. Solvents, supra note 30, at 407.
311. S. Lagakos, B. Wessen & M. Zelen, Synopsis: The Woburn Health Study, An
Analysis of Reproductive and Childhood Disorders and Their Relation to Environmental
Contamination (Jan. 1984) (Harvard School of Public Health study).
312. Holbrook, supra note 301, at 794.
313. Spengler & Colome, The In's and Out's of Air Pollution, 85 TECH. REV. 32, 41
(1982).
314. For example, "[n]itrogen dioxide within homes increases respiratory infections
and decreases lung function in children." Id. at 37.
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dividual.31 5 Disease states may also significantly alter and conceal genet-
ically controlled drug (and perhaps toxin) elimination.3 6
Persons with certain pre-existing diseases of non-occupational origin
may increase the severity or frequency of their symptoms when exposed
to certain workplace agents. For example, those with chronic respiratory
disease or asthma may have their symptoms aggravated by respiratory
irritants like ozone or sulfates.3 '7 Persons with coronary artery disease
may find the condition exacerbated by stress or exposure to carbon
monoxide, fluoride or respiratory irritants.3 '8
Medical surveillance measures not only the effects of current occu-
pational exposure, but also the deterioration of health status from occu-
pational disease induced by prior employment. For example, a worker
currently exposed to cotton dust may exhibit reduced lung function due
to both current exposures and prior impairment caused by exposure to
asbestos associated with work in construction.
V. CONSEQUENCES TO THE WORKER FROM MEDICAL REMOVAL
The decision to remove a worker from a job is closely linked to the
results of biological monitoring tests, medical surveillance tests, or a
combination of the two. Realizing that the decision to remove a worker
depends strongly on these results, one must assess again the appropri-
ateness and validity of the test for the substance of concern.319 For
example, in a situation in which testing may give false positive results,
workers incorrectly diagnosed as sick may be inappropriately removed.
Conversely, asymptomatic workers who have false negative results may
remain on the job when, in fact, they should be removed.
A. Medical Removal in OSHA Standards
Of the twenty-four OSHA standards, only the vinyl chloride and
lead standards discuss removal action based on medical surveillance or
biological monitoring results. The asbestos and cotton dust standards
contain medical removal provisions that apply only when a physician
determines that a worker is unable to wear a respirator. This determi-
nation is based on the results of non-specified medical surveillance
testing.
I. Standards Requiring Removal Based on Medical Surveillance and
Biological Monitoring Triggers
The OSHA vinyl chloride standard, promulgated in October 1974,
provides for medical removal. In the medical surveillance requirements,
315. CASARETT AND DOULL'S TOXICOLOGY, supra note 95, at 79.
316. Vesell, supra note 269. at 660.
317. E. CALABRESE, supra note 367, at 192.
318. Id. at 193.
319. See supra notes 78 & 249 and accompanying text.
1984] 321
Harvard Environmental Law Review [l
the standard states "[i]f any employee's health would be materially im-
paired by continuous exposure, such employee shall be withdrawn from
possible contact with vinyl chloride."32 0 The rule does not provide the
employee with either job or economic security after removal. Employees
might choose, therefore, not to consent to medical exams for fear of
abnormal findings that would lead to loss of their jobs, temporary lay-
offs, or transfers to a lower paying position. This non-specific removal
policy differs very little, if at all, from the policy of a typical lead smelter.
This policy states that an employee showing a blood lead level of eighty
or above will be given a written warning notice and advised that his blood
lead level must be returned to a level below eighty within the next ninety
days. The employee's blood lead level will be checked each thirty days
and he will be advised of the results. If at the end of the ninety day
period the employee's blood level has not returned to less than eighty,
excepting extraordinary mitigating circumstances, he shall be discharged.
The OSHA lead standard, promulgated in 1978, contains the most
specific and stringent medical removal protection (MRP) provisions of
any OSHA standard to date. 2 ' These MRP requirements are contained
in a separate MRP section of the standard. They are the first provisions
to be triggered by results of biological monitoring, not of medical sur-
veillance alone.
The lead standard does not specify where a removed worker must
be placed and states "practically any action is permissible provided the
worker is not exposed to lead at or above the action level [30 pxg/m 3]." 322
Removal options include reduction of hours worked, transfer to a job
with reduced or no lead exposure, or temporary lay-off. No matter which
option is selected, the standard requires that a removed worker receive
MRP benefits. "[T]he employer shall maintain the earnings, seniority,
and other employment rights and benefits of an employee as though the
employee had not been removed from normal exposure to lead or oth-
erwise limited."3 3 The employer must provide these MRP benefits for
up to eighteen months each time the employee is removed from lead
exposure. 324
Maintaining economic and employment benefits during removal is
an attractive feature for workers. The employee does not risk continued
exposure, and the guarantee of benefits encourages workers to participate
in medical exams and biological monitoring. This incentive is one reason
OSHA included MRP in the lead standard.325
320. 29 C.F.R. § 1910.1017(k)(5) (1983).
321. Id. § 1910.1025(k).
322. 43 Fed. Reg. at 52,975 (1978).
323. 29 C.F.R. § 1910.1025(k)(2)(ii).
324. Id.
325. The agency stated that "[clonvincing evidence presented during the lead pro-
ceedings established that many workers will either refuse or resist meaningful participation
in medical surveillance unless economic protection is provided .... MRP was included in
the final standard as a means of maximizing meaningful participation in medical surveillance
provided to lead-exposed workers." 43 Fed. Reg. at 52,973.
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An interesting distinction between the MRP provision of the lead
standard and that of the asbestos standard 2 6 involves the availability of
a comparable transfer job. While the MRP benefits for workers exposed
to asbestos are contingent on the availability of a comparable position,3 7
OSHA promulgated more stringent criteria in the final lead standard. The
agency stated that "the standard by implication rejects industry sugges-
tions that the provision of MRP benefits should be contingent upon the
employer's ability to locate an available transfer position. Such an avail-
able position precondition would end MRP's role as a means of effec-
tuating meaningful participation in medical surveillance."3 2 8
The removal provisions of the lead standard take individual varia-
bility into account and thereby recognize individual risk. The standard
(as of March 2, 1983) provides a blood lead trigger level for removal of
50 Lg/100 g, but not all workers will necessarily be safe with blood lead
at that level. The standard provides for removing a worker whose lead
levels remain below the threshold if a physician determines that, for
medical reasons, the worker should have reduced or no lead exposure.3 2 9
In such instances, removal would be triggered not necessarily or exclu-
sively by biological monitoring results, but also by results of medical
surveillance testing. Workers so removed are still entitled to full MRP
benefits. 330
2. Standards Requiring Removal Based on Respirator Usage
The OSHA asbestos standard, promulgated in 1972, contains an
MRP provision in the personal protective equipment section for employ-
ees who cannot wear respirators, provided that a different job is avail-
able.3 3' The regulation does not clarify what happens to a worker who is
unable to wear a respirator when no alternative position exists. In that
case, the worker may be limited to medical removal only, with no op-
portunity to retain wages or employment benefits. The asbestos standard
does not specify what types of medical surveillance results trigger re-
moval, where the removed worker is to go, what are the allowable
exposure limits in the different job, when the worker can return, or
whether he or she can return at all.
326. See infra note 331 and accompanying text.
327. Id.
328. 43 Fed. Reg. at 52,976.
329. 29 C.F.R. § 1910.1025.
330. Id.
331. The provision states:
No employee shall be assigned to tasks requiring the use of respirators if, based upon his most
recent examination, an examining physician determines that the employee will be unable to
function normally wearing a respirator, or that the safety or health of the employee or other
employees will be impaired by his use of a respirator. Such an employee shall be rotated to
another job or given the opportunity to transfer to a different position whose duties he is able
to perform with the same employer, in the same geographical area and with the same seniority.
status, and rate of pay he had just prior to such transfer. ifsuch a different position is available.
Id. § 1910.1001(d)(2)(iv)(c) (emphasis added).
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The respirator section of the OSHA cotton dust standard, promul-
gated in 1976, includes MRP provisions as well.33 As with asbestos,
these MRP provisions depend solely on the worker's inability to wear a
respirator, as determined by an examining physician. Again, there is no
link between the section in which the MRP provisions appear and the
section describing the medical surveillance tests. In addition, the standard
gives no criteria for removal. The MRP in this standard protects employ-
ment benefits more than the simple medical removal clause in the vinyl
chloride standard, but not as much as the MRP provision in the lead
standard.
On June 17, 1981, the Supreme Court upheld most of the cotton dust
standard. The court remanded the MRP provisions,333 however, stating
that "the Agency has failed to make the necessary determination or
statement of reasons that its wage guarantee requirement is related to
the achievement of a safe and healthful work environment."3 3 Since the
remand, the agency has not reintroduced the MRP provisions for the
cotton dust standard. Therefore, as of this writing, MRP is not legally
required under the cotton dust standard.
3. NIOSHIOSHA Guidelines on Removal
The NIOSHIOSHA Occupational Health Guidelines provides sub-
stance-by-substance recommendations, not requirements, for the type
and timing of medical surveillance and biological monitoring tests.335 In
following these guidelines, employers may, on their own initiative, choose
to remove workers from exposure on the basis of test results. The guide-
lines provide no recommendations for medical removal protection.
B. Limitations of Medical Removal
It is important to recognize that removing certain workers336 only
removes the "sensitive canaries." 337 Certain sensitive workers may sim-
332. The provision states:
Whenever a physician determines that an employee is unable to wear any form of respirator,
including a power air purifying respirator, the employee shall be given the opportunity to transfer
to another position which is available or which later becomes available having a dust level at or
below the PEL [Permissible Exposure Limitl. The employer shall assure tha [sic] an employee
who is tranferred due to an inability to wear a respirator suffers no loss of earnings or other
employment rights or benefits as a result of the transfer.
Id. § 1910.1043(f)(2)(v) (emphasis added).
333. Supreme Court Rejects Cost-Benefits, Upholds OSHA's Cotton Dust Standard,
II O.S.H. REP. (BNA) 54 (June 18, 1981).
334. American Textile Mfrs. Inst. v. Donovan, 452 U.S. 490, 537-38 (1981).
335. See supra notes 45-46 and accompanying text.
336. The Threshold Limit Values Committee of the American Conference: of Govern-
mental Industrial Hygienists advocates removing the sensitive worker, rather than attempt-
ing to set a safe level for exposure. See Steinberg, supra note 306. For a discussion of
OSHA's position on protecting sensitive workers, see generally Beliles, supra note 249.
337. Coal miners used to take caged canaries into the mines with them. When methane
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ply exhibit symptoms or suspicious monitoring results earlier than the
rest of the working population. "Like the proverbial canary in a coal
mine, the most sensitive worker may herald dangers that will ultimately
affect all workers."3 3 8 Removing particular employees may therefore give
a false sense of security to remaining and replacement workers. In ad-
dition, a false sense of security may develop from the unwarranted con-
clusion that because the risk to the removed individual is reduced, the
risk to the work group as a whole is lessened.
Before considering a medical removal strategy, it is important to
identify both the toxic substance of concern and the effects of exposure
to given levels. Determining dose-response relationships339 (especially at
low doses), however, is an area of much debate. Frequently, human data
are unavailable, and scientific studies on the substances involve only
animals. Even the best available data do not allow an accurate determi-
nation of a threshold or no-response level.
Dose-response relationships are usually available for the response
of a given population to an exposure to a single agent. In the workplace,
workers are frequently exposed to multiple agents simultaneously. It is
therefore difficult to ascertain which substance is responsible for the
observed effect or to determine whether the response is due to the
interaction of the multiple agents. Only when the dose-response curve
has been approximated from the best available scientific evidence can
one assess the usefulness of rotating workers.
The rotation of workers can, in some instances, cause more total
disease. This result depends on both the substance and the shape of the
curve. The rationale behind removing workers is that their exposure and
risk of harm decreases. If the dose per worker were reduced from a high
dose to a dose below the threshold, no worker would be at risk. If,
however, the dose per worker were reduced to a level that is above the
threshold, then each worker would still incur a finite, though lower risk.
If replacement workers fill the job assignments of the removed workers,
more workers are exposed to the toxin as a result of the rotation. For
those substances for which a threshold exists, rotating workers would
assure a reduction in total damage only if the dose for each worker were
below the threshold.340
concentrations reached a certain level, the canaries would die, signaling the: workers that
methane was climbing to unhealthy levels.
338. Banning Workers to Protect Them, N.Y. Times, Mar. 22, 1980, at 20, col. 2.
339. A dose-response relationship reflects the fraction of an exposed population
adversely affected as a function of dosage. It is, of course, dependent on what is defined
as an "effect" or "response." In contrast, a dose-effect relationship is expressed as the
fractionary loss of a vital function or organ either for a population average or for an
individual, e.g., fraction of liver destroyed as a function of alcohol intake. For a complete
discussion of dose-response relationships, see CASARETT AND DOULL's TOXICOLOGY, supra
note 95, at 17-22.
340. The basic pathological mechanisms underlying adverse responses to chemical
exposure have implications for the design of medical removal programs that redistribute
dosage among an exposed population. For classical reversible toxicity, which overwhelms
the body's homeostatic defense systems, one should expect that the dose response rela-
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Carcinogens and mutagens are presumed to exhibit a threshold at or
near zero. For a linear dose-response curve, rotating exposed workers
will not change the total amount of health damage. For those substances
that have a convex-upward shaped dose-response curve, one will observe
more adverse responses after rotation.-' The opposite occurs for those
substances with a concave-upward shaped curve. Unfortunately, except
in the case of radiation,3 42 no clear evidence reveals the shape of dose-
response curves at levels likely to be appropriate for rotation. 4
Rotation might be advantageous only if the biological effects or toxin
uptake were more reversible for rotated workers than for workers con-
tinuously exposed to higher doses. Available data rarely allow determi-
nation of a no-response threshold for a population, or of a no-effect level
or the dose at which the effects become irreversible on an individual
basis.3 44 If identification of hypersensitive individuals could in fact ensure
tionship will have a threshold. There should be some level of dose/perturbation that will
not produce an effect in a given individual (assuming that the individual is not already at
the borderline or beyond the ability to cope with the insult). Therefore, the effect usually
may be avoided entirely in an exposed population, if the dose is distributed among a group
large enough that no individual receives greater than an individual threshold dose of the
toxic agent. Further, if the agent, such as lead, induces a chronic rather than acute response,
biological monitoring will likely detect individuals who are approaching dangerous levels
of internal accumulation. Hattis, From Presence to Health Impact: Models for Relating
Presence to Exposure to Damage, in ANALYZING THE BENEFITS OF HEALTH, SAFETY,
AND ENVIRONMENTAL REGULATIONS Ch. 5 (Sept. 1982) (CPA-82-16) (submitted to the
U.S. Envtl. Protection Agency by the Center for Policy Alternatives, Massachusetts Insti-
tute of Technology).
341. For carcinogens, mutagens or those substances that cause irreversible, incre-
mental damage, the potential benefits of medical surveillance and dose redistribution mea-
sures are much more limited. If dose-response curves tend to be linear and without thresh-
olds at low doses, redistribution of dosage without changing the aggregate exposure of the
population as a whole will in general tend to leave the total number of individuals harmed
unchanged. To the extent that individuals in the population at risk have been exposed to
very high levels, redistributing new exposure to previously unexposed people may actually
increase the total number of people who get cancer, because those who already carry latent
mutations that will lead to fatal cancers may not be capable of suffering further injury. The
irreversible nature of previous damage means that if removals are to be used as a social
policy tool, the removals must essentially be permanent, in contrast to removals associated
with reversible disease. Society may still wish to avail itself of dosage redistribution
measures to limit the amount of damage that any individual is required to suffer, but the
permanent nature of the removal and the sometimes convex shape of the dose-response
curve mean that substantial net economic and health costs for society may accompany
such individual protection programs. Id.
342. See generally National Research Council, National Academy of Sciences, The
Effects on Populations of Exposure to Low Levels of Ionizing Radiation: 1980 (1980)
(report of the Committee on the Biological Effects of Ionizing Radiation prepared for the
EPA).
343. The dose-response curve for formaldehyde has been posited by Hattis as a
concave-upward shaped curve. See generally D. Hattis, C. Mitchell, J. McCleary-Jones,
N. Gorelick & N. Ashford, Control of Occupational Exposures to Formaldehyde: A Case
Study of Methodology for Assessing the Health and Economic Impacts of OSHA Health
Standards (Apr. 1981) (CPA-81-17) (submitted to the U.S. Dep't of Labor by the Center
for Policy Alternatives, Massachusetts Institue of Technology).
344. OSHA acknowledged that one of the major problems in setting a no-effect level
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the identification and removal of only the high-risk workers and if no
remaining or replacement workers were adversely affected (at high risk)
at a later time, then and only then would the total number of adverse
effects be certain to diminish (provided that the dose to which each
worker was exposed was below the level causing irreversible effects).
Indeed, partly because such special conditions are rarely ascertainable,
OSHA standards are to be established to protect the most sensitive
workers as much as possible.345
An employer may rotate workers for several reasons. The first is to
protect the individual worker by reducing his or her risk of an adverse
effect. A second motivation may be that of avoiding liability. As the
probability of disease per worker decreases, those workers who actually
contract disease have a harder time claiming compensation. Although the
process of rotating workers - spreading the same exposure over a large
number of workers - might lead to an increased number of claims, each
individual will have much more difficulty showing causation.
Rotating workers may also divert attention from cleaning up the
workplace. Instead, attention is placed on the affected worker. Such
action reinforces a "blame the worker" attitude, as though the worker
were responsible for his condition. By removing (with no MRP) those
workers who exhibit illness or toxin uptake, an employer may have less
economic motivation for more stringent engineering controls. The incen-
tives to remain lax persist. If the conditions of the workplace remain
unaltered, it seems likely that a removed worker will again be affected
when returned to the same environment, or that remaining or replacement
workers will also be affected. If workers are frequently removed, then
environmental exposures should be decreased to ensure that preventive
actions yield real results.
VI. LIMITATIONS ON THE AUTHORITY TO REQUIRE HUMAN
MONITORING
The employer who intends to implement a program of human mon-
itoring should be conscious of two related sets of constraints. First, the
imposition of human monitoring will be subject to limitations on the
employer's authority to compel the employee to submit to the monitoring
procedures. Second, the employer's authority to use the information
obtained through monitoring will be limited. This Part of the article
addresses the issues raised by the first set of constraints: the limits on
compulsion, the kinds of monitoring procedures that may be used and
the conditions of administration. The following Part discusses access to
and limitations on the use of monitoring information.
for a carcinogen is the large variation in individual susceptibilities. 45 Fed. Reg. 5137 (1980).
See also supra note 336.
345. R. FRIEDMAN, supra note 8, at 29-30.
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A. Personal Privacy
In the abstract sense, an employee may always refuse to be the
subject of human monitoring. OSHA, NIOSH and the employer have no
authority to compel employees to cooperate.34 6 Refusal to participate,
however, may well mean loss of a job. Thus, the relevant inquiry is the
extent to which the employer may condition employment on such co-
operation. For example, may an employer require a prospective em-
ployee to submit to genetic or biological screening as a precondition to
employment? May he or she require a current employee to submit to
periodic biological monitoring or medical surveillance? These questions
raise important issues of confidentiality and discrimination. Apart from
these issues, however, there remains a question as to the employer's
general authority to require human monitoring of his or her employees.
1. Monitoring in Response to Agency Directive
At the outset, a distinction must be made between human monitoring
that OSHA, NIOSH or the EPA requires 347 and monitoring that the
employer implements on his or her own initiative. In the first case, in
which a federal agency requires monitoring, the worker will have a valid
objection only if he or she asserts a constitutional violation. Congress
was mindful of constitutional considerations in developing human moni-
toring programs. For example, it specifically acknowledged the need for
a balancing of interests where an employee asserted a religious objection
to a monitoring procedure. 3 4 8 Human monitoring can also impinge on the
worker's constitutional right to privacy.3 49 In the case of human moni-
toring, the privacy right may be articulated in two ways: the right to
physical privacy and the right to withhold information likely to prove
detrimental to one's self-interest.
If an employee does not wish to comply with a monitoring procedure
required by agency regulation, imposing that procedure as a condition of
employment may invade that employee's constitutional right to physical
privacy. It may, depending on the nature of the procedure, infringe upon
the right to be free from unwelcome physical intrusions and on the right
to make decisions regarding one's own body. While these rights are
obviously related, the former is grounded in the fourth amendment's
346. Although the OSHAct grants explicit authority to OSHA and NIOSH to require
the employer to perform certain actions, it grants OSHA and NIOSH no similar authority
with regard to employees.
347. See infra notes 413-436 and accompanying text.
348. Section 20(a)(5) of the OSHAct provides that "[n]othing in this or any other
provision of this Act shall be deemed to authorize or require medical examination, immu-
nization, or treatment for those who object thereto on religious grounds, except where
such is necessary for the protection of the health or safety of others." 29 U.S.C. § 669(a)(5)
(1982). The balance struck here - protection of the rights of the individual except if they
are outweighed by the health needs of others - may well be appropriate in attempts to
reconcile the purpose of the Act with rights of individual privacy.
349. See infra notes 350-354 and accompanying text.
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proscription against unreasonable search and seizure,350 while the latter
is closely associated with the rights of personal privacy commonly iden-
tified with the ninth and tenth amendments.35 ' Although protected by the
Constitution, these rights of privacy are not inviolate.
Courts have recognized a general need to balance the privacy inter-
ests of the individual with the public health interests of society. In certain
situations, the former will be deemed to outweigh the latter, but in others
intrusion will be permitted in the name of public health. To date, no
reported decision has mentioned an asserted constitutional right to refuse
participation in human monitoring as a condition of employment. Never-
theless, one can identify the factors that would bear upon an evaluation
of that right.
The public health significance of human monitoring, when properly
used, is difficult to deny. Gathering information through human monitor-
ing to develop standards for the protection of worker health, or for the
enforcement or evaluation of existing standards, serves an important
public health purpose. Furthermore, although the Constitution protects
against government paternalism,35 the fact that this public health interest
parallels the affected worker's own interest in a healthy workplace may
make monitoring a less onerous invasion of privacy than it would be
otherwise. To the extent that monitoring serves a legitimate public health
purpose, a limited intrusion of physical privacy appears constitutionally
permissible. The less the accuracy, reliability, or predictability of a par-
ticular intrusion, however, the weaker the case for violating physical
privacy.
The scope of permissible intrusion depends on the nature of the
monitoring. The insertion of a urethral tube, for example, involves a
greater invasion of personal privacy than the taking of a blood sample.
Some monitoring procedures also involve greater risk than others. A
program of periodic lung x-rays, for instance, poses a greater risk than
a program of periodic lung function tests. At some point, the degree of
risk or intrusiveness may be sufficiently compelling to outweigh the public
health interests. Some forms of human monitoring may simply be too
risky or too intrusive to be constitutionally permissible. Furthermore,
even if a monitoring procedure is not constitutionally impermissible per
se, the worker may well have a right to insist on an alternate, less
intrusive procedure that adequately fulfills public health purposes. To
survive constitutional challenge, a regulation requiring human monitoring
should be reasonably related to a legitimate public health goal and should
impose the least intrusive method necessary to achieve its goal.
An additional and critical question is whether the employee may
refuse to participate in a program of agency-directed monitoring when
350. See, e.g., Mapp v. Ohio, 367 U.S. 643 (1961).
351. See, e.g., Roe v. Wade, 410 U.S. 113 (1973).
352. See, e.g., Griswold v. Connecticut, 381 U.S. 479 (1965).
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he or she believes that his or her employer may use the resulting infor-
mation as a basis for termination. For example, the worker who suffers
reduced lung capacity as a result of workplace particulate exposure may
fear that a program of medical surveillance will reveal this condition to
the employer and thus induce removal. Participation in a monitoring
program can be tantamount to self-incrimination.
This form of "self-incrimination" conflicts with the right to personal
privacy. 5 If there is a constitutional right to preserve the confidentiality
of information pertaining to one's health, there may also be a right to
retain that information within one's body. Stated differently, there may
well be a limited constitutional right to refuse to comply with physical
procedures that result in the initial disclosure of confidential information.
Although this right is not absolute, damage to the employee can be quite
substantial if health data is likely to affect employment status adversely.
A worker's interest in preserving his employment status may rise to the
level of "property" protected by the fifth amendment.3 s4
In developing monitoring requirements, an agency should seriously
consider the constitutional dimensions of human monitoring. To avoid a
challenge on a "self-incrimination" basis, OSHA and NIOSH might con-
sider including mandatory MRP programs as part of their human moni-
toring requirements. 35 5 Properly used, an MRP program would safeguard
the employment rights of employees whose health was damaged or threat-
ened by workplace exposure and would help ensure employee
cooperation. 356
353. In the criminal law context, the Court recognized the connection between the
fourth amendment right of privacy and the fifth amendment prohibition against compulsory
self-incrimination as early as Boyd v. United States, 116 U.S. 616, 630 (1885):
The principles laid down [in the British common law prescriptions against unreasonable searches
and seizures] affect the very essence of constitutional liberty and security .... [Tlhey apply to
all invasions on the part of the government and its employees of the sanctity of a man's home
and the privacies of life .... [A]ny forcible and compulsory extortion of a man's own testimony
or of his private papers to be used as evidence to convict him of crime or to forfeit his goods,
is within [those principles]. In this regard, the Fourth and Fifth Amendments run almost into
each other.
354. A contractual right to continued employment may, under certain circumstances,
be "property" within the meaning of the due process clause. This has been held to be the
case with tenured teachers. See Perry v. Sindermann, 408 U.S. 593 (1972); Connell v.
Higginbotham, 403 U.S. 207 (1971); Slochower v. Board of Educ., 350 U.S. 551 (1956);
Wieman v. Updegraff, 344 U.S 183 (1952).
355. CPA Medical Surveillance Report, supra note 22, at 26-27.
356. The Court of Appeals for the District of Columbia Circuit has upheld OSHA's
authority to require a mandatory MRP program as part of the lead standard. United
Steelworkers of Am. v. Marshall, 647 F.2d 1189, 1228-38 (D.C. Cir.), cert. denied, 453
U.S. 913 (1980). The court specifically noted that the MRP program would facilitate worker
cooperation with biological monitoring. See also supra note 325.
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2. Monitoring in the Absence of Agency Directive
Under common law, employers can require their employees to com-
ply with reasonable programs of human monitoring. 3 57 Congress did not
intend the OSHAct to "preempt the field" by authorizing the implemen-
tation of human monitoring requirements. One of the OSHAct's express
purposes is to "stimulate employers ... to institute new and to perfect
existing programs for providing safe and healthful working conditions."3 5 8
Congress intended that employers take the initiative on a number of
fronts, including human monitoring, in developing health and safety pro-
grams. As long as it promotes "safe and healthful working conditions,"
employer initiated human monitoring would appear to be welcome. Sim-
ilarly, nothing in the Act precludes employers who are subject to OSHA
monitoring requirements from implementing additional programs.
If an employer institutes a human monitoring program in the absence
of agency directive, he or she is still subject to applicable restrictions
under state common law, state statute and federal labor law. Common
law requires that human monitoring be implemented in a "reasonable"
fashion.3 5 9 Determining reasonableness involves balancing the benefits
gained by monitoring against the risk, discomfort and intrusiveness of
the monitoring procedure. The National Labor Relations Act may also
require such balancing.3 60 In a given jurisdiction, the balance might be
affected by a state statute defining a right of personal privacy.
B. Informed Consent
Assuming that a human monitoring program is permissible, there
will be limitations on the manner in which an employer implements the
program. In general, one who undertakes the performance of monitoring
procedures will have a duty to perform those procedures properly and
will face liability for damages caused by the negligent administration of
a monitoring procedure.3 6'
A troublesome question arises, however, with regard to the appli-
cability of the doctrine of informed consent. Strictly speaking, "informed
consent" is a medico-legal concept, and grows out of a belief that persons
357. See supra note 76 and accompanying text.
358. 29 U.S.C. § 651(b)(1) (1982).
359. See supra note 76 and accompanying text.
360. 29 U.S.C. §§ 151-169 (1982). This balancing is apparently required with regard
to employee confidentiality. See infra text accompanying notes 446-474.
361. Even if the procedure is not performed by a medical professional, ordinary rules
of negligence should mandate such a result. An employer might argue, however, that he
would not have undertaken to perform human monitoring in the absence of agency regu-
lation, and that he is thus relieved of liability for any damages that flow from that monitoring.
Unless he is ordered to perform an unreasonably dangerous procedure, this argument
should prove unpersuasive.
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have a right to make decisions governing their own bodies and health.36 2
Thus, a medical professional is said to have a duty to inform the patient
honestly and accurately of the potential risks and benefits of a proposed
medical procedure so that the patient can make an informed choice
whether to consent to that procedure. All human monitoring procedures
are medical or quasi-medical in nature. Most commonly, they will be
performed by medical professionals: physicians, physician assistants,
nurses or nurse practitioners. Thus, the oncept of informed consent
appears at first glance to be applicable. The differences between human
monitoring and medical treatment, however, are not insignificant, and
they raise serious questions whether and to what extent the traditional
doctrine of informed consent has meaning in the occupational setting.
Initially, one may inquire to what extent the relationship between
the worker and the medical professional who administers the monitoring
procedure can be characterized as a "physician-patient" relationship.
Quite often, neither the employee nor the union selects the occupational
physician. Rather, the employer selects and often directly employs the
physician. Accordingly, some courts have held that the performance of
a physical examination, which would clearly establish a physician-patient
relationship in a purely medical context, does not create that relationship
if it is a pre-employment exam requested by the prospective employer.3 63
To the extent that the physician-patient relationship does not exist in the
occupational setting, traditional notions of informed consent may not be
applicable to human monitoring.364
Similarly, the doctrine of informed consent is closely tied to the
concept of medical treatment. It assumes that not only is the patient
being requested to submit to a procedure designed for his or her own
benefit, but also that the patient is in a position to make a voluntary
choice to participate. Human monitoring calls both these assumptions
into question. In many cases, monitoring benefits the employer more
than the employee. Monitoring may not be "treatment" in the conven-
362. An excellent statement of the theoretical basis of the doctrine is found in Cobbs
v. Grant, 8 Cal. 3d 229, 242, 502 P.2d 1, 9 (1972), in which the court identified four
touchstones upon which informed consent can be said to rest:
The first is that patients are generally persons unlearned in the medical sciences and therefore,
except in rare cases, courts may safely assume the knowledge of patient and physician are not
in parity. The second is that a person of adult years and in sound mind has the right, in the
exercise of control over his own body, to determine whether or not to submit to lawful medical
treatment. The third is that the patient's consent to treatment, to be effective, must be an
informed consent. And the fourth is that the patient, being unlearned in medical sciences, has
an abject dependence upon and trust in his physician for the information upon which he relies
during the decisional process, thus raising an obligation in the physician that transcends arms-
length transactions.
363. See, e.g., Wilcox v. Salt Lake City Corp., 26 Utah 2d 78, 484 P.2d 1200 (1971);
Lotspeich v. Chance Vought Aircraft, 369 S.W.2d 705 (Tex. Civ. App. 1963); New York
Cent. R.R. v. Wilner, 124 Ohio St. 118, 177 N.E. 205 (1931).
364. See Cobbs v. Grant, 8 Cal. 3d 229, 502 P.2d 1.
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tional sense of the word. Furthermore, monitoring is usually compulsory
in that it is a condition of continued employment. It may be meaningless
to speak of "informed consent" if the worker/patient is not free to reject
the proffered procedure without jeopardizing his or her job. In this light,
the applicability of informed consent appears particularly dubious in the
case of agency-directed monitoring. Neither the employee nor the em-
ployer has the discretion to discontinue monitoring.3 65
Regardless of the applicability of informed consent in the traditional
sense, a complete and accurate disclosure of risks seems an advisable
adjunct to a program of human monitoring. Whether or not a physician-
patient relationship exists, imposing a medical procedure on a person not
fully informed of the risks of that procedure may still be a battery and
may give rise to liability in tort. In addition, prudent social policy requires
full disclosure of risks. If the employer is required to disclose all risks
inherent in a program of human monitoring, employee and union scrutiny
will act as an incentive to the employer to develop programs that use the
safest and least intrusive techniques possible. Indeed, unions may have
a right to demand such information as a part of the collective bargaining
process. 36 6 Recognition of a duty to disclose material risks seems as
appropriate in the area of human monitoring as it is in the area of medical
treatment.
A final question concerns the scope of the required disclosure. The
employer should, of course, disclose all material physical risks. The most
significant risk of all, however, may be dismissal from employment.
Should employers or occupational physicians be required to warn em-
ployees that one of the risks of submitting to a program of human mon-
itoring may be a loss of a job? The "Code of Ethical Conduct" adopted
by the American Occupational Medical Association and the American
Academy of Occupational Medicine, states that physicians should
treat as confidential whatever is learned about individuals served, releasing
information only when required by law or by over-riding public health
considerations, or to other physicians at the request of the individual
according to traditional medical ethical practice; and should recognize that
employers are entitled to counsel about the medical fitness of individuals
in relation to work, but are not entitled to diagnoses or details of a specific
nature.67
Under this formulation, even though the physician may not disclose to
the employer the specific results of human monitoring, the employee's
365. As the OSHAct expresses no congressional desire to infringe on the physician-
patient relationship, and as OSHA itself has been careful to limit its intrusions into this
relationship, OSHA monitoring regulations do not appear to preempt state laws regarding
informed consent without a specific statement to this effect.
366. See infra text accompanying notes 440-445.
367. Code of Ethical Conduct for Physicians Providing Occupational Medical Ser-
vices, 18 J. OCCUPATIONAL MED. 703, 703 (1976) (section 7).
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job security may be endangered nonetheless. Employers are "entitled to
counsel about the medical fitness of individuals in relation to work." A
preferable alternative practice would involve the worker in such discus-
sions between the physician and the employer.368
VII. USE OF MONITORING RESULTS
A. Employees' Right of Access
1. OSHA Regulations
An employer may not limit or deny an employee access to his or
her own medical or exposure records. The current OSHA regulation,3 6 9
promulgated on May 23, 1980, grants employees a general right of access
to medical and exposure records kept by their employer. Furthermore,
it requires the employer to preserve and maintain these records for an
extended period of time.3 70 There appears to be some overlap in the
definitions of "medical" and "exposure" records, because both may in-
clude the results of biological monitoring. The former, however, are
generally defined as those pertaining to "the health status of an em-
ployee," while the latter are defined as those pertaining to "employee
exposure to toxic substances or harmful physical agents."3 7'
The employer's duty to make these records available is a broad one.
The regulations provide that upon any employee request for access to a
medical or exposure record, "the employer shall assure that access is
provided in a reasonable time, place, and manner, but in no event later
than fifteen (15) days after the request for access is made."'37 2
Because the regulations define "access" as including the right to
make copies of records,373 the employer appears to have an affirmative
368. At the New York Conference on Ethical Issues in Occupational Medicine,
Donald Whorton and Morris Davis offered an alternative formulation to section 7 of the
AOMA Code, id.: "The occupational physician shall fully inform the employee in writing
of consequences of job changes or continuation that may affect his or her health status and
shall not make nor participate in restrictive decisions regarding the employee's ability to
work without the participation and concurrence of the employee." Whorton & Davis,
Ethical Conduct and the Occupational Physician, 54 BULL. N.Y. ACADEMY MED. 733, 740
(1978).
369. 29 C.F.R. § 1910.20 (1983). See also 45 Fed. Reg. 35,277 (1980). The regulation
has survived constitutional challenge in federal district court, Louisiana Chemical Ass'n v.
Bingham, 550 F. Supp. 1136 (W.D. La. 1982), appeal docketed, Nos. 80-1178, 80-1201, 80-
1199 (5th Cir. Jan. 3, 1983).
370. In the absence of OSHA regulation, employees would arguably still have a right
of access under common law or state statute in many jurisdictions. See generally Annas,
Legal Aspects of Medical Confidentiality in the Occupational Setting, 18 J. OCCUPATIONAL
MED. 537 (1976).
371. 29 C.F.R. §§ 1910.20(c)(5)-(6) (1983).
372. Id. § 1910.20(e)(1)(i) (emphasis added).
373. Id. § 1910.20(c)(1).
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duty to maintain such procedures as necessary to ensure that the em-
ployee has a copy of the records in his or her possession within fifteen
days after the request. The employer cannot escape this duty by con-
tracting with others to maintain the records. Although the regulations do
not specifically require a physician, health maintenance organization, or
other health care provider to permit employee access to records, they
do require the employer to "assure that the preservation and access
requirements of this section are complied with regardless of the manner
in which records are made or maintained."3 7 4 Thus, any employer con-
tract with a third party must provide for the disclosure of those records.3 75
An employee's right of access to medical records is limited to records
pertaining specifically to that employee.3 76 The regulations allow physi-
cians some discretion as well in limiting employee access. The physician
is permitted to "recommend" to the employee requesting access that the
employee: (I) review and discuss the records with the physician;
(2) accept a summary rather than the records themselves; or (3) allow
the records to be released instead to another physician. 377 Further, where
information in a record pertains to a "specific diagnosis of a terminal
illness or a psychiatric condition," the physician is authorized to direct
that such information be provided only to the employee's designated
representative.3 78 Although these provisions were apparently intended to
respect the physician-patient relationship3 7 9 and do not limit the employ-
ee's ultimate right of access, they could be abused. In situations in which
the physician feels loyalty to the employer rather than the employee, the
physician could use these provisions to discourage the employee from
seeking access to his or her records.
Similar constraints do not apply to employee access to exposure
records. Not only is the employee assured access to records of his or
her own exposure to toxic substances, but the employee is also assured
access to the exposure records of other employees "with past or present
job duties or working conditions related to or similar to those of the
employee."38 0 In addition, the employee enjoys access to all general
exposure information pertaining to the employee's workplace or working
conditions and to any workplace or working condition to which he or
she is to be transferred. All information in exposure records that cannot
be correlated with a particular employee's exposure is accessible.3 8'
374. Id. § 1910.20(b)(3) (emphasis added).
375. Section 1910.20(b)3) of Title 29 of the Code of Federal Regulations specifically
acknowledges that employers may maintain their records on "an in-house or contractual
(e.g., fee-for-service) basis." Id. The preparatory agency comments contain a discussion
of the various kinds of third-party arrangements that employers can make. See 45 Fed.
Reg. at 35,223.
376. 29 C.F.R. § 1910.20(e)(2)(ii) (1983).
377. Id. § 1910.20(e)(2)(ii)(C).
378. Id. § 1910.20(e)(2)(ii)(D).
379. 45 Fed. Reg. at 35,273.
380. 29 C.F.R. § 1910.20(e)(2)(i)(B).
381. Id. § 1910.20(e)(2)(i)(C)-(D). In the explanatory comments, OSHA noted that
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One criticism of the OSHA regulation is that it does not require the
employer to compile medical or exposure information but merely requires
employee access to such information if it is compiled. The scope of the
regulation, however, should not be underestimated. The term "record"
is meant to be "all-encompassing," and the access requirement appears
to extend to all information gathered on employee health or exposure,
no matter how it is measured or recorded.82 Thus, if an employer em-
barks upon any program of human monitoring, no matter how conducted,
he or she must provide the subjects access to the results. This access
requirement may serve as a disincentive for employers to monitor em-
ployee exposure or health if it is not clearly in the employer's interest to
do so.
Despite the fact that the access requirement has no effect on the
monitoring of exposures regulated under section 6(b) of the OSHAct, 83
it may affect the monitoring of other exposures. The NIOSHIOSHA
Occupational Health Guidelines offers medical surveillance and some
biological monitoring guidelines, but OSHA has not promulgated moni-
toring requirements for exposures to the 450 substances regulated under
section 6(a).384 Nor has OSHA imposed general monitoring requirements
for unregulated exposures. At present, the OSHA regulations do not
prevent employers from denying employees the benefit of having health
or exposure data for a number of substances merely by failing to record
such data. Any recordkeeping required under TSCA, however, will pre-
sumably be available to workers under the OSHA regulation.385
The trade secret interest of employers places a further limitation on
employee access. Section 15 of the OSHAct mandates that OSHA be
cognizant of the trade secret interest of employers in its collection and
use of occupational safety and health information.386 In promulgating the
this would include "area, grab, or wipe samples which would not specifically characterize
the exact exposure of any one employee" and "material safety data sheets and other records
which simply reveal the identity of a toxic substance or harmful physical agent." 45 Fed.
Reg. at 35,273.
382. The definition includes "any item." 29 C.F.R. § 1910.20(c)(9). As noted in the
preparatory comments, "the definition ... is meant to be all-encompassing." 45 Fed. Reg.
at 35,265. Further, even without such a broad definition, physicians and other health care
professionals who perform the monitoring would likely be induced by fear of malpractice
liability to keep accurate records.
383. Specific monitoring requirements have been included in the section 6(b) stan-
dards. See supra text accompanying notes 53-61.
384. See supra text accompanying notes 51 & 57. See also NIOSH/OSHA OCCUPA-
TIONAL HEALTH GUIDELINES, supra note 19.
385. See infra text accompanying notes 413-439.
386. 29 U.S.C. § 664 (1982) provides as follows:
All information reported to or otherwise obtained by the Secretary or his representative in
connection with any inspection or proceeding under this chapter which contains or which might
reveal a trade secret referred to in section 1905 of title 18 shall be considered confidential for
the purpose of that section, except that such information may be disclosed to other officers or
employees concerned with carrying out this chapter or when relevant in any proceeding under
this chapter. In any such proceeding the Secretary, the Commission, or the court shall issue
such orders as may be appropriate to protect the confidentiality of trade secrets.
-
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present regulations, OSHA noted that section 15 "reflects an apparent
Congressional interest in balancing competing interests based on provid-
ing protection to trade secrets to the extent consistent with carrying out
the overall statutory purposes [of the OSHAct]."3 87
In an attempt to achieve this balance, the regulations permit the
employer to deny access to "trade secret data which discloses manufac-
turing processes .. . or ... the percentage of a chemical substance in a
mixture," provided that the employer:
(1) notifies the party requesting access of the denial;
(2) if relevant, provides alternative information sufficient to permit
identification of when and where exposure occurred; and
(3) provides access to all "chemical or physical agent identities
including chemical names, levels of exposure, and employee health
status data contained in the requested records."3 s
The key feature of this provision is that it ensures employee access
to the precise identities of chemicals and physical agents. This access is
especially critical for chemical exposures. Within each "generic" class of
chemicals there are a variety of specific chemical compounds, each of
which may have its own particular effect on human health. The health
effects can vary widely within a given family of chemicals.3 8 9 Accord-
ingly, the medical and scientific literature on chemical properties and
toxicity is indexed by specific chemical name, not by generic chemical
class.390 To discern any meaningful correlation between a chemical ex-
posure and a known or potential health effect, an employee must know
the precise chemical identity of that exposure.3 9' Furthermore, in the
case of biological monitoring, the identity of the toxic substance or its
metabolite is itself the information monitored.
Particularly in light of the public health emphasis inherent in the
OSHAct, disclosure of such information does not constitute an unrea-
sonable infringement on the trade secret interests of the employer. In
general, chemical health and safety data are the least valuable to an
employer of all the "proprietary" information relevant to a particular
manufacturing process.39 2
387. 45 Fed. Reg. at 35,249-50.
388. 29 C.F.R. § 1910.20(f) (1983).
389. In vitro tests for metaphase arrest, an abnormality in nonreproductive cell di-
vision, produced by a number of chemicals in the hydantoin (2, 4-imidazoladinedione)
family, for example, produced widely different results. See MacKinney, A Comparison of
Potency of Hydantoins in Metaphase Arrest and Inhibition of Microtubular Polymerization,
17 MOLECULAR PHARMACOLOGY 275 (1980).
390. Chemicals are commonly indexed by their individual Chemical Abstracts Service
(CAS) number.
391. This is particularly the case where the route of entry (e.g., inhalation vs. dermal
exposure), particle size, synergism with other chemicals or metabolic conversion is a critical
factor in correlating exposure with health effects.
392. See M. King, Balancing Trade Secret Protection Against Regulatory Disclosure
in the Implementation of the Toxic Substances Control Act and the Occupational Safety
and Health Act 22-35 (May 11, 1979) (available from the Dep't of Political Science at the
Massachusetts Institute of Technology).
-
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2. Proposed OSHA Regulation
On July 13, 1982, OSHA proposed a modification of the employee
access regulations.3 9 3 The proposed regulation maintains much of the
form and spirit of the present access rule but contains certain provisions
that could significantly impair employee access to exposure information.
The proposed regulation would continue to require employers to maintain
and preserve medical and exposure records and would continue to place
the primary burden for ensuring employee access to these records on the
employer. The employer, however, would be permitted to delegate this
responsibility to third-party physicians or health care providers if the
employer advised them of the preservation and access requirements and
made "a good faith effort to assure, by modification of the contract [with
the third-party provider] if necessary, that such persons comply with
[them]."3 9 4
This language, on its face, appears less likely to ensure employee
access than the corresponding provision in the current regulations.3 95 The
explanatory comments, however, indicate that OSHA's intention is to
require employers to do "everything reasonably possible to assure com-
pliance."3 96 The proposed regulation should be modified to reflect this
intention clearly.3 97
The more critical proposed modifications are those that affect the
nature of the information to which employees will have access. In gen-
eral, the proposed regulations seem to favor reducing employer compli-
ance costs over promoting employee health and safety. Although a thor-
ough critique of these proposed changes is beyond the scope of this
article, the potential restrictions on employee access to exposure infor-
mation are worth noting. Under both the present and proposed regula-
tions, employers are only required to preserve records, if any, of expo-
sure to substances defined as "toxic." The current regulations define
"toxic substance" with appropriate breadth, and include as "toxic" all
chemicals identified as potential human toxins in the "Registry of Toxic
Effects of Chemical Substances" compiled by NIOSH.3 98 The proposed
regulation, however, includes as "toxic substances" only those chemicals
that have already been shown to be toxic in humans or toxic at specified
393. Occupational Safety and Health Administration Proposal to Modify the Access
to Medical Records Rule, 12 O.S.H. REP. (BNA) 164 (1982) hereinafter cited as OSHA
Proposal]; 47 Fed. Reg. 30,420 (1982).
394. Proposed language of 29 C.F.R. § 1910.20(b)(3); see also OSHA Proposal, supra
note 393, at 178 n.7.
395. The current regulations require the employer to "assure" compliance with the
access requirements, regardless of "good faith." Arguably, the proposed regulations provide
somewhat less incentive for employer compliance.
396. OSHA Proposal, supra note 393, at 167.
397. Medical providers will most probably feel constrained to preserve and maintain
accurate records out of fear of malpractice liability. Unless the employer takes pains to
ensure employee access to those records, however, that access might be limited in some
jurisdictions.
398. 29 C.F.R. § 1910.20(c)(ll 1) (1983).
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significant levels in animals.399 Not only would the proposed definition
potentially exclude certain human and animal mutagens and certain chem-
icals that display mutagenic potential in short-term, in vitro tests, but it
would also discourage epidemiological research on chemicals not already
known to be toxic.
One major purpose of occupational epidemiology is to determine the
toxic effects of substances not presently known to be toxic to humans,
so that employers can take the steps necessary to reduce workplace
exposure. The OSHAct was intended to facilitate that process. The value
of epidemiological research in this area, however, will depend in large
part on the availability of reliable data regarding employee exposure to
substances not already proven toxic. The proposed regulation, as OSHA
has acknowledged, would greatly reduce the availability of such data.400
The agency noted that the proposed redefinition of "toxic substance"
would bring about "a greater than 90 percent decrease in the number of
chemicals specified, "40' and commented that this modification
may cause some reduction in the benefits of the proposal because some
substances that do not currently meet the proposed criteria may be found
to be hazardous long after exposure has already occurred and the results
have been discarded. Asbestos, for example, was long believed to be
biologically inert, but has proven to be a potent carcinogen.402
The proposed regulation would narrowly constrain employee access
to exposure information when the employer claims that access would
infringe upon a trade secret. As under the present regulations, the em-
ployer would be permitted to withhold trade secret information pertaining
to manufacturing processes or mixture content. 403 The employer, how-
ever, would be permitted to withhold the "precise chemical name of a
chemical" if:
(1) it can "substantiate" that such information is a trade secret;
(2) the chemical "is not a carcinogen, mutagen, teratogen, or a
cause of significant irreversible damage to human organs or body
systems for which there is a need to know the precise chemical
name;"
(3) it provides a "generic chemical classification" as an alternative;
and
(4) it provides "all other information on the properties and effects
of the chemical.""
399. Proposed language of 29 C.F.R. § 1910.20(c)(10); see also OSHA Proposal, supra
note 393, at 170.
400. In the recently promulgated "Hazard Communication Standard," however,
OSHA has required the employer to notify employees of exposures to carcinogens for
which a single animal study is the only evidence available. 48 Fed. Reg. 53,208 (1983) (to
be codified at 29 C.F.R. 1910.1200(d)(2)).
401. OSHA Proposal, supra note 393, at 170.
402. Id. at 176.
403. Id. at 173-74 (to be codified at 29 C.F.R. § 1910.20(f)(1)).
4()4. Id. at 174 (to be codified at 29 C.F.R. § 1910.20(g)(2)).

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The employer, however, would have to disclose trade secret information
to a treating or consulting physician who submitted a written request
indicating that a worker had health problems that "may be the result of
occupational exposure."405 Such information would be provided "on a
confidential basis. "406
This access provision is unduly restrictive and defeats much of the
public health purpose of protecting employ6e access to exposure infor-
mation. Limiting access to precise chemical identities to only those sub-
stances already determined to be highly toxic could have a chilling effect
on efforts to determine what other substances may cause significant
human toxicity. Without ready access to adequate exposure data, it will
be difficult to establish the necessary baseline information on the rela-
tionship of various substances to various health outcomes. Piecemeal
dissemination of exposure data to physicians on a confidential basis will
not suffice, and may occur too late to prevent occupational disease.
A second disturbing feature of the proposed trade secret restrictions
is the inclusion of a provision that would permit the employer to condition
release of any "names of trade secret chemicals" upon "acceptance of a
reasonable confidentiality agreement."407 The current regulations contain
a similar provision,408 but the explanatory comments to those regulations
make it clear that the confidentiality agreement "may not be used as a
pretext for more onerous requirements such as the posting of penalty
bonds, liquidated or punitive damages clauses, or other preconditions."409
The proposed regulations, however, appear to welcome contractual re-
strictions of this nature. They specifically authorize the confidentiality
agreements to include clauses that "provide for compensation or other
legally appropriate relief for competitive harm." As the agency noted in
its explanatory comments, "OSHA intends to be neutral on the kinds of
damages provisions that may be included."4T 0 If put into effect, this
proposed regulation would permit employers to condition access to trade
secret data on whatever restrictions or penalties appeared "reasonable"
under state law. Liquidated damages clauses, at the very least., might be
routinely imposed.
In sum, the proposed regulation appears to be based on an implicit
determination that the protection of "trade secrets," however broadly
defined, is of greater social value than the preservation of employee
health. In light of the tenuous relationship between health and safety
data and legitimate trade secret protection, and especially in light of the
405. Id. (to be codified at 29 C.F.R. § 1910.20(g)(3)).
406. Id. (to be codified at 29 C.F.R. § 1910.20(g)(3)).
407. Id. (to be codified at 29 C.F.R. § 1910.20(f)(4)).
408. 29 C.F.R. § 1910.20(f)(3) (1983).
409. 45 Fed. Reg. at 35,275.
410. OSHA Proposal. supra note 393, at 174.
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language and purpose of the OSHAct,4 " this seems both dangerous and
unwarranted.4'2
3. Requirements of TSCA
TSCA4'3 imposes substantial requirements on chemical manufactur-
ers and processors to develop health effects data.4'4 TSCA requires test-
ing under section 4,41'5 pre-market manufacturing notification under sec-
tion 5,46 and reporting and retention of information under section 8.4'7
TSCA imposes no specific medical surveillance or biological monitoring
requirements. However, to the extent that human monitoring is used to
meet more general requirements of assessing occupational health or ex-
posure to toxic substances, the data resulting from such monitoring are
subject to an employer's recording and retention obligations.
Under section 8(a), the EPA has promulgated regulations' requiring
general reporting on some 300 chemicals, including information related
to occupational exposure.4 9 Section 8(a)(2) allows the EPA Administrator
to require the reporting and maintenance of those data "insofar as known"
or "insofar as reasonably ascertainable."420 Thus, if monitoring is under-
taken, it must be reported. The EPA appears to be authorized to require
monitoring as a way of securing information that is "reasonably
ascertainable."
411. The Act contains a strong and broad mandate to protect worker health. Section
2, for example, affirms that it is the "purpose and policy" of the OSHAct "to assure so far
as possible every working man and woman in the nation safe and healthful working
conditions." 29 U.S.C. § 651(b) (1982).
412. Although it does not pertain to monitoring information, OSHA's proposed "haz-
ard communication" regulation will be of interest to workers seeking information regarding
workplace exposures. This rule, which has a phased-in compliance period culminating on
May 25, 1986, requires employers in the manufacturing industry to provide data to their
employees regarding certain chemical hazards in the workplace. The rule also, however,
contains broad trade secret protections and purports to preempt many state "right to know"
laws.48 Fed. Reg. 53,208 (1983) (to be codified at 29 C.F.R. § 1910.1200).
413. 15 U.S.C. §§ 2601-2629 (1982).
414. Section 2601(b)(1) states that:
It is the policy of the United States that - () adequate data should be developed with respect
to the effect of chemical substances and mixtures on health and the environment and that the
development of such data should be the responsibility of those who manufacture and those who
process such chemical substances and mixtures.
Id. § 2601(b)(1)
415. Id. § 2603.
416. Id. § 2604.
417. Id. § 2607.
418. 40 C.F.R. § 712 (1983).
419. Id. §§ 712.1. 712.28(d).
420. Id. § 2607(a)(2).
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In addition to the general reports required for specific chemicals
listed in the section 8(a) regulations, the EPA has promulgated rules4 2'
for the submission of health and safety studies required for 169 substances
under section 8(d).4 22 A health and safety study includes "[a]ny data that
bear on the effects of a chemical substance on health."4 23 Examples are
"[m]onitoring data, when they have been' aggregated and analyzed to
measure the exposure of humans . . to a chemical substance or mix-
ture."4 24 As under section 8(a), only data that are "known" or "reasonably
ascertainable" need be reported.4 2 5
Records of "significant adverse reactions to [employee] health" must
be retained for thirty years under section 8(c).426 A recently promulgated
rule implementing this section4 27 defines significant adverse reactions as
those "that may indicate a substantial impairment of normal activities,
or long-lasting or irreversible damage to health or the environment."4 2 8
Under the rule, human monitoring data, especially if derived from a
succession of tests, would seem especially reportable.4 29 Genetic moni-
toring of employees, if some basis links the results with increased risk
of cancer, also seems to fall within the rule.
Section 8(e) imposes a statutory duty to report "immediately ...
information which supports the conclusion that [a] substance or mixture
presents a substantial risk of injury to health."4 3 0 In a policy statement
issued on March 16, 1978, the EPA interpreted "immediately" in this
context to require receipt by the agency within fifteen working days after
the reporter obtains the information.4 3 ' Substantial risk is defined exclu-
sive of economic considerations. 3 2 Evidence can be provided by either
designed, controlled studies or undesigned, uncontrolled studies, includ-
ing "medical and health surveys" or evidence of effects in workers.4 33 In
the EPA's rule for section 8(c),4 34 section 8(e) is distinguished from
section 8(c) in that "[a] report of substantial risk of injury, unlike an
allegation of a significant adverse reaction, is accompanied by information
which reasonably supports the seriousness of the effect or the probability
421. 40 C.F.R. § 716 (1983).
422. 15 U.S.C. § 2607(d).
423. 40 C.F.R. § 716.3(e)(1).
424. Id. § 716.3(e)(2).
425. 15 U.S.C. §§ 2607(d)(1)(B)-(C).
426. Id. § 2607(c).
427. 48 Fed. Reg. 38,178 (1983) (to be codified at 40 C.F.R. Part 717).
428. Id. at 38,188 (to be codified at 40 C.F.R. § 717.3(i)).
429. The proposed rule seems to envision that the employee, a union or others outside
of management will make the necessary report, although reports "[b]y any source" are
included. Id. at 38,189 (to be codified at 40 C.F.R. § 717. 10(c)). The plain language of the
Act does not support a restriction on who reports.
430. 15 U.S.C. § 2607(e) (1982).
431. 43 Fed. Reg. 11,110 (1978).
432. Id. at 11,111.
433. Id. at 11,112.
434. See supra text accompanying notes 426-429.
-
-~_
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of its occurrence."4 35 Human monitoring results indicating a substantial
risk of injury would thus seem reportable to the EPA. Either medical
surveillance or biological monitoring data would seem to qualify.4 3 6
Section 14(b) of TSCA gives the EPA authority to disclose from
health and safety studies the data pertaining to chemical identities, except
for the proportion of chemicals in a mixture.4 37 In addition, the EPA may
disclose information, otherwise classified as a trade secret, "if the Ad-
ministration determines it necessary to protect . . . against an unreason-
able risk of injury to health."4 3 8 Monitoring data thus seem subject to full
disclosure.4 3 9
4. Under Federal Labor Statutes
In addition to the access provided by OSHA regulations, individual
employees may have a limited right of access to medical and exposure
records under federal labor law. Logically, the right to refuse hazardous
work, inherent in section 7 of the NLRA and section 502 of the Labor
Management Relations Act, 440 carries with it the right of access to the
information necessary to determine whether or not a particular condition
is hazardous. In the case of toxic substance exposure, this may mean a
right of access to all information relevant to the health effects of the
exposure and may include access to both medical and exposure records.
This is clearly not an adequate substitute for OSHA access regulations,
however, as there is presently no systematic mechanism for enforcing
this right.
Collective employee access, however, is available to unionized em-
ployees through the collective bargaining process. In four recent cases,
the National Labor Relations Board (NLRB) has held that unions have
a right of access to exposure and medical records so that they may bargain
effectively with the employer regarding conditions of employment.44'
Citing the general proposition that employers are required to bargain on
health and safety conditions when requested to do so, 442 the NLRB
adopted a broad policy favoring union access. "Few matters can be of
435. 48 Fed. Reg. 38,178 (1983) (to be codified at 40 C.F.R. Part 717); 45 Fed. Reg.
47,008 (1980).
436. EPA has published three volumes of preliminary evaluations of initial section
8(e) notices. 4 TSCA CHEMICALS-IN-PROGRESS BULL. 12 (1983).
437. 15 U.S.C. § 2613(b) (1982).
438. Id. § 2613(a)(3).
439. See generally supra text accompanying note 392.
440. See generally Ashford & Katz, Unsafe Working Conditions: Employee Rights
Under the Labor Management Relations Act and the Occupational Safety and Health Act,
52 NOTRE DAME LAW. 802 (1977).
441. The first three were companion cases: Minnesota Mining & Mfg. Co., 261
N.L.R.B. 27 (1982); Borden Chemical 261 N.L.R.B. 64 (1982); and Colgate-Palmolive Co.
261 N.L.R.B. 90 (1982). Minnesota Mining is the lead case. Citing Minnesota Mining, the
Board then decided Plough, Inc., 262 N.L.R.B. 1095 (1982).
442. See, e.g., Gulf Power Co., 156 N.L.R.B. 622 (1966), enforced, 384 F.2d 822 (5th
Cir. 1967).
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greater legitimate concern to individuals in the workplace, and thus to
the bargaining agent representing them, than exposure to conditions po-
tentially threatening their health, well-being, or their very lives."44 3
The NLRB, however, did not grant an unlimited right of access. The
union's right of access is constrained by the individual employee's right
of personal privacy. Furthermore, the NLRB acknowledged an employ-
er's interest in protecting trade secrets. While ordering the employer in
each of the four cases to disclose the chemical identities of substances
to which the employer did not assert a trade secret defense, the NLRB
indicated that employers are entitled to take reasonable steps to safeguard
"legitimate" trade secret information.444 The NLRB did not delineate a
specific mechanism for achieving the balance between union access and
trade secret disclosure. Instead, it ordered the parties to attempt to
resolve the issue through collective bargaining. Given the complexity of
this issue and the potential for abuse in the name of "trade secret pro-
tection," the NLRB may find it necessary to provide further specificity
before a workable industry-wide mechanism can be achieved."44
B. Employees' Right to Confidentiality: Access to Employee Records
by Agencies, Unions and Employers
Of all of the issues raised by human monitoring, employee confiden-
tiality may have received the most attention.4 4 6 An employee's right to
maintain the confidentiality of information regarding his or her body and
health places a significant limitation on the ways in which others can use
that information. As programs of human monitoring are developed, mech-
anisms must be found that maximize both the employee's interest in
privacy and society's interest in promoting general workplace health and
safety. In the final analysis, this may be more a technological challenge
than a legal or ethical one.
In a broad sense, private citizens do have a right to protect the
confidentiality of their personal health information. With regard to gov-
ernmental invasions of privacy, this right is created by the Bill of Rights
443. Minnesota Mining, 261 N.L.R.B. at 29.
444. Id. at 32. Only three members out of five signed the majority opinion. One
concurring member would have granted broader access, while the other would have pro-
vided more protection for the employer.
445. The union has filed a petition for judicial review of the Board's order. For a
discussion of certain procedural issues in the case, see Oil, Chemical, & Atomic Workers
Union v. N.L.R.B., 694 F.2d 1289 (D.C. Cir. 1982). For an excellent treatment of the
Minnesota Mining cases, and the union access issues yet to be resolved, see Mentzer,
Union's Right to Information About Occupational Health Hazards Under the National
Labor Relations Act, 5 INDUS. REL. L.J. 247 (1983).
446. See, e.g., Schechter, Medical Records Access: Who Shall See What, and When?,
OCCUPATIONAL HEALTH AND SAFETY, July 1982, at 23; Collings, Medical Confidentiality
in the Work Environment, 20 J. OCCUPATIONAL MED. 461 (1978); McLean, Management
of Occupational Health Records, 18 J. OCCUPATIONAL MED. 530 (1976); Warshaw, Con-
fidentiality Versus the Need to Know. 18 J. OCCUPATIONAL MED. 534 (1976).
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and is one component of the right of personal privacy discussed above.44 7
With regard to private intrusions, the right is grounded in state law.448 In
the medical setting, it grows out of the confidential nature of the physi-
cian-patient relationship, although rights of confidentiality exist outside
this relationship as well. In essence, the recognition of a right of privacy
reflects an ongoing societal belief in the need to protect the integrity of
the individual.
This right to privacy, however, is not absolute 449 and may be limited
or waived. Courts nonetheless remain vigilant in their attempts to protect
individual privacy. They generally look for a reasonable middle ground
when faced with legitimate interests on both sides of the confidentiality
question. They prefer an approach that permits both the use of health
information for a socially useful purpose and the protection of the privacy
of the individual.4 5 0 The key is the development of technology that will
make that approach more readily available.
Developing such technology will be especially important in protect-
ing the confidentiality of information generated by human monitoring.
Both medical and exposure records contain health information of a con-
fidential nature, and the employee has a legitimate interest in limiting its
disclosure. At the same time, public agencies, unions and employers
have a legitimate interest in using this information. From a technical
point of view, the solution will lie in mechanisms that allow third parties
to use meaningfully health information that is not tied by name or other
common identifier (such as a social security number) to any one individ-
ual, and that allow data relevant to toxic substances exposure to be
separated from other health information. When disclosure is limited to
relevant medical and exposure information4 5' that cannot be traced to
any worker by name, the detrimental effect of disclosure will be held to
a minimum.
Proper development of the necessary technology, however, will not
follow from piecemeal solutions devised by reviewing courts. Rather,
what is needed is a concerted, comprehensive, multidisciplinary ap-
proach. OSHA, NIOSH and the EPA could pursue such technology
447. See, e.g., Whalen v. Roe, 429 U.S. 589 (1977) (discussed infra in text accom-
panying notes 452-455).
448. Depending on the state, this right may be part of the common law, may be
created by statute, or both. See generally Annas, supra note 370. At present, there is no
federal common law right of privacy beyond that embodied in the Constitution. Many
states have recognized the common law tort of invasion of privacy. See, e.g., Biederman's
of Springfield, Inc. v. Wright, 322 S.W.2d 892 (Mo. 1959); Hull v. Curtis Publishing Co.,
182 Pa. Super. 86, 125 A.2d 644 (1956).
449. See generally supra notes 348-354. See also Whalen v. Roe, 429 U.S. 589, 598-
604 (1977) (state system of monitoring sales of prescription drugs did not pose a threat to
patients' reputation or independence sufficient to invade any right to privacy).
450. See, e.g., Whalen v. Roe, 429 U.S. 589.
451. Much of the information found in medical records - such as details of the
patient's sexual activities, marital relations, emotional difficulties - may often have little
relevance to the workplace.
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either as an agency research and development project or through coop-
eration with private industry. This technology, once developed, could
then be made available to employers at the cost of installation and equip-
ment. No system will resolve completely the conflict between confiden-
tiality and disclosure, and the potential for abuse will always be present.
A method of recordkeeping, however, that permits the effective use of
relevant health information without requiring the disclosure of other
personal data would eliminate much of that conflict. Presently, the con-
flict remains substantial, especially regarding medical records prepared
under methods that are ill-adapted to protective disclosure.
. Agency Access
The Constitution imposes limitations on federal agency access to
monitoring information. 45 2 The Supreme Court has outlined a number of
important issues in this general area in Whalen v. Roe,4 53 a case involving
a New York law that required physicians to provide the state with the
names of persons receiving prescriptions for certain controlled drugs.
The court upheld the statute against privacy claims raised by both pa-
tients and physicians because the law was narrowly drawn to apply only
to a limited class of arguably dangerous drugs and New York had a
legitimate public health interest in controlling the dissemination and use
of those drugs.4 54 In doing so, the Court indicated the broad framework
within which questions of constitutional privacy rights must be decided.
On the one hand, the right to confidentiality clearly can be limited when
such limitation is necessary to meet a legitimate public health purpose:
[D]isclosures of private medical information to doctors, to hospital person-
nel, to insurance companies, and to public health agencies are often an
essential part of modern medical practice even where the disclosure may
reflect unfavorably on the patient. Requiring such disclosures to represen-
tatives of the State having responsibility for the health of the community
does not automatically amount to an impermissible invasion of privacy.45
On the other hand, the Court also indicated the confidential information
disclosed should be confined to that necessary to meet the desired public
health purpose. "The right to collect and use such data for public pur-
poses is typically accompanied by a concomitant statutory or regulatory
duty to avoid unwarranted disclosures." 4 56 As with the protection of
physical privacy, the Constitution demands a careful balancing of the
individual's right to confidentiality and the legitimate interests of society.
452. Any state law of confidentiality would probably be preempted by the federal
statute creating agency access. See, e.g., General Motors Corp. v. Director of Nat'l Inst.
for Occupational Safety and Health, 636 F.2d 163, 165 (6th Cir. 1980).
453. 429 U.S. 589 (1977).
454. Id. at 598-604.
455. Id. at 602 (emphasis added).
456. Id. at 605 (emphasis added).
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Both OSHA and NIOSH have sought to achieve this balance. The
agencies, however, have taken markedly different paths toward this end.
OSHA access to medical records is secured by a regulation4 57 designed
to protect employee confidentiality. In general, records obtained under
this regulation must be secured through a specific, written access order,4 58
must be used only for the purposes indicated on the order, 4 59 and must
be destroyed or returned after OSHA has completed such use.460 A
significant flaw in this regulation is the fact that it applies only to "per-
sonally identifiable employee medical information." 46' By its terms, it is
inapplicable to "exposure records, including biological monitoring rec-
ords."46 2 Instead, OSHA access to exposure records is governed by a
separate regulation that grants OSHA "immediate" entry to such records
without privacy protection provisions.4 63 To the extent that these records
contain constitutionally protected health information, this lack of privacy
protection appears to violate the doctrine enunciated in Whalen v. Roe.
NIOSH, on the other hand, has not promulgated access regulations.
Instead, it has sought access on a case-by-case basis by using its sub-
poena power. In each case, the employer has resisted the subpoena on
the basis of the employees' constitutional rights to privacy. As a result,
decisions of various federal courts have developed limitations on NIOSH
access. 464
In general, the courts have applied the Whalen doctrine and have
conditioned access by NIOSH upon the development of procedures de-
signed to limit the intrusion on individual worker privacy. The Court of
Appeals for the Sixth Circuit, for example, noted that there should be
"no public disclosure of the medical information" beyond the agency
itself.465 Significantly, the court also recognized that the conflict between
confidentiality and public health grows more out of practical than philo-
sophical considerations. It "[did] not believe that the parties' interests
... were mutually exclusive. With proper security administration,
[NIOSH] should be able to complete [its health studies] without jeopar-
dizing the constitutional rights of the individuals involved."4 6 6 This rec-
ognition of practical constraints underscores the need for a creative
approach to medical and exposure information storage and transfer.
457. 29 C.F.R. § 1913.10 (1983).
458. Id. § 1913.10(d).
459. Id. § 1913.10(h)(4).
460. Id. § 1913.10(j).
461. Id. § 1913.10(b)(1) (emphasis added).
462. Id. § 1913.10(b)(3) (emphasis added).
463. Id. § 1910.20(e)(3).
464. See generally Walderman, Investigative Authority of the National Institute for
Occupational Safety and Health, in LEGAL AND ETHICAL DILEMMAS IN OCCUPATIONAL
HEALTH 131 (J. Lee & W. Rom eds. 1982).
465. General Motors Corp. v. Director of Nat'l Inst. for Occupational Safety and
Health, 636 F.2d at 166.
466. Id.
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2. Union Access
Although a union is usually presumed to be acting on behalf of its
members, at times the union's assertion of access to medical or exposure
records will conflict with an employee's interest in keeping those results
confidential. All employees have an interest in ensuring that the union's
right of access is not unchecked, but rather is limited to legitimate
purposes.
Employee interests are protected under federal labor law467 and will
be balanced against the union's interest in securing disclosure. The nature
of this balance is not yet clear. The NLRB has acknowledged the impor-
tance of protecting employee confidentiality, but has not specified the
extent to which such confidentiality will bar disclosure. In two recent
cases before the NLRB, an employer asserted the physician-patient priv-
ilege as a defense to a union's claim of access to medical records.4 6 8 In
both cases, the NLRB ordered the employer to provide access "to the
extent that such data does not include medical records from which iden-
tifying data have not been removed." 469 Although the removal of personal
identifying data may not serve as a solution in all cases of this nature,
the NLRB did indicate in both of these decisions that the union's interest
in securing health and safety information could be satisfied without dis-
closure of personal identifiers. It thus did not foreclose the possibility
that a broader right of access might be appropriate if the union establishes
a legitimate need for such data.
It is not clear, however, whether more exacting employee protection
might be required when the employee, rather than the employer, asserts
the right to confidentiality. The additional protection, if any, available to
dissenting union employees has not yet been delineated. As a matter of
policy, it seems that the rationale for protecting personal privacy is as
compelling in the case of union access as it is in the case of agency
access and that the union's interest in collective bargaining could be
accommodated in a manner that respects the confidentiality of the indi-
vidual employee.
3. Employer Access
Perhaps the most obvious threat to employee confidentiality is that
posed by employer access. Of all parties seeking access to employee
health information, the employer has a direct economic incentive to use
467. See generally O'REILLY, UNIONS' RIGHT TO COMPANY INFORMATION (1980).
468. Minnesota Mining & Mfg., Inc., 261 N.L.R.B. 27; Plough, Inc., 262 N.L.R.B.
1095.
469. Plough, Inc., 262 N.L.R.B. at 1095. In Minnesota Mining, the union asked only
for access to medical records from which all personal identifying data had been removed.
261 N.L.R.B. at 30. In Plough, the union requested access to "the results of all physicals
taken by employees" for a particular time period. 262 N.L.R.B. at 1095. Noting that it did
not agree with the administrative law judge's conclusion that this information would lose
its value if all identifying data were removed, the Board conditioned disclosure on the
removal of such data. Id. at 1096.
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that information in ways detrimental to the employee. On the one hand,
the employer may choose to use human monitoring data to screen "sus-
ceptible" prospective employees from the workplace or to discharge
employees once it becomes clear that an unsafe workplace is proving
hazardous to their health. On the other hand, human monitoring data is
essential for those employers who strive in good faith to eliminate work-
place hazards. The proper balance between confidentiality and disclosure
thus may be difficult to achieve.
By accepting or seeking employment, the employee implicitly con-
sents to certain limitations on his right of confidentiality. To the extent
that health information is relevant to a legitimate employer interest,4 70
disclosure of human monitoring data to the employer is permissible. In
general, employers should have access to information that bears upon
the employee's ability to perform his or her job and to information that
indicates the levels of toxic substance exposure in the workplace. Other
health and personal information is arguably protected either by the phy-
sician-patient relationships4 or by tort concepts of personal privacy, 4 72
and therefore should be unavailable to the employer.
In practice, however, this may not be the case. Testimony taken
before the promulgation of the present OSHA employee access regulation
indicates that many employers routinely gain access to an employee's
complete medical file. According to OSHA, the following statement by
a member of the United Auto Workers is representative of the testimony
received:
I have been in medical ... trying to talk to the company doctor. A member
of [management] would come down and just, you know, hi, doc, and then
go through the records, the medical records, and pull a particular individ-
ual's medical record and without even consulting the doctor first or a nurse
or anybody as far as that goes, just directly [go] to the cabinet and pull an
individual's record .... They will just go directly down and pull the file
themselves. So there is no confidentiality. 47'
It appears that many employees do not presently enjoy the level of
confidentiality that the law presumes.
OSHA has acknowledged that this is a "serious problem"4 7 4 but has
thus far declined to take any specific remedial action. It does not discuss
the issue in the proposed revisions to the employee access rule. As a
470. The "legitimacy" of an employer's interest, of course, will be shaped in part by
federal and state statutes forbidding certain kinds of discrimination.
471. If the company doctor takes in personal information unrelated to employer
needs, he or she is arguably acting on behalf of the employee, not the employer.
472. The employee may have a cause of action against the doctor for invasion of
privacy. See generally Annas, supra note 370.
473. 45 Fed. Reg. 35,243 (1980). The quote is attributed to Mattillion of the United
Auto Workers.
474. Id.
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practical matter, much of the problem might be alleviated if human mon-
itoring and the maintenance of medical and exposure records were under-
taken by a third-party health care provider, such as a health maintenance
organization.4 7 5 Much of the abuse inherent in employer access to em-
ployee health information arises from simple proximity. The employer is
often the keeper of the information to which claims of confidentiality
attach. If this information were held by a'third party, such as a health
maintenance organization, that party would be in a better practical po-
sition to ensure that all those with legitimate rights of access - the
employee, the agency, the union and the employer - exercise those
rights in full compliance with the law.
C. Limitations on Employer Use
Even if an employer obtains human monitoring data through a legit-
imate exercise of his or her right of access, the right to use such data is
not absolute. Employers may not use health information to discriminate
against employees on a basis deemed impermissible by federal or state
law. Beyond discrimination, however, a more essential - and perhaps
more difficult - question arises: to what extent may employers use health
information to limit or terminate the employment status of individual
employees or to deny employment to a prospective employee?
I. Under Common Law
At early common law, an employer had the right to take an employ-
ee's health into account in determining whether to continue to employ
that person. If the employment contract was "open," with no definite
term, the employee could be discharged for any reason, including health
status, at the will of the employer.47 6 If the contract of employment was
for a definite term, the employee could be discharged for "just cause."
Typically, significant illness or disability constituted "just cause. "4 77 Al-
though federal labor law, workers compensation and recent common law
limitations on the doctrine of "employment at will" 478 have profoundly
475. See N. Ashford & S. Owen, Draft Report: Expanded HMOs for Providing
Comprehensive Health and Safety Services to Small- and Medium-Sized Firms (1977)
(manuscript from Center for Policy Alternatives, Massachusetts Institute of Technology).
476. See generally 53 AM. JUR. 2D, Master and Servant §§ 49, 123 (1970).
477. Id. §§ 50, 123.
478. A number of courts have held that an employer may be liable in tort if the
discharge of an employee violates a clear mandate of public policy. See, e.g., Parnar v.
Americana Hotels, Inc., 65 Hawaii 370, 652 P.2d 625 (1982) (tort of retaliatory discharge
recognized when plaintiff discharged as inducement to leave jurisdiction in order to prevent
her from testifying against employer); Palmateer v. International Harvester Co., 85 III. 2d
124, 421 N.E.2d 876 (1981) (tort of retaliatory discharge recognized when employee dis-
charged for informing police of fellow employee's suspected criminal behavior); Lally v.
Copygraphics, 85 N.J. 668, 428 A.2d 1317 (1981) (cause of action upheld for wrongful
discharge of employee who had filed workers' compensation claim). See also 81 AM. JUR.
2D, Workmen's Compensation § 55 (Supp. 1983) (citing recent cases on this topic). But see
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affected the nature of employee-employer relations in this century, courts
continue to recognize an employer's interest in discharging employees
who cannot perform their work safely.479 Thus, if the worker has no
statutory or contractual protection, an employer may retain a general
common law right to discharge the worker whose health status makes
continued employment dangerous or whose health status prevents him
or her from performing his or her job.480
Human monitoring, however, places the issue in a somewhat differ-
ent light. Monitoring is designed to reveal whether an employee has been,
or in the future may be, harmed by the workplace itself. It raises the
question whether the employer may discharge an employee merely be-
cause the employee was, or may be, harmed by a situation created by
the employer. The rights of the employer to discharge the employee might
not be as broad then as in the general case.
Suppose that an employer is complying with an existing OSHA
standard for a particular toxic exposure and monitoring reveals that one
of the firm's employees is likely to suffer serious and irreparable health
damage unless he or she is removed from the workplace. In this situation,
the employer is complying with public policy as enunciated by OSHA
and, absent a mandatory MRP provision, is arguably free to discharge
the employee. If an employer-fails to comply with applicable OSHA
standards, however, or if no standard exists, and the employer permits
workplace exposure levels that violate state and federal requirements to
maintain a safe place of employment,48 ' the employer is violating the
public policy embodied in the OSHAct. To permit him or her to take
advantage of that violation by discharging the employee is to permit a
further violation of public policy. The courts would be loath to allow the
Green v. Amerada-Hess Corp., 612 F.2d 212 (5th Cir.), cert. denied, 449 U.S. 952 (1980)
(no cause of action under Mississippi statutes or common law for retaliatory employment
practices).
479. See, e.g., Cussimanio v. Kansas City S. R.R., 5 Kan. App. 2d 379, 617 P.2d
107 (1980).
480. See Dairy Equip. Co. v. Department of Indus., Labor & Human Relations, 95
Wis. 2d 319, 290 N.W.2d 330 (1980). Pension plans, obviously, may affect the terms of the
discharge.
481. Section 5(a)(i) of the OSHAct imposes a general duty on an employer to "furnish
to each of his employees employment and a place of employment which are free of
recognized hazards that are causing or likely to cause death or serious physical harm to
his employees." 29 U.S.C. § 654(a)(1) (1982). In addition, many states have statutes creating
a similar duty, and there is a generally recognized common law duty as well. See, e.g.,
Shimp v. New Jersey Bell Tel. Co., 145 N.J. Super. 156, 368 A.2d 408 (1976).
The courts have placed OSHA in a peculiar position. OSHA may not issue a citation
for a violation of the general duty clause cited above if an applicable OSHA standard
exists, governing the route of exposure for a particular substance. National Realty & Constr.
Co. v. OSHRC, 489 F.2d 1257 (D.C. Cir. 1973). Thus, if an existing standard is acknowl-
edged to be imperfect in its protection of all workers because of feasibility limitations, the
employer need not protect all workers. If no standard exists, however, the employer is
obligated to protect all workers from recognized serious hazards under his general duty
obligation.
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employer who wrongfully breaks the arm of an employee subsequently
to fire that employee because of a resultant inability to do heavy lifting.
Although the analogy is not perfect, one who subjects employees to toxic
substances commits substantially the same act.48 2 An employer's use of
human monitoring data for this purpose may well be impermissible as a
matter of public policy and employers may be obliged at common law to
find safe assignments for the workers at comparable pay or bear the cost
of their removal as part of doing business.4 8 3
2. Under the OSHAct General Duty Clause
The use of monitoring data to limit or deny employment opportuni-
ties raises other issues under the general duty clause of the OSHAct.44
When monitoring information reveals that an employee risks serious
health damage from continued exposure to a workplace toxin, it may
also indicate that the employer is in violation of the general duty clause.
When a workplace exposure constitutes a "recognized hazard" likely to
cause death or serious physical harm, an employer violates the general
duty clause if he or she does not take appropriate steps to eliminate the
hazard.4 8 5 In the case of toxic substances, this would appear to require
reduction of the exposure itself, not mere removal of presumptively
sensitive employees from the site of exposure.4 8 6
The issue is amenable to regulatory solution. The implementation of
mandatory MRP for toxic substances exposure in general, as OSHA has
482. A key to judicial treatment of this issue at common law may be the extent to
which the employee can be otherwise compensated for his loss of employment. A federal
district court in Georgia took this approach some years ago in Jones v. Central of Georgia
Ry. Co., 220 F. Supp. 909 (N.D. Ga. 1963). Although that case did not involve exposure
to toxic substances, it did involve a worker who was discharged as the result of a job-
related injury. After receiving a permanent disability award through the workers' compen-
sation system, the worker brought suit to regain his former job. The court reasoned that
he had been compensated for lost future earnings through the award of disability and was
thus not entitled to receive those earnings a second time through subsequent employment.
Accordingly, it dismissed his suit. The applicability of the Jones rationale to the use of
human monitoring data is unclear. If a worker has been incapacitated by toxic substance
exposure and a right of compensation clearly exists, this doctrine may apply. But in cases
in which the worker is discharged merely because he or she displays an increased suscep-
tibility to disease from toxic substance exposure, either because of past exposure levels or
because of a perceived genetic or biological predisposition, there is likely to be no com-
pensation for lost future earnings.
483. If the courts apply the rationale of the "retaliatory discharge" cases, supra note
478, it is not clear that reinstatement or job reassignment would be available remedies. The
employer would still bear the cost of removal, however, in the form of damages to the
discharged employee.
484. 29 U.S.C. § 654(a)(1) (1982).
485. Id.
486. Under the OSHAct, the primary burden of ensuring workplace health and safety
rests with the employer. As noted in a Senate Committee report to Congress on the general
duty clause, "[e]mployers have primary control of the work environment and should insure
that it is safe and healthful." S. REP. No. 1282, 91st Cong., 2d Sess. 9, reprinted in 1970
U.S. CODE CONG. AND AD. NEWS 5177, 5186 (emphasis added).
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done with its lead standard,4 87 might be accomplished by a generic MRP
standard. 48 8 An employer's compliance with a mandatory MRP provision
for a particular exposure would remove the threat of a general duty
clause citation.
3. Under Anti-Discrimination Laws
In addition to potential liability under the common law and the
OSHAct general duty clause, an employer who uses monitoring infor-
mation to limit employment opportunities may also face liability under
anti-discrimination laws. Although not all workplace discrimination is
prohibited,4 8 9 state and federal law forbid certain bases for discrimination.
Many of these may apply to an employer's use of human monitoring
information. A detailed discussion of the relevant discrimination laws is
beyond the scope of this article, but an outline of their potential impact
on human monitoring is set forth below.49
a. Section II(c) of the OSHAct
Section I I(c)(1) of the OSHAct prohibits employers from discharging
or otherwise discriminating against any employee "because of the exer-
cise by such employee on behalf of himself or others of any right afforded
by this chapter."4 9 ' If an employee insists on retaining his or her job in
the face of medical data indicating that continued exposure to a workplace
toxin will likely pose a danger to health, the employee may well be
asserting a "right" afforded by the OSHAct. The Act's general duty
clause imposes on employers a duty to maintain a workplace that is free
of "recognized hazards" likely to cause death or serious physical harm.4 92
Inferentially, then, the Act vests employees with a concomitant right to
insist that their workplace be free of such hazards. In insisting on retain-
ing employment, the employee is asserting his or her right to a workplace
that comports with the requirements of the general duty clause.49 3 Ac-
cordingly, an employer who discharges or otherwise discriminates against
487. See supra note 67.
488. See supra note 22.
489. As used here, the term "discrimination" means nothing more than treating a
particular worker, or class of workers, differently from the majority of workers. This
discussion assumes that the discrimination in question is based on human monitoring data
and not some other reason. It assumes that the excluded workers would be qualified to
perform the work in question if the monitoring data were ignored.
490. For more extensive treatments of this issue, see Rothstein, supra note 9, and
McGarity & Schroeder, supra note 9.
491. 29 U.S.C. § 660(c)(1) (1982).
492. See supra notes 484-485 and accompanying text.
493. Although an employee has no right to prosecute a violation of the general duty
clause because OSHA is the "exclusive prosecutor" of OSHAct violations, Oil, Chemical
& Atomic Workers Union v. Occupational Safety & Health Review Comm'n, 671 F.2d 643,
649 (D.C. Cir.), cert. denied, 456 U.S. 969 (1982), this is mainly a procedural limitation on
the employee's exercise of his right to a workplace free of serious hazards, not an eradi-
cation of the right itself.
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a worker because of perceived susceptibility to a toxic exposure arguably
violates the section I 1(c) prohibition. When an employer asserts that an
employee cannot work without injury to health, the employer admits that
the workplace is unsafe. That admission triggers the remedial provisions
of the OSHAct.49 4
An OSHA regulation, issued under section I l(c) and upheld in an
unanimous Supreme Court decision,49 5 gives individual workers a limited
right to refuse hazardous work when there is a situation likely to cause
'serious injury or death."49 6 The employer may not take discriminatory
action against the employee by discharging the employee or by issuing a
reprimand to be included in the employment file.49 7 According to the
district court to which the issue was remanded for consideration,4 98 with-
holding the employee's pay during the period in which the employee
exercises the right is also prohibited.
As a worker may absent him or herself from a hazardous work
assignment under certain conditions without loss of pay or job security,
it seems anomalous to allow an employer to discharge or remove the
employee without pay because of the same hazardous condition. This
would make the employee's status depend on whether he or she asserted
a right to refuse hazardous work before the employer took action to
discharge him or her from employment.
b. Handicap Discrimination
Employees may be able to assert further rights against discriminatory
use of human monitoring data under laws protecting the handicapped.
Congress 49 9 and most states 500 have passed laws barring discrimination
against handicapped individuals in certain employment situations. The
laws, which vary widely among the jurisdictions, all place potential lim-
itations on the use of human monitoring data. Although the courts have
494. Section 11(c) provides a procedure for redress against the employer. 29 U.S.C.
§ 660(c)(2)(3) (1982). The aggrieved worker must file a complaint with OSHA within 30
days, and OSHA must then conduct an investigation. If OSHA "determines that the
provisions of [section 1 I(c)] have been violated," it must then institute legal action to obtain
"all appropriate relief." Id. Although the extent to which the worker may be able to compel
OSHA to take action under this section is not yet clear, at least one c -:rt has held that
OSHA is liable in tort for negligently representing a worker's interest under section 11(c).
Chadsay v. United States, 11 O.S.H. REP. (BNA) [Cases] 1198 (D. Ore. 1983).
495. Whirlpool Corp. v. Marshall, 445 U.S. 1, 21 (1980).
496. 29 C.F.R. § 1977.12(b)(2) (1983). See also Ashford & Katz, supra note 440.
497. Whirlpool Corp. v. Marshall, 445 U.S. at 21.
498. Marshall v. Whirlpool Corp., 9 O.S.H. Cas. (BNA) 1038 (N.D. Ohio 1980).
499. 29 U.S.C. §§ 701-794 (1982). For a general discussion of the federal act, see
Comment, Potluck Protection for Handicapped Discriminatees: The Need to Amend Title
VII to Prohibit Discrimination on the Basis of Disability, 8 LoY. U. CHm. L.J. 814 (1977).
500. As of 1983, 41 states and the District of Columbia reportedly had laws prohibiting
employer discrimination against the handicapped. For a listing of the state statutes, see
Rothstein, supra note 9. at 1436-37.
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adopted a case-by-case approach, 5°1 the worker who is denied employ-
ment opportunities on the basis of monitoring results often falls within
the literal terms of many handicap discrimination statutes. In general,
two issues will be determinative: whether the workplace in question is
covered by a state or federal handicap act and, if so, whether the worker
in question is "handicapped" under that act.
The Federal Rehabilitation Act of 1973502 provides handicapped per-
sons with two potential avenues of protection against job discrimination.
Section 503 prohibits private employers with federal contracts of $2500
or more from discriminating against a present or prospective employee
on the basis of handicap.50 3 Courts have generally held, however, that
section 503 does not create a private right of action on the part of the
aggrieved individual. 504 A private right of action is available under a
companion provision, section 504,505 but many courts have held that this
section applies only to employers who have received federal funds for
the specific purpose of creating employment.506 Consequently, the scope
of the federal act is far from all-inclusive and at least half of the nation's
employers probably lie beyond its purview. 5 07
The various state acts offer a potential for more extensive coverage.
Most extend beyond public contractors and apply to most of the major
employers within the state.508 The state acts may have the most telling
impact on human monitoring.
A worker excluded from a workplace or job assignment because of
the results of human monitoring has been removed because he or she is
ostensibly at higher risk of injury or illness than the majority of workers.
The worker is perceived as having a physical condition that sets him or
her apart from others. Although this is clearly discrimination on the basis
of physical status, an applicable handicap discrimination statute will not
prohibit the action unless it meets the relevant definitional criteria. The
stated criteria do not differ widely among most jurisdictions,509 but judi-
cial interpretations of these criteria have varied substantially. Some state
501. See, e.g., E.E. Black, Ltd. v. Marshall, 497 F. Supp. 1088, 1100 (D. Hawaii
1980).
502. 29 U.S.C. §§ 701-796 (1982).
503. Id. § 793(a).
504. See, e.g., Davis v. United Air Lines, 662 F.2d 120 (2d Cir. 1981), cert. denied,
102 S. Ct. 2045 (1982); Rogers v. Frito-Lay, Inc., 611 F.2d 1074 (5th Cir. 1980), cert. denied,
449 U.S. 889 (1980). But see Clarke v. Felec Serv., Inc., 489 F. Supp. 165 (D. Alaska 1980).
505. 29 U.S.C. § 794 (1982); see, e.g., Pushkin v. Regents of Univ. of Colo., 658 F.2d
1372, 1380 (10th Cir. 1981).
506. See, e.g., Trageser v. Libbie Rehabilitation Center, Inc., 590 F.2d 87 (4th Cir.
1978), cert. denied, 442 U.S. 947 (1979). But see Jones v. Metropolitan Atlanta Rapid
Transit Auth., 681 F.2d 1376 (11th Cir. 1982), petition for cert. filed, 51 U.S.L.W. 3535
(U.S. Jan. 11, 1983).
507. Rothstein estimates that "[t]hree million firms - about half the businesses in
the country - may be covered by the Act." Rothstein, supra note 9, at 1439.
508. According to Rothstein, state handicap discrimination laws "usually only exempt
small employers." Id. at 1437 n.392.
509. Most of the state laws are modeled after the federal law. Some, however, are
more restrictive. See. e.g.. HAWAII REV. STAT. § 378-1(7) (1976).
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courts have interpreted handicap discrimination laws broadly, taking po-
sitions that appear to limit significantly the use of monitoring data for
employee exclusion.5 '0 Others have taken much more restrictive posi-
tions.5" At least one federal court has adopted a middle-ground
approach." 2
At present, the general applicability of,handicap discrimination stat-
utes to the use of human monitoring information remains unclear. Ex-
amining the definitional criteria in the federal act, on which many of the
state statutes are based, will illustrate the issues facing courts - and the
potential range of logical interpretations. The Rehabilitation Act of 1973
defines a "handicapped" individual as "any person who (i) has a physical
or mental impairment which substantially limits one or more of such
person's major life activities, (ii) has a record of such an impairment, or
(iii) is regarded as having such an impairment." 5 '3
In the great majority of cases, the persons facing reduced employ-
ment opportunity as a result of human monitoring data do not presently
have a substantially debilitating medical condition and thus do not satisfy
either the first or second clauses of the federal definition. Rather, they
are perceived as having an increased risk of developing such a condition
in the future. Are they, then, "regarded" as having a substantial impair-
ment under the third clause? A narrow reading of the statute might lead
to a negative conclusion. In a literal sense, such persons are regarded
only as being at risk of an impairment, and cannot be said to be regarded
as having the impairment itself.514 They are arguably being treated, how-
ever, as if they had a substantial impairment by being denied employment
opportunities normally extended to those without such a disability. In
this sense, they are regarded as substantially impaired. This latter inter-
pretation finds support in the Senate Committee Report presented before
510. See, e.g., Dairy Equip. Co. v. Department of Indus., Labor and Human Rela-
tions, 95 Wis. 2d 319, 290 N.W.2d 330 (1980); Chicago, Milwaukee, & St. Paul R.R. v.
Washington State Human Rights Comm'n., 87 Wash. 2d 802, 557 P.2d 307 (1976).
511. See, e.g., Advocates for the Handicapped v. Sears, Roebuck &. Co., 67 I11. App.
3d 512, 385 N.E.2d 39 (1978), cert. denied, 444 U.S. 981 (1979); Burgess v. Joseph Schlitz
Brewing Co., 298 N.C. 520, 259 S.E.2d 248 (1979).
512. See infra text accompanying notes 517-521.
513. 29 U.S.C. § 706(7)B). The Department of Labor has promulgated a set of
implementing regulations that contain further interpretive definitions at 41 C.F.R. § 60-
741.2 (1983). To prove discrimination under the Act, the handicapped individual must prove
that he or she was "qualified" for the job. See SENATE COMM. ON LABOR AND PUBLIC
WELFARE, REHABILITATION ACT AMENDMENTS OF 1974, S. REP. No. 1297, 93d Cong.,
2d Sess. 5, 24, reprinted in 1974 U.S. CODE CONG. & AD. NEWS 6373, 6390. The Supreme
Court has held that the handicapped person must be so qualified even though he or she is
handicapped; it is not sufficient that he or she would be qualified if there were no handicap.
Southeastern Community College v. Davis, 442 U.S. 397 (1979).
514. Rothstein, in fact, cautions that "because a handicapped individual must have
an impairment that substantially limits one or more major life activities, the Rehabilitation
Act may not prohibit the most arbitrary, illogical, and baseless form of discrimination -
that based on an individual's slight medical or genetic imperfection." Rothstein, supra note
9, at 1451.
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the insertion of this language into the Act.515 The Senate Report explained
that the third clause of the definition applies both to "persons who do
not in fact have the condition which they are perceived as having" and
to "persons whose mental or physical condition does not substantially
limit their life activities."5 '6 This second provision appears broad enough
to cover persons excluded on the basis of monitoring information.
The one federal district court that directly examined the issue has
affirmed the applicability of the 1973 Rehabilitation Act to pre-employ-
ment screening of perceived high-risk individuals. In E.E. Black, Ltd. .
Marshall,5 7 the federal district court for Hawaii held that a twenty-nine-
year-old who had been denied employment as a carpenter's apprentice
as a result of positive findings in lower back x-rays was protected by
section 503. The court rejected the suggestion that employers may avoid
the Act's proscriptions merely by establishing that they have discrimi-
nated against a worker on the basis of an insubstantial physical disability.
In this regard, the opinion noted that the purpose of the Act is not to
permit an employer to "be rewarded if his reason for rejecting the appli-
cant were ridiculous enough."5T
Nonetheless, the court in E.E. Black also emphasized that not all
high risk individuals would be treated as "handicapped" under the Act.
Addressing the requirement that the actual or perceived disability must
"substantially limit" a major life activity, the court read into the Act a
requirement that the actual or perceived impairment be "a substantial
handicap to employment."5'9 In determining whether a particular condi-
tion meets this criterion, the court indicated that one must first assume
that all similar employers within the relevant geographic area use the
disputed pre-employment screen (or other discriminatory practice) and
then weigh that against the physical and mental capabilities of the partic-
ular applicant. If the resultant employment limitations appear "substan-
tial," the person will be deemed "handicapped." 520
Although perhaps not wholly consistent with the literal terms of the
Act, this construction of the statute appears to be an attempt to fashion
a viable framework for evaluating the treatment of perceived high-risk
individuals within the context of "handicap" discrimination. The Act
seems designed primarily to protect the seriously handicapped,5 ' but its
language is broad enough to cover discriminatory practices based on data
515. The definition of "handicap" was revised in 1974. See supra note 513.
516. SENATE COMM. ON LABOR AND PUBLIC WELFARE, REHABILITATION ACT
AMENDMENTS OF 1974, S. REP. No. 1297, 93d Cong., 2d Sess. 39, reprinted in 1974 U.S.
CODE CONG. & AD. NEWS 6373, 6389-90.
517. 497 F. Supp. 1088, 1100 (D. Hawaii 1980). For further proceedings, see E.E.
Black, Ltd. v. Donovan, 26 Fair Empl. Prac. Cas. (BNA) 1183 (D. Hawaii 1981).
518. 497 F. Supp. at 1100.
519. Id. (emphasis added).
520. Id. at 1100-02.
521. See, e.g.. S. REP. No. 318, 93d Cong., Ist Sess. 18-19, reprinted in 1973 U.S.
CODE CONG. & AD. NEWS 2076, 2092.
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obtained through human monitoring. The middle-ground adopted in E.E.
Black imposes a reasonable limitation on an employer's use of monitoring
data.
Even in cases in which handicap discrimination is established, an
employer may escape liability if the discriminatory practice is reasonably
necessary for efficient operation of the business. The Rehabilitation Act
provides employers with no affirmative defense, but does require the
handicapped individual to prove that he br she is "qualified" for the
job.5 22 Thus, if a handicap prevents a worker from safely or effectively
performing the job, an exclusionary practice may be permissible under
the Act.5 23 Most state handicap statutes include some form of affirmative
defense.5 2 Although these vary among jurisdictions, many appear anal-
ogous to the familiar defenses that have developed under Title VII of the
Civil Rights Act.525
c. Civil Rights and Age Discrimination
Employers who exclude workers on the basis of monitoring infor-
mation may also run afoul of the more general laws against discrimina-
tion. Title VII 526 prohibits employment discrimination on the basis of
race, color, religion, sex or national origin. The scope of the Civil Rights
Act is substantially broader than that of the federal handicap discrimi-
nation act, and it affords protection for the great majority of the nation's
employees. In addition, many states extend similar protection to em-
ployees not covered by the federal act.5 2 7 The Age Discrimination in
522. See supra note 513. Although this appears to place the burden on the worker to
prove that the worker could properly perform the job if given the opportunity - rather
than requiring the employer to prove that the worker could not do so - it also appears to
remove from consideration the various economic arguments that may be available to
employers asserting a "business necessity" defense under Title VII or the Age Discrimi-
nation in Employment Act. See infra text accompanying notes 539-545. Indeed, the court
in E.E. Black declined to consider employer cost in determining whether or not the applicant
was "qualified." Nonetheless, many of the factors relevant to a consideration of the "busi-
ness necessity" defense may still be relevant here.
523. See, e.g., Strathie v. Dep't of Transp., 547 F. Supp. 1367 (E.D. Pa. 1982).
524. McGarity and Schroeder note that "almost all state handicap laws contain some
reference to employer defense." McGarity & Schroeder, supra note 9, at 1035.
525. See id. for a short discussion of the types of defenses available. Although the
wording of each statute's defense should be examined with care, three general classes of
defense may be identified: (I) those that require the employer to establish a "bona fide
occupational qualification," see infra note 542; (2) those that require the employer to
establish "business necessity" (indeed, Rothstein assumes that a "business necessity"
defense is available under the federal act, Rothstein, supra note 9, at 1445); and (3) those
that require the employer to prove that the handicapped individual cannot perform the job
(similar to the federal act, but a shifting of the burden, see, e.g., N.J. REV. STAT. § 10:5-
4.1 (1978)).
For a discussion of the applicability of the "business necessity" test to discrimination
based on human monitoring, see infra text accompanying notes 542-549.
526. 42 U.S.C. § 2000e (1976 & Supp. 11 1978).
527. See. e.g.. MASS. GEN. LAws ANN. ch. 151b (West 1979).
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Employment Act 528 and some state acts 529 provide protection of compar-
able breadth against discrimination on the basis of age.
As with handicap discrimination, the applicability of these laws to
the use of human monitoring information is not yet clear. In the ordinary
case, exclusionary practices based on monitoring data will not be per se
discriminatory on the basis of race, sex, national origin or age. 530 Nor
are they likely to involve disparate treatment of one of these protected
classes. They will not be part of a policy that, while neutral on its face,
masks a specific employer intent to discriminate on one or more of these
impermissible bases.53 ' The practical impact of an exclusionary practice,
however, may fall disproportionately on a particular race, sex, ethnic or
age group.
The Supreme Court has long held that a claim of disparate impact
states a viable cause of action under the Civil Rights Act.532 A similar
rationale has been applied in the area of age discrimination.53 In a 1975
decision,534 the Court held that job applicants denied employment on the
basis of a pre-employment screen establish a prima facie case of racial
discrimination when they demonstrate that "the tests in question select
applicants for hire or promotion in a racial pattern significantly different
from that of the pool of applicants."5 35 Proof of disparate impact thus
requires statistical analysis demonstrating a "significantly" disproportion-
ate effect on a protected class. The cases provide no clear guidance,
however, as to the level of disproportion that is required before an effect
is deemed "significant."5 36
The potential for disparate impact inheres in many uses of human
monitoring data. A genetic screen for sickle-cell anemia, for example,
528. 29 U.S.C. §§ 621-678 (1982).
529. See, e.g., MASS. GEN. LAWS ANN. ch. 149, § 24A (West 1979).
530. The policies will not be discriminatory on theirface. For example, they will not
by their express terms exclude blacks, but may exclude persons who have the sickle-cell
trait. See infra notes 537-538 and accompanying text. An employer would be engaging in
per se discrimination if it required genetic screening for male but not for female employees.
Such discrimination, however, would be based on sex, rather than on human monitoring
data.
531. For example, an employer might have a neutrally worded policy requiring genetic
screening for all workers, but might use only men. Here again, the discrimination would
be on the basis of sex.
532. The court recognized disparate impact in Griggs v. Duke Power Co., 401 U.S.
424 (1971).
533. See generally Note, The Cost of Growing Old: Business Necessity and the Age
Discrimination in Employment Act, 88 YALE L.J. 565 (1979).
534. Albermarle Paper Co. v. Moody, 422 U.S. 405 (1975).
535. Id. at 425.
536. "Significantly" refers to more than mere statistical significance. Guidelines es-
tablished by the Equal Employment Opportunity Commission suggest that a difference of
more than 20% (that is, where the selection rate for the racial, sexual or ethnic class in
question is less than 80% of the rate for the group with the highest selection rate) should
be sufficient. 29 C.F.R. § 1607.4 (1983).
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will disproportionally exclude blacks537 and certain ethnic groups 3 be-
cause they have a much higher incidence of this trait than does the general
population. Similarly, tests that consistently yield a higher percentage of
positive results in one gender than the other may give rise to exclusionary
practices that discriminate on the basis of sex. 539 Finally, a wide variety
of exclusionary practices based on monitoring data may have a disparate
impact on older workers. Older workers have been in the workforce
longer and usually have been exposed to hazardous work environments
much more often than their younger colleagues. Their prior exposure
may have impaired their health or left them more vulnerable to current
workplace hazards. They may, for example, have a pre-existing illness
as a result of previous workplace exposures.5 '4 Their age alone may
account for a certain degree of body deterioration.5 4'
When the plaintiff establishes a primafacie case of disparate impact,
the employer will have an opportunity to justify the alleged exclusionary
practice by showing that its use constitutes a "business necessity."5 4 If
such a showing is made, the practice will withstand a charge of disparate
impact discrimination. 5 4 3 The Supreme Court has characterized the busi-
ness necessity defense as requiring "a manifest relation to the employ-
ment in question."544 In the words of an often cited opinion, this means
that the practice must be "necessary to the safe and efficient operation
of the business." 54 5 Further, if the plaintiff can establish that another,
537. See, e.g., OTA REPORT, supra note 2, at 91; E. CALABRESE, supra note 267, at
153.
538. OTA REPORT, supra note 2, at 91. The sickle cell trait is reported to be more
prevalent in equatorial Africa, parts of India, the Middle East, and the countries along the
Mediterranean.
539. The permissibility of "fetus protection policies," which exclude fertile women
from the workplace to avoid exposure to reproductive hazards, is beyond the scope of this
article, as it does not involve discrimination on the basis of monitoring data. For a brief
discussion of that issue, see Ashford & Caldart, The Control of Reproductive Hazards in
the Workplace: A Prescription for Prevention, 5 INDUS. REL. L.J. 523, 533-35, 541-47
(1983).
540. See supra text accompanying notes 317-318.
541. See supra text accompanying notes 276-282.
542. The "business necessity" defense is available only in cases of disparate impact.
If a practice is discriminatory on its face or involves disparate treatment, the employer
may avoid liability only by demonstrating that the basis of the discrimination constitutes a
"bona fide occupational qualification" (BFOQ). This defense is available under the Civil
Rights Act for discrimination based on sex, national origin or religion (but not for discrim-
ination based on race or color), 42 U.S.C. § 2000e-2(e) (1976), and under the Age Discrim-
ination in Employment Act, 29 U.S.C. § 623(f)(1) (1982). The BFOQ defense requires the
employer to establish that the discriminatory practice is "reasonably necessary to the
normal operation of... business." 42 U.S.C. § 2000e-2(e) (1976). The Supreme Court has
characterized the defense as an "extremely narrow" one. Dothard v. Rawlinson, 433 U.S.
321, 334 (1977).
543. See Griggs v. Duke Power Co., 401 U.S. at 431 (as to Title VII); supra note 528
(as to the Age Discrimination in Employment Act).
544. Griggs v. Duke Power Co., 401 U.S. at 431.
545. Robinson v. Lorillard Corp., 444 F.2d 791, 798 (4th Cir.), cert. denied, 404 U.S.
1006 (1971).
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less discriminatory practice will accomplish the same purpose, the busi-
ness necessity defense will not stand.546
There are two principal reasons why a "business necessity" may be
difficult to establish for exclusionary practices based on human monitor-
ing data. The first is that the great majority of these practices are not
designed to protect the health and safety of the public or of other workers.
Instead, their "business purpose" is the protection of the excluded worker
and, not incidentally, the protection of the employer from the anticipated
costs associated with the potential illness of that worker. 5 47 That position
may well encounter a chilly judicial reception. As noted in one recent
analysis, "the courts are usually skeptical of an employer's argument
that it refuses to hire qualified applicants for their own good, and they
often require a higher level of justification in these cases than in cases in
which public safety is at stake." 548
Another, and potentially more serious, obstacle to the successful
assertion of a business necessity defense is the unreliability of the screen-
ing procedures themselves. If the exclusion of susceptible (i.e., high-risk)
individuals truly is a "business necessity," its rationale disappears if the
test used as the basis for such exclusion cannot provide reasonable
assurance that those excluded are actually susceptible (i.e., at high risk).
Indeed, without such assurance, the test becomes little more than an
instrument for arbitrariness and only adds to the discriminatory nature
of the exclusionary practice. As many of the tests are currently far from
reliable,549 the availability of the business necessity defense is
questionable.
The foregoing discussion of discrimination has presupposed that the
"screened" worker will be excluded from the workplace. Employers may,
however, have another option. In many cases, they may be in a position
to provide these workers with other jobs in workplaces that do not
involve exposures to the substances from which they may suffer adverse
health effects. If such alternative positions were supplied, at benefit levels
comparable to those of the positions from which exclusion was sought,
employers might avoid the proscriptions of the various discrimination
laws. Providing an alternative position would certainly remove much of
the incentive for filing a discrimination claim. Further, even if such a
claim was filed, courts might find that an adequate MRP program obviated
the charge of discrimination.55 This could be one area where good law
and good social policy coincide.
546. Albermarle Paper Co. v. Moody, 422 U.S. at 425.
547. These anticipated "costs" might include: an employer's future liability to pay
workers' compensation or, in some cases, a tort judgment; adverse publicity from having
a high incidence of occupational illness at its workplace; decreased productivity associated
with occupational illness; and the expense of training replacement employees.
548. McGarrity & Schroeder, supra note 9, at 1049.
549. See supra text accompanying notes 82-221.
550. In E.E. Black, the court indicated that employees who were offered reasonable
alternative positions would not be considered "substantially" limited - and thus would not
be considered "handicapped" - under the federal handicap law. 497 F. Supp. at 1099.
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VIII. POLICY CONSIDERATIONS
A. Goals of Human Monitoring
As discussed in the Introduction, human monitoring activities have
a number of sometimes conflicting goals: (I) to discover an increased
harm or risk of harm in a population of workers; (2) to encourage the
removal of especially sensitive workers or workers who are in a high-
risk group; (3) to reduce actual harm to workers and subsequent employer
liability; and (4) to relieve the employer of costs that would otherwise be
expended for cleaning up the workplace.
Both workers and employers tend to be risk-averse, i.e., to err on
the side of caution to avoid human and economic costs each might
otherwise have to bear. The worker, however, would prefer to have the
workplace as hazard-free as possible, while the employer would prefer
to minimize legal and financial liability by removing "problems" (workers)
before they arise. The resolution of conflicts between these goals fun-
damentally depends on one's sense of fairness about where the costs of
preventing harm should lie.
B. Recommendations for Proper Use of Human Monitoring
Each type of monitoring has certain advantages and limitations.
Strategies for coordinating the several activities that constitute human
monitoring with environmental monitoring must be designed to optimize
the reduction of risk from workplace hazards. Considering the various
advantages and limitations for each type of monitoring, an optimal com-
bination could include environmental monitoring (ambient and personal),
medical surveillance and, where appropriate, biological monitoring.
Environmental monitoring can, in theory, detect the presence of a
toxic substance prior to significant exposure. Thus, the most preventive
strategy is the early elimination of a potential hazard from the workplace.
If medical surveillance is used as the sole monitoring mechanism, many
physiological effects may not be detected until late in the progression of
a disease. This limitation has significant negative impact for those dis-
eases that are serious, or reversible only in early stages.
Biological monitoring falls between environmental monitoring and
medical surveillance in preventive potential. Biological monitoring hope-
fully occurs before any significant health impact. Genetic monitoring may
detect an early, pre-clinical disease state resulting from exposure. Further
development of this type of monitoring may at some point lead to con-
firmation of exposure and suggest possible health consequences.
The strategies used for human monitoring must be fashioned on a
toxin-specific basis because the state-of-the-art techniques differ from
substance to substance. In general, medical surveillance and biological
monitoring for populations should be used only in combination with
environmental monitoring. In a case in which a specific harmful substance
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cannot be identified, however, and the workplace is suspected of being
unsafe, medical surveillance may indicate whether a problem exists. In
the future, genetic monitoring may also serve as an early indicator that
exposure to certain chemicals has occurred in a worker population.
Genetic screening focuses on removal of the worker before exposure and
is preventive for that worker only.
In sum, human monitoring should be used only if: (I) given the
specific workplace problem, monitoring serves as an appropriate preven-
tive tool; (2) it is used in conjunction with environmental monitoring;
(3) the tests are accurate and reliable and the predictive values are high;
(4) it is not used to divert resources from reducing the presence of toxic
substances in the workplace or from redesigning technology; and
(5) medical removal protection for earnings and job security is provided.
New solutions involving both technological innovation and job rede-
sign may obviate the necessity of human monitoring. Conflicts now arise
only because, under existing technology, workers continue to be exposed
to toxic substances.
C. Conclusion
Discriminatory practices and consequential tort suits, anti-discrimi-
nation suits, deterioration of labor-management relations and agency
sanctions may follow poorly conceived and poorly executed human mon-
itoring programs. The weaker the scientific foundation for the tests, the
less secure are the legal grounds and defenses available to the employer.
In light of the sometimes preliminary, unreliable and nonspecific nature
of the techniques used in human monitoring, the practice is a problematic
activity itself in most instances.
If the courts do extend protection from responsibility for discrimi-
natory practices to employers who remove workers "for their own good,"
then expansion of the worker's right to refuse hazardous work should
follow. It seems likely that the employer will either pay for medical
removal protection or the worker will be inclined to "remove himself,"
with the consequence that he or she will demand pay to exercise fully
the right to refuse hazardous work. The economic burden of removal
will then have to be weighed against the cost of hazard reduction by the
employer. The authors believe that when costs of removal are fully
internalized in the costs of production, human monitoring as a primary
control strategy will not be as economically attractive as early proponents
have argued.
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